0001214659-12-002341.txt : 20120517 0001214659-12-002341.hdr.sgml : 20120517 20120517140144 ACCESSION NUMBER: 0001214659-12-002341 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120517 DATE AS OF CHANGE: 20120517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EMERGING MEDIA HOLDINGS INC CENTRAL INDEX KEY: 0001307140 STANDARD INDUSTRIAL CLASSIFICATION: TELEVISION BROADCASTING STATIONS [4833] IRS NUMBER: 131026995 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-52408 FILM NUMBER: 12851352 BUSINESS ADDRESS: STREET 1: 1809 E. BROADWAY ST. STREET 2: SUITE 175 CITY: OVIEDO STATE: FL ZIP: 32765 BUSINESS PHONE: 407-620-1063 MAIL ADDRESS: STREET 1: 1809 E. BROADWAY ST. STREET 2: SUITE 175 CITY: OVIEDO STATE: FL ZIP: 32765 FORMER COMPANY: FORMER CONFORMED NAME: Beverly Hills Film Studios Inc DATE OF NAME CHANGE: 20041027 10-Q 1 c51412010q.htm FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 c51412010q.htm


 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
(Mark One)

x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended                        March 31, 2012            


o     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                                      to                                                      

Commission File Number:                0-52408          

EMERGING MEDIA HOLDINGS, INC.  

(Exact Name of Registrant as Specified in Its Charter)

 
NEVADA
 
13-1026995
(State of other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
201 SOUTH ORANGE AVE., SUITE 1510, ORLANDO, FLORIDA
 
32810
(Address of principal executive offices)
 
(Zip Code)
 
(407) 514-1260
(Registrant's Telephone Number, Including Area Code)
 
 

(Former name, former address and former fiscal year, if changed since last report)

Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes x  No  o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x    No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a smaller reporting company.  (Check One):

Large accelerated filer  o
Accelerated filer  o
   
Non-accelerated filer    o
Smaller reporting company  x
(Do not check if a smaller reporting company)
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes  o   No  x

As of May 11, 2012, there were 25,205,101 shares of Common Stock, $0.001 par value, issued and outstanding.
 


 
 

 
 
EMERGING MEDIA HOLDINGS, INC.
 
INDEX
 
 
Page
   
Part I.  Financial Information
1
   
Item 1. Financial Statements.
1
   
Consolidated Balance Sheets as of March 31, 2012 (unaudited) and December 31, 2011 (unaudited)
2
   
Consolidated Statements of Operations for the Three months Ended March 31, 2012 and 2011 (unaudited)
3
   
Consolidated Statement of Stockholders’ Deficiency for the Period Ended March 31, 2012 (unaudited)
4
   
Consolidated Statements of Cash Flows for the Three months Ended March 31, 2012 and 2011 (unaudited)
5
   
Notes to Unaudited Consolidated Financial Statements
7
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
16
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
18
   
Item 4.Controls and Procedures.
18
   
Part II. Other Information
18
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
18
   
Item 6.  Exhibits.
19
   
Signatures
19
 
 
 

 
 
PART I — FINANCIAL INFORMATION

ITEM 1.
CONSOLIDATED FINANCIAL STATEMENTS.
 
Certain information and footnote disclosures required under accounting principles generally accepted in the United States of America have been condensed or omitted from the following consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission. The following unaudited consolidated financial statements should be read in conjunction with the year-end restated consolidated financial statements and notes thereto included in the Company's Form 10-K for the year ended December 31, 2011.

The results of operations for the three months ended March 31, 2012 and 2011 are not necessarily indicative of the results for the entire fiscal year or for any other period.   
 
 
 
 
 
 
 
1

 

EMERGING MEDIA HOLDINGS INC. AND SUBSIDIARIES
 
(a Development Stage Company)
 
CONSOLIDATED BALANCE SHEETS
 
(Unaudited)
 
             
ASSETS
 
   
 
 
   
March 31,
   
December 31,
 
   
2012
   
2011
 
CURRENT ASSETS:
           
    Cash and cash equivalents
  $ 1,734     $ 33  
    Loan receivable
    32,000       -  
      33,734       33  
                 
Intangible assets - net
    6,000,000       6,000,000  
Other asets
    6,000       -  
TOTAL ASSETS
  $ 6,039,734     $ 6,000,033  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
       
                 
CURRENT LIABILITIES:
               
  Short-term debt
  $ 338,000     $ 3,000,000  
  Accrued expenses
    35,500       356,200  
                 
       Total Current Liabilities
    373,500       3,356,200  
                 
                 
Commitments and Contingencies
    -       -  
                 
STOCKHOLDERS' EQUITY:
               
      Common stock, $.001 par value, 200,000,000 shares
               
       authorized; 25,205,101 and 6,195,101 shares issued and 25,204,983 and 6,194,983
               
       shares oustanding at March 31, 2012 and December 31, 2011, respectively
    25,205       6,195  
     Additional paid-in-capital
    6,212,672       3,003,342  
     Deficit
    (562,406 )     (356,467 )
     Less: Cost of common stock in treasury, 118 and 118 shares
               
       at March 31, 2012 and December 31, 2011, respectively
    (9,237 )     (9,237 )
        Total Stockholders' Equity
    5,666,234       2,643,833  
                 
      TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
  $ 6,039,734     $ 6,000,033  
 
See notes to unaudited consolidated financial statements.
 
2

 
 
EMERGING MEDIA HOLDINGS INC. AND SUBSIDIARIES
 
(a Development Stage Company)
 
CONSOLIDATED STATEMENTS OF OPERATIONS
 
(Unaudited)
 
 
       
         
 
   
For the Period
 
   
For the Three Months Ended
   
October 8, 2010
 
   
March 31,
   
(Date of Formation)
 
   
2012
   
2011
   
through March 31, 2012
 
Revenues
  $ -     $ -     $ -  
                         
Costs and expenses:
                       
  Selling, general and administrative expenses
    160,939       -       397,406  
      160,939       -       397,406  
                         
Loss from operations
    (160,939 )     -       (397,406 )
                         
Other income (expense):
                       
  Interest expense
    (45,000 )     -       (165,000 )
                         
Loss from operations before
                       
  provision for income taxes
    (205,939 )     -       (562,406 )
                         
Provision for income taxes
    -       -       -  
                         
Net loss
  $ (205,939 )   $ -     $ (562,406 )
                         
                         
Loss per common share
  $ (0.01 )   $ 0.00          
                         
                         
Weighted average common shares outstanding
                       
  - basic and diluted
                       
      17,264,661       5,000,000          
 
See notes to unaudited consolidated financial statements.
 
 
3

 
 
EMERGING MEDIA HOLDINGS INC. AND SUBSIDIARIES
 
(a Development Stage Company)
 
CONSOLIDATED STATEMENT OF EQUITY
 
(Unaudited)
 
 
 
                                     
                                     
         
Common Stock
         
Retained
       
         
Number of
         
Additional Paid
   
Earnings
   
Treasury
 
   
Total
   
Shares
   
Amount
   
In Capital
   
(Deficit)
   
Stock
 
Balance, October 8, 2010 (Date of Formation)
  $ -       5,000,000     $ 5,000     $ (5,000 )   $ -     $ -  
                                                 
                                                 
Balance, December 31, 2010
    -       5,000,000       5,000       (5,000 )     -       -  
                                                 
Effect of reverse acquisition
    -       1,195,101       1,195       8,042       -       (9,237 )
                                                 
Contribution of capital from shareholders
    3,000,300                       3,000,300                  
 
                                               
Net loss for the year ended
                                               
  December 31, 2011
    (356,467 )                             (356,467 )        
                                                 
Balance, January 1, 2012
    2,643,833       6,195,101       6,195       3,003,342       (356,467 )     (9,237 )
                                                 
Issuance of common stock for repayment
                                               
  of note payable and accrued interest
    3,165,000       19,000,000       19,000       3,146,000                  
                                                 
Issuance of common stock for services
    5,500       10,000       10       5,490                  
                                                 
Issuance of warrants
    57,840                       57,840                  
                                                 
Net loss for the three months ended
                                               
  March 31, 2012
    (205,939 )                             (205,939 )        
                                                 
Balance, March 31, 2012
  $ 5,666,234       25,205,101     $ 25,205     $ 6,212,672     $ (562,406 )   $ (9,237 )
 
See notes to unaudited consolidated financial statements.
 
4

 
 
EMERGING MEDIA HOLDINGS INC. AND SUBSIDIARIES
 
(a Development Stage Company)
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(Unaudited)
 
                   
                   
         
 
   
For the Period
 
   
For The Three Months Ended
   
October 8, 2010
 
   
March 31,
   
(Date of Formation)
 
   
2012
   
2011
   
through March 31, 2012
 
Cash flows from operating activities:
                 
Net loss
  $ (205,939 )   $ -     $ (562,406 )
Adjustments to reconcile net loss to net cash
                       
 used in operating activities:
                       
   Non-cash compensation
    63,340       -       63,340  
   Changes in operating assets and liabilities:
                       
   Increase in other assets
    (6,000 )     -       (6,000 )
   Decrease in accrued expenses
    (155,700 )     -       200,500  
                         
   Net Cash Used In Operating Activities
    (304,299 )     -       (304,566 )
                         
Cash flows from investing activities:
                       
   Advances on loans
    (32,000 )     -       (32,000 )
 
                       
   Net Cash Used In Investing Activities
    (32,000 )     -       (32,000 )
                         
Cash flows from financing activities:
                       
   Proceeds from contributions from shareholders
    -       -       3,000,300  
   Proceeds from related parties
    338,000       -       338,000  
   Repayment of debt
    -       -       (3,000,000 )
                         
   Net Cash Provided by Financing Activities
    338,000       -       338,300  
                         
Net increase in cash
    1,701       -       1,734  
                         
Cash and cash equivalents - Beginning of period
    33       -       -  
                         
Cash and cash equivalents - End of period
  $ 1,734     $ -     $ 1,734  
 
See notes to unaudited consolidated financial statements.
 
 
5

 
 
EMERGING MEDIA HOLDINGS INC. AND SUBSIDIARIES
 
(a Development Stage Company)
 
CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
 
(Unaudited)
 
                   
                   
         
 
   
For the Period
 
   
For The Three Months Ended
   
October 8, 2010
 
   
March 31,
   
(Date of Formation)
 
   
2012
   
2011
   
through March 31, 2012
 
                   
Supplemental disclosure cash flow information:
                 
                   
Cash paid for interest
  $ -     $ -     $ -  
                         
Cash paid for income taxes
  $ -     $ -     $ -  
                         
                         
                         
Supplementary information:
                       
Non-cash during the year for:
                       
                         
Issuance of common stock
                  $ 5,000  
                         
Intangible asset in exchange for
                       
  short-term debt
                  $ 6,000,000  
                         
Common stock issued in exchange
                       
  for debt and interest
  $ 3,165,000             $ 3,165,000  
                         
Details of reverse acquisition:
                       
Common stock issued
                  $ 1,195  
                         
Paid-in capital in connection with
                       
  common stock issued
                    8,042  
                         
Treasury stock acquired
                    (9,237 )
                         
Net assets acquired
                  $ -  
 
See notes to unaudited consolidated financial statements.
 
6

 
 
EMERGING MEDIA HOLDINGS INC. AND SUBSIDIARIES
(a "Development Stage Company")
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
AS OF AND FOR THE THREE MONTHS ENDED MARCH 31, 2012 AND THE PERIOD OCTOBER 8, 2010 (Date of Formation) THROUGH MARCH 31, 2012

 
1.
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The consolidated balance sheet as of March 31, 2012 and the consolidated statements of operations, stockholders' equity and cash flows for the periods presented have been prepared by Emerging Media Holdings, Inc. and Subsidiaries (the "Company" or "EMH") and are unaudited.  In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in stockholders' equity and cash flows for all periods presented have been made.  The information for the consolidated balance sheet as of December 31, 2011 was derived from audited financial statements of the Company.

Organization

Emerging Media Holdings, Inc. (the "Company" or "EMH") was incorporated in the State of Nevada.  The Company directs its operations through its subsidiaries.  During 2011, the Company sold its media business in Moldova in exchange for 730,000 of its common shares.  In December 2011, the Company entered into an exchange agreement and purchased LifeStyle Medical Corp. ("LMC").  In connection with the acquisition, the operations of the Company are now the operations of LMC.  LMC operates its business under a License related to patent rights used in connection with the operations of medical clinics that provide medical services related to men's health, with proprietary trade names and logo designs.

The Company is considered a development stage enterprise as defined in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 915, "Development Stage Entities" ("ASC 915").  The Company has limited revenue to date, continues to raise capital and there is no assurance that ultimately the Company will achieve a profitable level of operations.

Acquisition of Lifestyle Medical Corporation

On December 29, 2011, the Company closed an acquisition of 100% of the outstanding shares of Lifestyle Medical Corp., incorporated under the laws of Florida, pursuant to an Exchange Agreement, executed on that date, by and between the Company and Lifestyle Medical Corporation. The consideration paid by the Company for the acquisition of LMC was 5,000,000 shares of the Company's common stock paid to the holders of 100% of the outstanding shares of LMC, valued at $2,500,000, the fair market value at the date of issuance.
 
 
7

 
 
LMC was incorporated under the laws of the state of Florida on November 14, 2011, and on December 27, 2011 (immediately prior to LMC’s acquisition by the Company) acquired 100% of the membership interests in Elite Professional IP Licensing, LLC, a Delaware limited liability company formed on October 8, 2010 (“Elite”), and 100% of the outstanding shares of Regional Professional Alliance, Inc., a Florida corporation incorporated on October 11, 2010 (“RPA”).  LMC, Elite and RPA are entities under common control and all three entities have the same ownership. At the time of its acquisition by LMC, Elite was the assignee, pursuant to an assignment effective May 9, 2011 (the “Assignment”), from Worldwide Medassets, Ltd. SAL (“WMA”) of WMA’s rights as licensee under an October 5, 2010, License Agreement (the “License” or "License Agreement") with Modular Properties Limited, Inc., as Licensor (“MPL”).  The fee that was payable to WMA in connection with the Assignment of the MPL License was $6,000,000, represented by a secured promissory note dated May 7, 2011 the (“WMA Note”) in the principal amount of $6,000,000 issued by Saddleworth Ventures, LLC, a Florida limited liability company ("Saddleworth Ventures") to WMA.  At that time the ownership of Saddleworth Ventures was identical to the ownership of Elite (now a wholly-owned subsidiary of the Company).  Mr. Christopher Smith, the Company's Chief Executive Officer, had a 25.6% equity interest in Elite at the time of the assignment of the license and the same interest in Saddleworth Ventures.  As of the December 27, 2011 acquisition of Elite by LMC, $3,000,000 of the amount owing under the WMA Note had been paid to WMA.
 
For accounting purposes only, the transactions between LMC with Elite and RPA and the transaction between EMH and LMC were treated as a recapitalization of LMC, as of December 29, 2011, with LMC as the acquirer.  The financial statements prior to December 29, 2011, are those of LMC and reflect the assets and liabilities of LMC at historical carrying amounts.  The financial statements show a retroactive restatement of LMC's historical stockholders' equity to reflect the equivalent number of shares issued to LMC.

Acquisition by the Company of the Rights to the License with MPL

As of January 5, 2012,  Saddleworth Ventures, with the consent of WMA, assigned the WMA Note to Saddleworth Consulting, LLC, a Florida limited liability company (“Saddleworth Consulting”), and Saddleworth Consulting assumed all obligations under the WMA Note, $3,000,000 of the principal amount of which was outstanding as of the date of the assignment.

Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and accrued interest on the WMA Note.  In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA were satisfied by Saddleworth Consulting.  
 
 
Going Concern

The consolidated financial statements for the three months ended March 31, 2012 and December 31, 2011 have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.  The Company has a past history of recurring losses from operations and is a development stage company.  The Company will require additional funding to execute its future strategic business plan.  Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue to support its cost structure.  These factors raise substantial doubt about the Company's ability to continue as a going concern.

 
8

 
 
Significant Accounting Policies

The Company’s significant accounting policies are summarized in Note 1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.  There were no significant changes to these accounting policies during the three months ended March 31, 2012 and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.
 
 




2.
FAIR VALUE MEASUREMENTS

The Company utilizes the accounting guidance for fair value measurements and disclosures for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the condensed consolidated financial statements on a recurring basis or on a nonrecurring basis during the reporting period.  The fair value is an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based upon the best use of the asset or liability at the measurement date.  The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability.  The accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.  These tiers are defined as follows:
 
  Level 1  - Observable inputs such as quoted market prices in active markets
     
 
Level 2
- Inputs other than quoted prices in active markets that are either directly or indirectly observable
     
 
Level 3
- Unobservable inputs about which little or no market data exists, therefore requiring an entity to develop its own assumptions
 
As of March 31, 2012, the Company held certain financial assets that are measured at fair value on a recurring basis.  These consisted of cash and cash equivalents, investments in marketable securities and restricted cash.  The fair values of the cash and cash equivalents and restricted cash is determined based on quoted market prices in public markets and is categorized as Level 1.  The investment in marketable securities is determined by the Company based on market prices other than quoted prices in active markets and is categorized as Level 2.  These are also categorized as held-to-maturity securities.  The Company does not have any financial assets measured at fair value on a recurring basis as Level 3 and there were no transfers in or out of Level 1, Level 2 or Level 3 during the three months ended March 31, 2012 and the period October 8, 2010 (Date of Formation) through March 31, 2012.
 
The following table sets forth by level, within the fair value hierarchy, the Company’s financial assets accounted for at fair value on a recurring basis as of March 31, 2012 and December 31, 2011:

 
9

 

 
         
Assets at Fair Value Using
 
         
Quoted Prices in
   
Significant
   
Significant
 
         
Active Markets
   
Other
   
Other
 
         
for Identical
   
Observable
   
Unobservable
 
         
Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
March 31, 2012
                       
Cash and cash equivalents
  $ 1,734     $ 1,734     $ -     $ -  
                                 
December 31, 2011
                               
Cash and cash equivalents
  $ 33     $ 33     $ -     $ -  


The Company has other financial instruments, such as accounts payable and other liabilities which have been excluded from the tables above.  Due to the short-term nature of these instruments, the carrying value of accounts payable and other liabilities approximate their fair values.  The Company did not have any other financial instruments with the scope of the fair value disclosure requirements as of March 31, 2012.
 
Non-financial assets and liabilities, such as goodwill and long-lived assets, are accounted for at fair value on a nonrecurring basis.  These items are tested for impairment on the occurrence of a triggering event or in the case of goodwill, on at least an annual basis.  The Company's annual test on its long-lived assets indicated that the carrying value of its long-lived assets was recoverable and that no impairment existed as of the testing date. 

3.
INTANGIBLES

The MPL License Agreement

The MPL License Agreement, under which the Company's wholly-owned subsidiary, Elite, is the licensee pursuant to the Assignment from WMA, provides for the license of medical services, operational systems, manuals, certain names and logo designs and other intellectual property in connection with the operation of medical clinics that provide services related to men’s health within the territory of the continental United States (the “Licensed Rights”).  The License Agreement provides for a fee of 6% of gross receipts of Licensee, payable quarterly.  The term of the License Agreement is for twenty (20) years from the effective date, May 9, 2011. The Company plans to establish new medical clinics or acquire existing clinics, as well as to provide consulting services to medical clinics utilizing the Licensed Rights.

Intangibles are the value of the MPL license.  Amounts assigned to this intangible were determined by management.  Management considered a number of factors in determining the allocations, including valuations and independent appraisals.  The intangibles are being amortized over 20 years, the life of the license.  Amortization expense will commence upon the use of the license during 2012.

The components of intangible assets are as follows:

 
10

 

   
March 31, 2012
   
December 31, 2011
 
   
Gross Carrying
   
Accumulated
   
Gross Carrying
   
Accumulated
 
   
Amount
   
Amortization
   
Amount
   
Amortization
 
                         
License agreements
  $ 6,000,000     $ -     $ 6,000,000     $ -  

Estimated amortization expense for intangible assets for the next five years is as follows:


Year Ending
 
Amortization
December 31,
 
Expense
2012
 
 $   150,000
2013
 
      300,000
2014
 
      300,000
2015
 
      300,000
2016
 
      300,000
 
4.
LOAN RECEIVABLE

On February 3, 2012, LMC loaned $32,000 to Health Clinics of Florida, LLC.  The unsecured note is interest free and due May 15, 2012.  In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.  The manager of Health Clinics of Florida, LLC is a shareholder of the Company.

5.
DEBT
 
Short-term debt as of March 31, 2012 and December 31, 2011 were as follows:

 
11

 

   
March 31,
   
December 31,
 
   
2012
   
2011
 
Secured promissory
  $ -     $ 3,000,000  
 note to Worlwide Medassets, Ltd. SAL,
               
 interest @ 6% per annum.  The note was
               
 paid in full February 2, 2012 (1)
               
                 
Unsecured promissory note, interest free,
               
 due July 15, 2012 (2)
    200,000       -  
                 
Unsecured promissory note, interest free,
               
 due August 15, 2012 (3)
    75,000       -  
                 
Unsecured promissory note, interest free,
               
 due June 1, 2012 (3)
    60,000       -  
                 
Unsecured promissory note, interest @ 10%
               
 per annum, due July 3, 2012 (4)
    3,000       -  
      338,000       3,000,000  
Less: Current portion
    338,000       3,000,000  
    $ -     $ -  
 
(1) Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and accrued interest on the WMA Note.  In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA, a shareholder of the Company, were satisfied by Saddleworth Consulting.

(2) On January 5, 2012, LMC borrowed $200,000 from the Dellinger Fund, a shareholder of the Company.  The note is interest free and has been extended to July 15, 2012.  In the event of default, the Dellinger Fund has the right to request and will be granted the issuance of two million shares of the Company's common stock.

(3) On February 3, 2012 and March 1, 2012, LMC borrowed $75,000 and $60,000, respectively, from the Dellinger Fund, a shareholder of the Company.  The unsecured notes are interest free and are due August 15, 2012 and June 1, 2012, respectively.  In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.

Interest expense for the three months ended March 31, 2012 and 2011 and the period October 8, 2010 (Date of Formation) through March 31, 2012 amounted to $45,000, $-0- and $165,000, respectively.

 
12

 
 
6.
ACCRUED EXPENSES


   
March 31,
   
December 31,
 
   
2012
   
2011
 
Interest
  $ -     $ 120,000  
Acquisition costs
    -       200,000  
Other
    35,500       36,200  
    $ 35,500     $ 356,200  
 
7. INCOME TAXES
 
The Company adopted the provisions of ASC 740, "Income Taxes", ("ASC 740").  As a result of the implementation of ASC 740, the Company recognized no adjustment in the net liability for unrecognized income tax benefits.  The Company believes there are no potential uncertain tax positions and all tax returns are correct as filed.  Should the Company recognize a liability for uncertain tax positions, the Company will separately recognize the liability for uncertain tax positions on its balance sheet.  Included in any liability for uncertain tax positions, the Company will also setup a liability for interest and penalties.  The Company’s policy is to recognize interest and penalties related to uncertain tax positions as a component of the current provision for income taxes.

There is no U.S. tax provision due to losses from U.S. operations during the three months ended March 31, 2012 and 2011.  Deferred income taxes are provided for the temporary differences between the financial reporting and tax basis of the Company's assets and liabilities. The principal item giving rise to deferred taxes is the net operating loss carryforward in the U.S.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  The Company has set up a valuation allowance for losses for certain carryforwards that it believes may not be realized.

Section 382 of the U.S. Internal Revenue Code imposes an annual limitation on the availability of NOL carryforwards to offset taxable income when an ownership change occurs.  The Company's reverse capitalization meets the definition of an ownership change and some of the NOL's will be limited.

8.
STOCKHOLDERS' EQUITY

Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and $165,000 of accrued interest on the WMA Note.  In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA, a shareholder of the Company, were satisfied by Saddleworth Consulting.

9.
STOCK-BASED COMPENSATION

The Company accounts for stock-based compensation under ASC 718, "Compensation - Stock Compensation" ("ASC 718").  The compensation cost of the portion of the awards is based on the grant date fair value of these awards as calculated for either recognition or pro forma disclosure under ASC 718.

 
13

 
 
For the three months ended March 31, 2012 and 2011, the Company issued 10,000 and -0- shares and recorded compensation expense of $5,500 and $-0-, respectively.

10.
WARRANTS

On February 6, 2012, the Company issued warrants as compensation to a third party to purchase 2,400,000 shares of the Company's common stock for services performed.  The warrants expire February 6, 2017.  The estimated value of the compensatory warrants was determined using the Black Scholes pricing model using the following assumptions:  Expected term of 5 years, a risk free interest rate of 4%, a dividend yield of -0-% and volatility of 64%.  The fair value of the warrant amounted to $57,840 and is included in the Company's consolidated statement of operations for the three months ended March 31, 2012.

The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company's common stock issued to non-employees of the Company.  The warrants were granted in lieu of cash compensation for services performed.
 
         
Weighted Average
 
   
Shares
   
Exercise Price
 
Outstanding, January 2012
    -     $ -  
Granted
    2,400,000       0.20  
Expired/Cancelled
    -       -  
Exercised
    -       -  
Outstanding - period ending March 31, 2012
    2,400,000     $ 0.20  
Exercisable - period ending March 31, 2012
    2,400,000     $ 0.20  


11.
RELATED PARTY TRANSACTIONS

During the year ended December 31, 2011, Elite had activities with Saddleworth Ventures, a related party.  The ownership of Saddleworth Ventures is identical to the ownership of Elite.  Saddleworth Ventures assigned the rights to Elite as licensee under the License Agreement with MPL.  In connection with the purchase of the license , $3 million of the $6 million purchase price was paid by the members of Elite on the amount owing under the WMA note.

 
12. COMMITMENTS AND CONTINGENCIES
 
Consulting Agreements
 
  a)
In January 2012, Lifestyle entered into a consulting agreement with Saddleworth Ventures LLC ("Consultant").  The Consultant will provide services for management consulting, business advisory, shareholder information and public relations.  The term of the agreement is for three years.  Upon execution of the agreement, Lifestyle issued a payment to the Consultant in the amount of $25,000.  Additional cash fees or reimbursement of expenses shall be agreed upon by Lifestyle and the Consultant from time to time during the term of the agreement.
 
 
14

 
 
 
  b) During 2012, Lifestyle entered into various consulting agreements with third parties in connection with business advisory services.  For the three months ended March 31, 2012, consulting services amounted to $40,500.
 
13.
SUBSEQUENT EVENTS
 
 
  a)
In April 2012, Lifestyle borrowed $112,000 from the Dellinger Fund, a shareholder of the Company.  The note bears interest @ 10% per annum and is due July 31, 2012.
  b)
In April 2012, Lifestyle advanced Health Clinics of Florida, LLC an additional $4,500.  The advance is in addition to the previous advance in February 2012.  See Note 4 for further information.
 
 
15

 
 
ITEM 2.       MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and notes thereto and the other financial information included elsewhere in this report.  Certain statements contained in this report, including, without limitation, statements containing the words “believes,” “anticipates,” “expects” and words of similar import, constitute “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Such forward-looking statements involve known and unknown risks and uncertainties.  Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including our ability to create, sustain, manage or forecast our growth; our ability to attract and retain key personnel; changes in our business strategy or development plans; competition; business disruptions; adverse publicity; and international, national and local general economic and market conditions.

Organization

Emerging Media Holdings, Inc was incorporated in the State of Nevada on September 3, 2003. On June 30, 2006, we effectuated a share exchange whereby we acquired all of the outstanding equity interests in our wholly-owned subsidiary, IM “Media Alianta” SRL, the 100% owner of SA “Analiticmedia-Grup”, both Moldovan companies ("AMG"), and on May 2, 2008, the Company acquired the common stock of “TNT-Bravo” channel-ICS “Media Top Prim” SRL, the exclusive operator in Moldova of Russian channel TNT programs owned by Gazprom Media.

As of February 10, 2011, we agreed to the acquisition of Men’s Medical Corporation, which proposed to acquire men’s sexual health clinics, and on February 10, 2011 sold three of our subsidiary companies, IM Media Alianti SRL, Analytic Media Group SA and Alkazar Media Services SRL, to our major shareholder, in exchange for 4,800,000 shares of our common stock and the assumption of liabilities associated with these subsidiaries. Our acquisition of Men’s Medical Corporation was not completed and was subsequently terminated on May 31, 2011 by agreement of both parties.

Recent Developments

On December 29, 2011, we closed an acquisition of 100% of the outstanding shares of Lifestyle Medical Corp. (“Lifestyle Medical”), which manages two men’s sexual health clinics, utilizing technologies and practices licensed to its subsidiary, Elite Professional IP Licensing, LLC (“Elite”), pursuant to an October 5, 2010 License Agreement with Modular Properties Limited, Inc. (the “License Agreement”). The consideration paid by the Company for the acquisition of Lifestyle Medical was 5,000,000 shares of our common stock paid to the holders of a majority of the outstanding shares of LMC, valued at $2,500,000. On February 2, 2012, we completed acquisition of the rights to our licensed men’s medical clinic operating technologies and processes, by acquiring from Worldwide Medassets, Ltd. (SAL) the full assignment of rights to the License Agreement, by the issuance of 19,000,000 shares of our common stock in exchange for the satisfaction of the outstanding $3,000,000 principal balance on the note issued to Worldwide Medassets, Ltd. in connection with the assignment of rights to the License Agreement to Elite.

On December 30, 2011, we completed the sale of our remaining Moldova media subsidiaries in exchange for the assumption of the liabilities of the subsidiaries and 250,000 shares of our common stock.
 
 
16

 
 
Basis of Presentation

Throughout this Form 10-Q, the terms "we," "us," "our," "EMH" and "Company" refer to Emerging Media Holdings, Inc., a Nevada corporation, and, unless the context indicates otherwise, includes our subsidiaries.

Significant Accounting Policies

The Company’s significant accounting policies are summarized in Note 1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.  There were no significant changes to these accounting policies during the three months ended March 31, 2012, and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.

PLAN OF OPERATION

Through our Lifestyle Medical Corp. subsidiary, we intend to open, operate and acquire men’s sexual health clinics. We have no acquisitions contemplated or under discussion at this time.

RESULTS OF OPERATIONS
 
THREE MONTHS ENDED MARCH 31, 2012 COMPARED TO THE THREE MONTHS ENDED MARCH 31, 2011

During the three months ended March 31, 2012, we incurred a net loss of $205,939, due to our having incurred $155,439 in general and administrative expense, primarily consulting and professional fees, and $45,000 in interest expense.


LIQUIDITY AND FINANCIAL RESOURCES

At March 31, 2012, we had a working capital deficiency of approximately $340,000.  At March 31, 2012, we had total assets of approximately $6,039,000, including cash of $1,734. Net cash used in operating activities in the three months ended March 31, 2012 was $304,299, primarily from the net loss of approximately $206,000, offset by net cash from financing activities of $338,000, primarily from proceeds from a related party, in that period.

Our operations have never been profitable, and it is expected that we will continue to incur operating losses in the future. In 2011, we generated revenues of $-0-, incurred operating expenses of $356,467, and had no net income.  There is no assurance that we will operate profitably in the future.

We will have  to  obtain  significant  additional  capital  to  continue with our proposed business. There is no assurance that we will be able to obtain sufficient capital to implement either of our alternative business plans. The accompanying  financial statements have been prepared assuming that the Company will continue as a going concern.  These conditions and uncertainties raise  substantial doubt about the Company's ability to continue as a going  concern.  The financial  statements do not include any  adjustments  that might result from the outcome of this uncertainty.
 
 
17

 

Off Balance Sheet Arrangements
We do not currently have any off balance sheet arrangements falling within the definition of Item 303(a) of Regulation S-K.

Inflation

To date inflation has not had a material impact on our operations.


ITEM 3.       Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

ITEM 4.       Controls and Procedures.

As of March 31, 2012, the end of the period covered by this quarterly report, the Chief Executive and Chief Financial Officer of the Company (the “Certifying Officer”) conducted an evaluation of the Company’s disclosure controls and procedures.  As defined under Sections 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the term “disclosure controls and procedures” means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the Certifying Officer, to allow timely decisions regarding required disclosure. Based on this evaluation, the Certifying Officer has concluded that the Company’s disclosure controls and procedures were effective to ensure that material information is recorded, processed, summarized and reported by management of the Company on a timely basis in order to comply with the Company’s disclosure obligations under the Exchange Act, and the rules and regulations promulgated there under.
 
Further, there were no changes in the Company’s internal control over financial reporting during the first fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
 
PART II

Other Information

Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds.

The following table sets forth the unreported sales of unregistered securities by the Company in the quarterly period ended March 31, 2012.
                                                                                                                                                                                              
      Principal Total Offering Price/
Date Title and Amount(1) Purchaser Underwriter Underwriting Discounts
 
February 6, 2012
Warrants to purchase 2,400,000 shares of common stock.
Financial Consultant
NA
$57,840/NA
February 28, 2012
10,000 shares issued in payment of legal fees.
Attorney
NA
$0.55 per share/NA

(1) The issuances to executives, employees, lenders, consultants and investors are viewed by the Company as exempt from registration under the Securities Act of 1933, as amended (“Securities Act”), alternatively, as transactions either not involving any public offering, or as exempt under the provisions of Regulation D or Rule 701 promulgated by the SEC under the Securities Act.

 
18

 
 
Item 6. Exhibits.
 
31
Certification of Chief Executive Officer and Principal Financial Officer
 
pursuant to Rule 13a-14(a)
32
Certification of Chief Executive Officer and Principal Financial Officer
 
 pursuant to 18 U.S.C. Section 1350

Copies of the following documents are included as exhibits to this report pursuant to Item 601 of Regulation S-K.

SEC Ref.
No.
Title of Document
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Calculation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
XBRL Taxonomy Label Linkbase Document
101.PRE
XBRL Taxonomy Presentation Linkbase Document


The XBRL related information in Exhibits 101 to this Quarterly Report on Form 10-Q shall not be deemed “filed” or a part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, and is not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of those sections.

SIGNATURES

         Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
EMERGING MEDIA HOLDINGS, INC.
 
 
(Registrant)
 
     
     
Date: May 16, 2012
By:
/s/ Christopher Smith
 
       
   
Christopher Smith, Chief Executive Officer
and Principal Financial Officer
 
 
 
19

EX-31 2 ex31.htm EXHIBIT 31 ex31.htm
Exhibit 31
 
CERTIFICATION
 

 
I, Christopher Smith, certify that:
 
1.     I have reviewed this quarterly report on Form 10-Q of Emerging Media Holdings, Inc.;
 
2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.     I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
 
 
(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:       May 16, 2012
 
  /s/ Christopher Smith  
  Iurie Christopher Smith  
  Chief Executive Officer and Principal Financial Officer  
 
 

EX-32 3 ex32.htm EXHIBIT 32 ex32.htm
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C.  SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Emerging Media Holdings, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Christopher Smith, Chief Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C.  section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
  /s/ Christopher Smith   
  Christopher Smith  
   Chief Executive Officer and Principal Financial Officer  
May 16, 2012
 
 
 
 
 
 

EX-101.INS 4 emdh-20120331.xml EXHIBIT 101.INS 0001307140 2012-03-31 0001307140 2011-12-31 0001307140 2012-01-01 2012-03-31 0001307140 2012-05-11 0001307140 2011-01-01 2011-03-31 0001307140 2010-10-09 2012-03-31 0001307140 2010-10-08 0001307140 us-gaap:CommonStockMember 2010-10-08 0001307140 us-gaap:AdditionalPaidInCapitalMember 2010-10-08 0001307140 us-gaap:RetainedEarningsMember 2010-10-08 0001307140 us-gaap:TreasuryStockMember 2010-10-08 0001307140 2010-12-31 0001307140 us-gaap:CommonStockMember 2011-12-31 0001307140 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001307140 us-gaap:RetainedEarningsMember 2011-12-31 0001307140 us-gaap:TreasuryStockMember 2011-12-31 0001307140 us-gaap:CommonStockMember 2012-03-31 0001307140 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0001307140 us-gaap:RetainedEarningsMember 2012-03-31 0001307140 us-gaap:TreasuryStockMember 2012-03-31 0001307140 us-gaap:CommonStockMember 2012-01-01 2012-03-31 0001307140 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-03-31 0001307140 us-gaap:RetainedEarningsMember 2012-01-01 2012-03-31 0001307140 us-gaap:TreasuryStockMember 2012-01-01 2012-03-31 0001307140 2011-03-31 0001307140 2011-01-01 2011-12-31 0001307140 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0001307140 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0001307140 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0001307140 us-gaap:TreasuryStockMember 2011-01-01 2011-12-31 0001307140 us-gaap:CommonStockMember 2010-10-09 2012-03-31 0001307140 us-gaap:AdditionalPaidInCapitalMember 2010-10-09 2012-03-31 0001307140 us-gaap:TreasuryStockMember 2010-10-09 2012-03-31 0001307140 us-gaap:CommonStockMember 2010-12-31 0001307140 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001307140 us-gaap:RetainedEarningsMember 2010-12-31 0001307140 us-gaap:TreasuryStockMember 2010-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares EMERGING MEDIA HOLDINGS INC 0001307140 --12-31 Smaller Reporting Company 10-Q 2012 2012-03-31 Q1 false No No Yes 25205101 1734 33 32000 33734 33 6000000 6000000 0 6039734 6000033 338000 3000000 35500 356200 373500 3356200 25205 6195 6212672 3003342 -562406 -356467 9237 9237 5666234 2643833 6039734 6000033 .001 .001 200000000 200000000 25205101 6195101 6194983 118 118 0 0 0 160939 0 397406 160939 0 397406 -160939 0 -397406 45000 0 165000 -205939 0 -562406 0 0 0 0 -562406 -0.01 0.00 17264661 5000000 5000000 5000 -5000 57840 57840 25205101 25205 6212672 -562406 -9237 63340 0 63340 -6000 0 -6000 -155700 0 200500 -304299 0 -304566 32000 0 32000 -32000 0 -32000 0 3000300 338000 0 338000 0 0 3000000 338000 338300 1701 0 1734 0 0 0 0 0 0 0 0 5000 6000000 3165000 3165000 1195101 1195 0 8042 0 -9237 3000300 3000300 -356467 -356467 19000 3146000 3165000 25204983 0 0 0 0 0 0 0 0 0 19000000 0 0 0 0 0 0 0 6195101 6195 3003342 -356467 -9237 5500 10 5490 0 0 10000 1195 8042 -9237 0 5000 5000000 -5000 0 0 -205939 -205939 6000 0 <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">2.</font></div></td> <td> <div align="justify"><font style="display: inline; font-size: 10pt; ">FAIR VALUE MEASUREMENTS</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The Company utilizes the accounting guidance for fair value measurements and disclosures for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the condensed consolidated financial statements on a recurring basis or on a nonrecurring basis during the reporting period.&#160;&#160;The fair value is an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based upon the best use of the asset or liability at the measurement date.&#160;&#160;The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability.&#160;&#160;The accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.&#160;&#160;These tiers are defined as follows:</font></div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div> <div align="center"> <table width="100%" bgcolor="white" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td width="5%">&#160;</td> <td width="6%"><font style="font-family: 'times new roman'; font-size: 10pt; ">Level 1&#160;</font></td> <td width="89%"><font style="font-family: 'times new roman'; font-size: 10pt; ">- Observable inputs such as quoted market prices in active markets</font></td></tr> <tr> <td width="5%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td width="6%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td width="89%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td width="5%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td width="6%"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Level 2</font></div></td> <td width="89%"> <div align="left"><font style="font-family: 'times new roman'; font-size: 10pt; ">- Inputs other than quoted prices in active markets that are either directly or indirectly observable</font></div></td></tr> <tr> <td width="5%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td width="6%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td width="89%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td width="5%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td width="6%"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Level 3</font></div></td> <td width="89%"> <div align="left"><font style="font-family: 'times new roman'; font-size: 10pt; ">- Unobservable inputs about which little or no market data exists, therefore requiring an entity to develop its own assumptions</font></div></td></tr></table></div> <div>&#160;</div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">As of March 31, 2012, the Company held certain financial assets that are measured at fair value on a recurring basis.&#160;&#160;These consisted of cash and cash equivalents, investments in marketable securities and restricted cash.&#160;&#160;The fair values of the cash and cash equivalents and restricted cash is determined based on quoted market prices in public markets and is categorized as Level 1.&#160;&#160;The investment in marketable securities is determined by the Company based on market prices other than quoted prices in active markets and is categorized as Level 2.&#160;&#160;These are also categorized as held-to-maturity securities.&#160;&#160;The Company does not have any financial assets measured at fair value on a recurring basis as Level 3 and there were no transfers in or out of Level 1, Level 2 or Level 3 during the three months ended March 31, 2012 and the period October 8, 2010 (Date of Formation) through March 31, 2012.</font></div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">&#160;</font></div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="left" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The following table sets forth by level, within the fair value hierarchy, the Company&#8217;s financial assets accounted for at fair value on a recurring basis as of March 31, 2012 and December 31, 2011:</font></div></div> <div style="text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="font-size: 13px; text-indent: 0pt; ">&#160;</div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div></div> <div align="center" style="font-size: 13px; background-color: rgb(255, 255, 255); margin-left: 18pt; "> <table width="90%" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="52%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="10" width="34%" align="left" nowrap="nowrap"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Assets at Fair Value Using</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="52%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Quoted Prices in</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Significant</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Significant</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="52%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Active Markets</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Other</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Other</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="52%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">for Identical</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Observable</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Unobservable</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="52%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Assets</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Inputs</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Inputs</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="52%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Total</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">(Level 1)</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">(Level 2)</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">(Level 3)</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="52%"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">March 31, 2012</font></font></div></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="10%" nowrap="nowrap" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left" style="padding-bottom: 2px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Cash and cash equivalents</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">1,734</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">1,734</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">December 31, 2011</font></font></div></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left" style="padding-bottom: 2px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Cash and cash equivalents</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">33</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">33</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="9%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div> <div style="text-indent: 0pt; ">&#160;</div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The Company has other financial instruments, such as accounts payable and other liabilities which have been excluded from the tables above.&#160;&#160;Due to the short-term nature of these instruments, the carrying value of accounts payable and other liabilities approximate their fair values.&#160;&#160;The Company did not have any other financial instruments with the scope of the fair value disclosure requirements as of March 31, 2012.</font></div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">&#160;</font></div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Non-financial assets and liabilities, such as goodwill and long-lived assets, are accounted for at fair value on a nonrecurring basis.&#160;&#160;These items are tested for impairment on the occurrence of a triggering event or in the case of goodwill, on at least an annual basis.&#160;&#160;The Company's annual test on its long-lived assets indicated that the carrying value of its long-lived assets was recoverable and that no impairment existed as of the testing date.&#160;</font></div></div> <p>&#160;</p> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">3.</font></div></td> <td> <div align="left"><font style="display: inline; font-size: 10pt; ">INTANGIBLES</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div></div> <div align="justify" style="font-size: 13px; background-color: rgb(255, 255, 255); text-indent: 36pt; margin-left: 0pt; margin-right: 0pt; "><font style="font-style: italic; display: inline; font-size: 10pt; "><font style="display: inline; text-decoration: underline; ">The MPL License Agreement</font></font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The MPL License Agreement, under which the Company's wholly-owned subsidiary, Elite, is the licensee pursuant to the Assignment from WMA, provides for the license of medical services, operational systems, manuals, certain names and logo designs and other intellectual property in connection with the operation of medical clinics that provide services related to men&#8217;s health within the territory of the continental United States (the &#8220;Licensed Rights&#8221;).&#160;&#160;The License Agreement provides for a fee of 6% of gross receipts of Licensee, payable quarterly.&#160;&#160;The term of the License Agreement is for twenty (20) years from the effective date, May 9, 2011. The Company plans to establish new medical clinics or acquire existing clinics, as well as to provide consulting services to medical clinics utilizing the Licensed Rights.</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Intangibles are the value of the MPL license.&#160;&#160;Amounts assigned to this intangible were determined by management.&#160;&#160;Management considered a number of factors in determining the allocations, including valuations and independent appraisals.&#160;&#160;The intangibles are being amortized over 20 years, the life of the license.&#160;&#160;Amortization expense will commence upon the use of the license during 2012.</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The components of intangible assets are as follows:</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div id="PGBRK" style="text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div id="FTR"> <div id="GLFTR" align="left" style="width: 1583px; ">&#160;</div></div></div> <div align="center" style="font-size: 13px; background-color: rgb(255, 255, 255); "> <table width="80%" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="40%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="6" width="28%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">March 31, 2012</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="6" width="28%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">December 31, 2011</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="40%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Gross Carrying</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Accumulated</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Gross Carrying</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Accumulated</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="40%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Amount</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Amortization</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Amount</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Amortization</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="40%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left" style="padding-bottom: 4px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">License agreements</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">6,000,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">6,000,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="left" style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Estimated amortization expense for intangible assets for the next five years is as follows:</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="center" style="font-size: 13px; background-color: rgb(255, 255, 255); "> <table width="20%" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="7%"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Year Ending</font></div></td> <td valign="bottom" width="2%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="7%"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Amortization</font></div></td></tr> <tr> <td valign="bottom" width="7%"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">December 31,</font></font></div></td> <td valign="bottom" width="2%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="7%"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Expense</font></font></div></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="7%" align="right"> <div align="right" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2012</font></div></td> <td valign="bottom" width="2%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="7%" style="text-align: right; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;$&#160;&#160;&#160;150,000</font></div></td></tr> <tr bgcolor="white"> <td valign="bottom" width="7%" align="right"> <div align="right" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2013</font></div></td> <td valign="bottom" width="2%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="7%" style="text-align: right; text-indent: 9pt; "> <div style="text-indent: 9pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;&#160;&#160;&#160;&#160;&#160;300,000</font></div></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="7%" align="right"> <div align="right" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2014</font></div></td> <td valign="bottom" width="2%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="7%" style="text-align: right; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;&#160;&#160;&#160;&#160;&#160;300,000</font></div></td></tr> <tr bgcolor="white"> <td valign="bottom" width="7%" align="right"> <div align="right" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2015</font></div></td> <td valign="bottom" width="2%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="7%" style="text-align: right; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;&#160;&#160;&#160;&#160;&#160;300,000</font></div></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="7%" align="right"> <div align="right" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2016</font></div></td> <td valign="bottom" width="2%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="7%" style="text-align: right; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;&#160;&#160;&#160;&#160;&#160;300,000</font></div></td></tr></table></div> <p>&#160;</p> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; background-color: rgb(255, 255, 255); "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">4.</font></div></td> <td> <div align="left"><font style="display: inline; font-size: 10pt; ">LOAN RECEIVABLE</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">On February 3, 2012, LMC loaned $32,000 to Health Clinics of Florida, LLC.&#160;&#160;The unsecured note is interest free and due May 15, 2012.&#160;&#160;In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.&#160;&#160;The manager of Health Clinics of Florida, LLC is a shareholder of the Company.</font></div></div> <p>&#160;</p> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; ">5.</div></td> <td>DEBT</td></tr></table></div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div></div></div></div> <div align="left" style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Short-term debt as of March 31, 2012 and December 31, 2011 were as follows:</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div id="PGBRK" style="text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div id="FTR"> <div id="GLFTR" align="left" style="width: 1583px; ">&#160;</div></div></div> <div align="center" style="font-size: 13px; background-color: rgb(255, 255, 255); "> <table width="80%" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">March 31,</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">December 31,</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; "> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2012</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; "> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2011</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Secured promissory</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">3,000,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;note to Worlwide Medassets, Ltd. SAL,</font></div></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;interest @ 6% per annum.&#160;&#160;The note was</font></div></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;paid in full February 2, 2012 (1)</font></div></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Unsecured promissory note, interest free,</font></div></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;due July 15, 2012 (2)</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">200,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Unsecured promissory note, interest free,</font></div></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;due August 15, 2012 (3)</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">75,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Unsecured promissory note, interest free,</font></div></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;due June 1, 2012 (3)</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">60,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Unsecured promissory note, interest @ 10%</font></div></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left" style="padding-bottom: 2px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;per annum, due July 3, 2012 (4)</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">3,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">338,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">3,000,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left" style="padding-bottom: 2px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Less: Current portion</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">338,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">3,000,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="70%" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">(1) Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and accrued interest on the WMA Note.&#160;&#160;In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA, a shareholder of the Company, were satisfied by Saddleworth Consulting.</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">(2) On January 5, 2012, LMC borrowed $200,000 from the Dellinger Fund, a shareholder of the Company.&#160;&#160;The note is interest free and has been extended to July 15, 2012.&#160;&#160;In the event of default, the Dellinger Fund has the right to request and will be granted the issuance of two million shares of the Company's common stock.</font></div> <div style="text-indent: 0pt; ">&#160;</div> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">(3) On February 3, 2012 and March 1, 2012, LMC borrowed $75,000 and $60,000, respectively, from the Dellinger Fund, a shareholder of the Company.&#160;&#160;The unsecured notes are interest free and are due August 15, 2012 and June 1, 2012, respectively.&#160;&#160;In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.</font></div> <div style="text-indent: 0pt; ">&#160;</div></div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Interest expense for the three months ended March 31, 2012 and 2011 and the period October 8, 2010 (Date of Formation) through March 31, 2012 amounted to $45,000, $-0- and $165,000, respectively.</font></div> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; background-color: rgb(255, 255, 255); "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">6.</font></div></td> <td> <div align="left"><font style="display: inline; font-size: 10pt; ">ACCRUED EXPENSES</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="center" style="font-size: 13px; background-color: rgb(255, 255, 255); "> <table width="60%" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="64%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="16%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">March 31,</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="16%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">December 31,</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="64%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="16%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">2012</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="16%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">2011</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="64%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Interest</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="15%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="15%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">120,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="64%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Acquisition costs</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="15%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="15%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">200,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left" style="padding-bottom: 2px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Other</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="15%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">35,500</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="15%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">36,200</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="64%" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="15%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">35,500</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="15%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">356,200</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr></table></div> <p>&#160;</p> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); "> <div> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; ">7.</td> <td>INCOME TAXES</td></tr></table></div> <div style="text-indent: 0pt; ">&#160;</div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The Company adopted the provisions of ASC 740, "Income Taxes", ("ASC 740").&#160;&#160;As a result of the implementation of ASC 740, the Company recognized no adjustment in the net liability for unrecognized income tax benefits.&#160;&#160;The Company believes there are no potential uncertain tax positions and all tax returns are correct as filed.&#160;&#160;Should the Company recognize a liability for uncertain tax positions, the Company will separately recognize the liability for uncertain tax positions on its balance sheet.&#160;&#160;Included in any liability for uncertain tax positions, the Company will also setup a liability for interest and penalties.&#160;&#160;The Company&#8217;s policy is to recognize interest and penalties related to uncertain tax positions as a component of the current provision for income taxes.</font></div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="justify" style="text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">There is no U.S. tax provision due to losses from U.S. operations during the three months ended March 31, 2012 and 2011.&#160;&#160;Deferred income taxes are provided for the temporary differences between the financial reporting and tax basis of the Company's assets and liabilities. The principal item giving rise to deferred taxes is the net operating loss carryforward in the U.S.&#160;&#160;Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&#160;&#160;The Company has set up a valuation allowance for losses for certain carryforwards that it believes may not be realized.</font></div></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div></div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Section 382 of the U.S. Internal Revenue Code imposes an annual limitation on the availability of NOL carryforwards to offset taxable income when an ownership change occurs.&#160;&#160;The Company's reverse capitalization meets the definition of an ownership change and some of the NOL's will be limited.</font></div> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; background-color: rgb(255, 255, 255); "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">8.</font></div></td> <td> <div align="justify"><font style="display: inline; font-size: 10pt; ">STOCKHOLDERS' EQUITY</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and $165,000 of accrued interest on the WMA Note.&#160;&#160;In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA, a shareholder of the Company, were satisfied by Saddleworth Consulting.</font></div> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; background-color: rgb(255, 255, 255); "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">9.</font></div></td> <td> <div align="justify"><font style="display: inline; font-size: 10pt; ">STOCK-BASED COMPENSATION</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The Company accounts for stock-based compensation under ASC 718, "Compensation - Stock Compensation" ("ASC 718").&#160;&#160;The compensation cost of the portion of the awards is based on the grant date fair value of these awards as calculated for either recognition or pro forma disclosure under ASC 718.</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">For the three months ended March 31, 2012 and 2011, the Company issued 10,000 and -0- shares and recorded compensation expense of $5,500 and $-0-, respectively.</font></div> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; background-color: rgb(255, 255, 255); "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">10.</font></div></td> <td> <div align="justify"><font style="display: inline; font-size: 10pt; ">WARRANTS</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">On February 6, 2012, the Company issued warrants as compensation to a third party to purchase 2,400,000 shares of the Company's common stock for services performed.&#160;&#160;The warrants expire February 6, 2017.&#160;&#160;The estimated value of the compensatory warrants was determined using the Black Scholes pricing model using the following assumptions:&#160;&#160;Expected term of 5 years, a risk free interest rate of 4%, a dividend yield of -0-% and volatility of 64%.&#160;&#160;The fair value of the warrant amounted to $57,840 and is included in the Company's consolidated statement of operations for the three months ended March 31, 2012.</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); text-align: left; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company's common stock issued to non-employees of the Company.&#160;&#160;The warrants were granted in lieu of cash compensation for services performed.</font></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="center" style="font-size: 13px; background-color: rgb(255, 255, 255); "> <table width="80%" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Weighted Average</font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Shares</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" colspan="2" width="13%" nowrap="nowrap"> <div align="center" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; text-decoration: underline; "><font style="display: inline; ">Exercise Price</font></font></div></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Outstanding, January 2012</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Granted</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2,400,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">0.20</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left"> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Expired/Cancelled</font></div></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left" style="padding-bottom: 2px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Exercised</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">-</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 2px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="white"> <td valign="bottom" width="70%" align="left" style="padding-bottom: 4px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Outstanding - period ending March 31, 2012</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2,400,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">0.20</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="70%" align="left" style="padding-bottom: 4px; "> <div align="left" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">Exercisable - period ending March 31, 2012</font></div></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">2,400,000</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" align="left" style="padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: left; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">$</font></td> <td valign="bottom" width="12%" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double; text-align: right; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">0.20</font></td> <td valign="bottom" width="1%" nowrap="nowrap" style="text-align: left; padding-bottom: 4px; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td></tr></table></div> <p>&#160;</p> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; background-color: rgb(255, 255, 255); "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">11.</font></div></td> <td> <div align="justify"><font style="display: inline; font-size: 10pt; ">RELATED PARTY TRANSACTIONS</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); ">&#160;</div> <div align="justify" style="font-size: 13px; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">During the year ended December 31, 2011, Elite had activities with Saddleworth Ventures, a related party.&#160;&#160;The ownership of Saddleworth Ventures is identical to the ownership of Elite.&#160;&#160;Saddleworth Ventures assigned the rights to Elite as licensee under the License Agreement with MPL.&#160;&#160;In connection with the purchase of the license , $3 million of the $6 million purchase price was paid by the members of Elite on the amount owing under the WMA note.</font></div> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); "> <div> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; ">12.</td> <td>COMMITMENTS AND CONTINGENCIES</td></tr></table></div> <div style="text-indent: 0pt; ">&#160;</div></div> <div style="text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div align="left" style="font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Consulting Agreements</font></div> <div style="font-size: 13px; text-indent: 0pt; ">&#160;</div> <div style="text-indent: 0pt; "> <div align="center"> <table width="100%" bgcolor="white" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td width="5%">&#160;</td> <td width="6%">a)</td> <td width="89%"> <div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">In January 2012, Lifestyle entered into a consulting agreement with Saddleworth Ventures LLC ("Consultant").&#160;&#160;The Consultant will provide services for management consulting, business advisory, shareholder information and public relations.&#160;&#160;The term of the agreement is for three years.&#160;&#160;Upon execution of the agreement, Lifestyle issued a payment to the Consultant in the amount of $25,000.&#160;&#160;Additional cash fees or reimbursement of expenses shall be agreed upon by Lifestyle and the Consultant from time to time during the term of the agreement.</font></div></td></tr></table> <div style="font-size: 13px; text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; ">&#160;</div> <div align="center" style="font-size: 13px; "> <table width="100%" bgcolor="white" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td width="5%">&#160;</td> <td width="6%"><font style="font-family: 'times new roman'; font-size: 10pt; ">b)</font></td> <td width="89%"><font style="font-family: 'times new roman'; font-size: 10pt; ">During 2012, Lifestyle entered into various consulting agreements with third parties in connection with business advisory services.&#160;&#160;For the three months ended March 31, 2012, consulting services amounted to $40,500.</font></td></tr></table></div></div></div></div> <p>&#160;</p> <p>&#160;</p> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <table id="hangingindent" width="100%" border="0" align="center" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">13.</font></div></td> <td> <div align="left"><font style="display: inline; font-size: 10pt; ">SUBSEQUENT EVENTS</font></div></td></tr></table></div> <div style="font-size: 13px; text-align: -webkit-left; text-indent: 0pt; background-color: rgb(255, 255, 255); margin-left: 0pt; margin-right: 0pt; "> <div style="text-indent: 0pt; ">&#160;</div> <div style="text-indent: 0pt; "> <div>&#160;</div> <div align="center"> <table width="100%" bgcolor="white" style="font-size: 10pt; " cellspacing="0" cellpadding="0"> <tr> <td width="5%">&#160;</td> <td width="6%">a)</td> <td width="89%"> <div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">In April 2012, Lifestyle borrowed $112,000 from the Dellinger Fund, a shareholder of the Company.&#160;&#160;The note bears interest @ 10% per annum and is due July 31, 2012.</font></div></td></tr> <tr> <td width="5%"><font style="font-family: 'times new roman'; font-size: 10pt; ">&#160;</font></td> <td width="6%">b)</td> <td width="89%"> <div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; ">In April 2012, Lifestyle advanced Health Clinics of Florida, LLC an additional $4,500.&#160;&#160;The advance is in addition to the previous advance in February 2012.&#160;&#160;See Note 4 for further information.</font></div></td></tr></table></div></div></div> <p>&#160;</p> <p>&#160;</p> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; "> <table cellpadding="0" width="100%" id="hangingindent" align="center" style="font-size: 9pt; font-family: arial; " border="0" cellspacing="0"> <tr valign="top"> <td style="width: 36pt; "> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt; "><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; ">1.</font></div></td> <td> <div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; ">DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div></td></tr></table></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The consolidated balance sheet as of March 31, 2012 and the consolidated statements of operations, stockholders' equity and cash flows for the periods presented have been prepared by Emerging Media Holdings, Inc. and Subsidiaries (the "Company" or "EMH") and are unaudited.&#160;&#160;In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in stockholders' equity and cash flows for all periods presented have been made.&#160;&#160;The information for the consolidated balance sheet as of December 31, 2011 was derived from audited financial statements of the Company.</font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="left" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="font-style: italic; display: inline; font-size: 10pt; "><font style="display: inline; text-decoration: underline; ">Organization</font></font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Emerging Media Holdings, Inc. (the "Company" or "EMH") was incorporated in the State of Nevada.&#160;&#160;The Company directs its operations through its subsidiaries.&#160;&#160;During 2011, the Company sold its media business in Moldova in exchange for 730,000 of its common shares.&#160;&#160;In December 2011, the Company entered into an exchange agreement and purchased LifeStyle Medical Corp. ("LMC").&#160;&#160;In connection with the acquisition, the operations of the Company are now the operations of LMC.&#160;&#160;LMC operates its business under a License related to patent rights used in connection with the operations of medical clinics that provide medical services related to men's health, with proprietary trade names and logo designs.</font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The Company is considered a development stage enterprise as defined in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 915, "Development Stage Entities" ("ASC 915").&#160;&#160;The Company has limited revenue to date, continues to raise capital and there is no assurance that ultimately the Company will achieve a profitable level of operations.</font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="left" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 36pt; margin-left: 0pt; margin-right: 0pt; "><font style="font-style: italic; display: inline; font-size: 10pt; "><font style="display: inline; text-decoration: underline; ">Acquisition of Lifestyle Medical Corporation</font></font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">On December 29, 2011, the Company closed an acquisition of 100% of the outstanding shares of Lifestyle Medical Corp., incorporated under the laws of Florida, pursuant to an Exchange Agreement, executed on that date, by and between the Company and Lifestyle Medical Corporation. The consideration paid by the Company for the acquisition of LMC was 5,000,000 shares of the Company's common stock paid to the holders of 100% of the outstanding shares of LMC, valued at $2,500,000, the fair market value at the date of issuance.</font><font style="font-size: 10pt; text-indent: 0pt; ">LMC was incorporated under the laws of the state of Florida on November 14, 2011, and on December 27, 2011 (immediately prior to LMC&#8217;s acquisition by the Company) acquired 100% of the membership interests in Elite Professional IP Licensing, LLC, a Delaware limited liability company formed on October 8, 2010 (&#8220;Elite&#8221;), and 100% of the outstanding shares of Regional Professional Alliance, Inc., a Florida corporation incorporated on October 11, 2010 (&#8220;RPA&#8221;).&#160;&#160;LMC, Elite and RPA are entities under common control and all three entities have the same ownership. At the time of its acquisition by LMC, Elite was the assignee, pursuant to an assignment effective May 9, 2011 (the &#8220;Assignment&#8221;), from Worldwide Medassets, Ltd. SAL (&#8220;WMA&#8221;) of WMA&#8217;s rights as licensee under an October 5, 2010, License Agreement (the &#8220;License&#8221; or "License Agreement") with Modular Properties Limited, Inc., as Licensor (&#8220;MPL&#8221;).&#160;&#160;The fee that was payable to WMA in connection with the Assignment of the MPL License was $6,000,000, represented by a secured promissory note dated May 7, 2011 the (&#8220;WMA Note&#8221;) in the principal amount of $6,000,000 issued by Saddleworth Ventures, LLC, a Florida limited liability company ("Saddleworth Ventures") to WMA.&#160;&#160;At that time the ownership of Saddleworth Ventures was identical to the ownership of Elite (now a wholly-owned subsidiary of the Company).&#160;&#160;Mr. Christopher Smith, the Company's Chief Executive Officer, had a 25.6% equity interest in Elite at the time of the assignment of the license and the same interest in Saddleworth Ventures.&#160;&#160;As of the December 27, 2011 acquisition of Elite by LMC, $3,000,000 of the amount owing under the WMA Note had been paid to WMA.</font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">For accounting purposes only, the transactions between LMC with Elite and RPA and the transaction between EMH and LMC were treated as a recapitalization of LMC, as of December 29, 2011, with LMC as the acquirer.&#160;&#160;The financial statements prior to December 29, 2011, are those of LMC and reflect the assets and liabilities of LMC at historical carrying amounts.&#160;&#160;The financial statements show a retroactive restatement of LMC's historical stockholders' equity to reflect the equivalent number of shares issued to LMC.</font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 36pt; margin-left: 0pt; margin-right: 0pt; "><font style="font-style: italic; display: inline; font-size: 10pt; "><font style="display: inline; text-decoration: underline; ">Acquisition by the Company of the Rights to the License with MPL</font></font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">As of January 5, 2012,&#160;&#160;Saddleworth Ventures, with the consent of WMA, assigned the WMA Note to Saddleworth Consulting, LLC, a Florida limited liability company (&#8220;Saddleworth Consulting&#8221;), and Saddleworth Consulting assumed all obligations under the WMA Note, $3,000,000 of the principal amount of which was outstanding as of the date of the assignment.</font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and accrued interest on the WMA Note.&#160;&#160;In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA were satisfied by Saddleworth Consulting.&#160;&#160;</font></div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; ">&#160;</div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="font-style: italic; display: inline; font-size: 10pt; "><font style="display: inline; text-decoration: underline; ">Going Concern</font></font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The consolidated financial statements for the three months ended March 31, 2012 and December 31, 2011 have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.&#160;&#160;The Company has a past history of recurring losses from operations and is a development stage company.&#160;&#160;The Company will require additional funding to execute its future strategic business plan.&#160;&#160;Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue to support its cost structure.&#160;&#160;These factors raise substantial doubt about the Company's ability to continue as a going concern.</font></div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="font-size: 10pt; font-weight: bold; text-indent: 0pt; ">Significant Accounting Policies</font></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-align: -webkit-left; text-indent: 0pt; ">&#160;</div> <div align="justify" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13px; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt; "><font style="display: inline; font-size: 10pt; ">The Company&#8217;s significant accounting policies are summarized in Note 1 of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011.&#160;&#160;There were no significant changes to these accounting policies during the three months ended March 31, 2012 and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.</font></div> EX-101.SCH 5 emdh-20120331.xsd EXHIBIT 101.SCH 001000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 001010 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Parenthetical link:presentationLink link:calculationLink link:definitionLink 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 003000 - Statement - CONSOLIDATED STATEMENT OF EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 006010 - Disclosure - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 007400 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 006020 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 006030 - Disclosure - INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 007000 - Disclosure - DISPOSITION OF SUBSIDIARIES link:presentationLink link:calculationLink link:definitionLink 007100 - Disclosure - MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 007200 - Disclosure - PROPERTY, PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 007300 - Disclosure - NONCONTROLLING INTEREST link:presentationLink link:calculationLink link:definitionLink 006060 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 006065 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 006130 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 006140 - Disclosure - BUSINESS SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 006080 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 000010 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 005000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 006040 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 006120 - Disclosure - NET LOSS PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 006050 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 006090 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 006070 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 006035 - Disclosure - LOAN RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 006068 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 006066 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 emdh-20120331_cal.xml EXHIBIT 101.CAL EX-101.DEF 7 emdh-20120331_def.xml EXHIBIT 101.DEF EX-101.LAB 8 emdh-20120331_lab.xml EXHIBIT 101.LAB CONSOLIDATED BALANCE SHEETS ASSETS CURRENT ASSETS: Cash and cash equivalents Cash and cash equivalents - End of period Cash and cash equivalents - Beginning of period Accounts receivable - net of allowance for doubtful accounts of $-0- and $5,000 Inventories Carrying amount as of the balance sheet date of employee receivables and other current assets. Employee receivables and other current assets Net assets of subsidiaries sold Total Current Assets Total Current Assets Property, plant and equipment, net Intangible assets - net Goodwill TOTAL ASSETS TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY Accounts payable Accrued expenses Customer deposits Total Current Liabilities Total Current Liabilities CURRENT LIABILITIES: Commitments and Contingencies EQUITY: STOCKHOLDERS' EQUITY: Common stock, $.001 par value, 200,000,000 shares authorized; 6,195,101 and 5,000,000 shares issued and 6,194,983 and 5,000,000 shares outstanding at December 31, 2011 and 2010, respectively Common stock, $.001 par value, 200,000,000 shares and 5,000,000 shares oustanding at December 31, 2011 and 2010, respectively Common stock, $.001 par value, 200,000,000 shares authorized; 25,205,101 and 6,195,101 shares issued and 25,204,983 and 6,194,983 shares outstanding at March 31, 2012 and December 31, 2011, respectively Additional paid-in-capital Deficit Deficit Accumulated other comprehensive income (loss) Less: Cost of common stock in treasury, 118 and -0- shares at December 31, 2011 and 2010, respectively Less: Cost of common stock in treasury, 118 and 118 shares at March 31, 2012 and December 31, 2011, respectively Total Stockholders' Equity without noncontrolling interest Total Stockholders' Equity Noncontrolling interest Total Equity with noncontrolling interest Total Stockholders' Equity with noncontrolling interest Balance Balance TOTAL LIABILITIES AND EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Accounts receivable, allowance for doubtful accounts Common stock, par value (in dollars per share) Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Less: Cost of common stock in treasury, shares (in shares) CONSOLIDATED STATEMENTS OF OPERATIONS Revenues Costs and expenses: Cost of sales Selling, general and administrative expenses Total costs and expenses Total costs and expenses Loss from operations Loss from operations Other income (expense): Loss on disposition of subsidiaries Other income (principally interest income) Total other income (expense) Total other income (expense) Loss from operations before provision for income taxes Loss from operations before provision for income taxes Provision for income taxes Provision for income taxes Earnings (loss) from continuing operations Earnings (loss) from continuing operations Discontinued operations (Note 18): Earnings (loss) from operations of SC Genesis International S.A. Total discontinued operations earnings (loss) Total discontinued operations earnings (loss) Net loss Net loss Net loss for the year ended December 31, 2011 Less: Net loss attributable to the noncontrolling interest Net earnings (loss) attributable to Emerging Media Holdings, Inc. and Subsidiaries Net earnings (loss) attributable to Emerging Media Holdings, Inc. and Subsidiaries Net loss Earnings (loss) per common share: Loss per common share (in dollars per share) Earnings (loss) per common share attributable to Emerging Media Inc. and Subsidiaries common shareholders from discontinued operations - basic and diluted (in dollars per share) CONSOLIDATED STATEMENTS OF CASH FLOWS CONSOLIDATED STATEMENT OF EQUITY Statement [Table] Statement, Equity Components [Axis] Equity Component [Domain] Statement [Line Items] Comprehensive Income Common Stock Common stock issued Additional Paid In Capital Paid-in capital in connection with common stock issued Retained Earnings (Deficit) Accumulated Other Comprehensive Income (Loss) Treasury Stock Treasury stock acquired Noncontrolling Interest Balance, (in shares) Balance, (in shares) Common stock, shares outstanding (in shares) Effect of reverse acquisition Effect of reverse acquisition (in shares) Common stock received for disposition of subsidiaries Common stock received for disposition of subsidiaries Common stock received for disposition of subsidiaries (in shares) Non-cash based compensation Non-cash based compensation (in shares) 1:5 Forward split adjustment 1:5 Forward split adjustment (in shares) Currency translation Currency translation adjustment Comprehensive loss Comprehensive income (loss) attributable to Emerging Media Inc. and Subsidiaries Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization (Gain) loss on disposition of fixed assets Changes in operating assets and liabilities: (Increase) decrease in trade receivables (Increase) in inventories (Increase) decrease in employee receivables and other current assets Decrease in restricted cash Increase (decrease) in accounts payable, accrued liabilities and income taxes payable Increase (decrease) in customer deposits Net Cash Used In Operating Activities Net Cash Used In Operating Activities Cash flows from operating activities: Cash flows from investing activities: Purchase of property, plant and equipment Purchase of property, plant and equipment Proceeds from sale of fixed assets Proceeds from sale of marketable securities Net Cash Provided by (Used In) Investing Activities Net Cash Used In Investing Activities Cash flows from financing activities: Proceeds from loans Repayment of debt Repayment of debt Net Cash Used In Financing Activities Net Cash Provided by Financing Activities Effect of exchange rate changes on cash Net decrease in cash Net increase in cash Supplemental disclosure cash flow information: Cash paid for income taxes Cash paid for interest Supplementary information: Non-cash during the year for: Adjustment of noncontrolling interest in connection with disposition of subsidiaries Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Document and Entity Information [Abstract] Description Of Business And Summary Of Significant Accounting Policies [Text Block] DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings). This element also represents the entire disclosure for all significant accounting policies of the reporting entity. Description of Business and Summary of Significant Accounting Policies [Abstract] ACQUISITIONS Acquisitions [Abstract] Details of reverse acquisition FAIR VALUE MEASUREMENTS Fair Value Measurements [Abstract] INTANGIBLES Intangibles [Abstract] DISPOSITION OF SUBSIDIARIES Disposition of Subsidiaries [Abstract] MARKETABLE SECURITIES PROPERTY, PLANT AND EQUIPMENT Property, Plant and Equipment [Abstract] NONCONTROLLING INTEREST Noncontrolling Interest [Abstract] INCOME TAXES Income Taxes [Abstract] STOCKHOLDERS' EQUITY Stockholders' Equity [Abstract] Discontinued Operations [Text Block] DISCONTINUED OPERATIONS Disclosure of sale of and operating income from discontinued operations. Discontinued Operations [Abstract] BUSINESS SEGMENT INFORMATION Business Segment Information [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies [Abstract] Weighted average common shares outstanding - basic and diluted (in shares) The average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share during the period. Marketable Securities [Abstract] Adjustment to noncontrolling interest for sale of SC Genesis International S.A. for the year ended 12/31/2010 and the sale of Alkasar Media Services S.R.L. for the six months ended 9/30/2011 Adjustment to noncontrolling interest International S.A. for sale of SC Genesis Short-term debt Interest expense Interest expense Gain on sale of SC Genesis International S.A. Sale of SC Genesis International S.A. Cash given upon sale of Genesis Cash given upon sale of Genesis Non-cash compensation Stock Divested From Deconsolidation Reduction in common stock and additional paid in capital due to no longer including the former subsidiary's equity in the consolidated entity's equity. Sale of SC Genesis International S.A. (in shares) CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Other comprehensive income (loss) - net of tax: Comprehensive income (loss) Comprehensive income (loss) Less: Comprehensive income (loss) attributable to noncontrolling interest Disposal Group Not Discontinued Operation Gain Loss Loss on disposition of subsidiaries Debt [Text Block] DEBT Debt [Abstract] NET LOSS PER COMMON SHARE Net Loss Per Common Share [Abstract] Contribution of capital from shareholders Proceeds from contributions from shareholders Increase in accrued expenses Decrease in accrued expenses Intangible asset in exchange for short-term debt Issuance of common stock Accrued Expenses [Abstract] ACCRUED EXPENSES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Net assets acquired Entity Public Float Loan receivable Other assets Issuance of warrants Increase in other assets Advances on loans Advances on loans Proceeds from related parties Common stock issued in exchange for debt and interest Net loss for the three months ended March 31, 2012 Issuance of common stock for repayment of note payable and accrued interest Common Stock Issued for the repayment of related party note and accrued interest Issuance of common stock for repayment of note payable and accrued interest (in shares) Issuance of common stock for services Issuance of common stock for services (in shares) Other assets Other assets noncurrent Loan Receivable [Abstract] LOAN RECEIVABLE Disclosure of acquired related party receivable. Stock-Based Compensation [Abstract] STOCK-BASED COMPENSATION Warrants [Abstract] WARRANTS Disclosure of warrants issued to third party as compensation. EX-101.PRE 9 emdh-20120331_pre.xml EXHIBIT 101.PRE XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
INTANGIBLES
3 Months Ended
Mar. 31, 2012
Intangibles [Abstract]  
INTANGIBLES

 

3.
INTANGIBLES
 
The MPL License Agreement
 
The MPL License Agreement, under which the Company's wholly-owned subsidiary, Elite, is the licensee pursuant to the Assignment from WMA, provides for the license of medical services, operational systems, manuals, certain names and logo designs and other intellectual property in connection with the operation of medical clinics that provide services related to men’s health within the territory of the continental United States (the “Licensed Rights”).  The License Agreement provides for a fee of 6% of gross receipts of Licensee, payable quarterly.  The term of the License Agreement is for twenty (20) years from the effective date, May 9, 2011. The Company plans to establish new medical clinics or acquire existing clinics, as well as to provide consulting services to medical clinics utilizing the Licensed Rights.
 
Intangibles are the value of the MPL license.  Amounts assigned to this intangible were determined by management.  Management considered a number of factors in determining the allocations, including valuations and independent appraisals.  The intangibles are being amortized over 20 years, the life of the license.  Amortization expense will commence upon the use of the license during 2012.
 
The components of intangible assets are as follows:
 
 
   
March 31, 2012
   
December 31, 2011
 
   
Gross Carrying
   
Accumulated
   
Gross Carrying
   
Accumulated
 
   
Amount
   
Amortization
   
Amount
   
Amortization
 
                         
License agreements
  $ 6,000,000     $ -     $ 6,000,000     $ -  
 
Estimated amortization expense for intangible assets for the next five years is as follows:
 
 
Year Ending
 
Amortization
December 31,
 
Expense
2012
 
 $   150,000
2013
 
      300,000
2014
 
      300,000
2015
 
      300,000
2016
 
      300,000

 

EXCEL 12 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\T96(S83%C,5]E,#4S7S1A-&)?834R-5\Q,&$R M8C-E8S)E93DB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E1?3T9?15%5 M23PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1%4T-225!424].7T]&7T)54TE.15-37T%. M1%]353PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9! M25)?5D%,545?345!4U5214U%3E13/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I7 M;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-4 M3T-+2$],1$524U]%455)5%D\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E=!4E)!3E13/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E13 M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I!8W1I=F53 M:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA2!);F9O2!296=I M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^36%R(#,Q+`T* M"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO'0^43$\ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!#=7)R96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@("`@("`\=&0@ M8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T96(S83%C M,5]E,#4S7S1A-&)?834R-5\Q,&$R8C-E8S)E93D-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-&5B,V$Q8S%?93`U,U\T831B7V$U,C5?,3!A,F(S M96,R964Y+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@R,#4L.3,Y*3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T M96(S83%C,5]E,#4S7S1A-&)?834R-5\Q,&$R8C-E8S)E93D-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5B,V$Q8S%?93`U,U\T831B7V$U,C5? M,3!A,F(S96,R964Y+U=O'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T96(S83%C,5]E,#4S7S1A M-&)?834R-5\Q,&$R8C-E8S)E93D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-&5B,V$Q8S%?93`U,U\T831B7V$U,C5?,3!A,F(S96,R964Y+U=O M'0O:'1M M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6UE;G0@;V8@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAAF4Z(#$S M<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@)SX-"CQT86)L92!C96QL M<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&ED/3-$:&%N9VEN9VEN9&5N="!A M;&EG;CTS1&-E;G1EF4Z(#EP=#L@9F]N="UF M86UI;'DZ(&%R:6%L.R`G(&)O3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O M;G0M3H@)U1I;65S M($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X="UA;&EG;CH@+7=E M8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R`G/B8C,38P.SPO9&EV/@T* M/&1I=B!A;&EG;CTS1&IUF4Z(#$S<'@[('1E>'0M:6YD96YT.B`P<'0[(&UA2!A;F0@8V%S:"!F;&]W2!%;65R9VEN9R!-961I M82!(;VQD:6YG3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN M9&5N=#H@,'!T.R`G/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0@ MF4Z(#$S<'@[('1E>'0M86QI9VXZ M("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN+6QE9G0Z M(#,V<'0[(&UA6QE/3-$)V9O M;G0M3H@:6YL:6YE.R!F;VYT+7-I>F4Z M(#$P<'0[("<^/&9O;G0@3H@:6YL:6YE.R!T97AT M+61E8V]R871I;VXZ('5N9&5R;&EN93L@)SY/3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N M=#H@,'!T.R`G/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&IUF4Z(#$S<'@[('1E>'0M:6YD96YT M.B`P<'0[(&UA2!S;VQD(&ET&-H86YG92!A M9W)E96UE;G0@86YD('!U6QE/3-$)V-O;&]R.B!R9V(H,"P@,"P@,"D[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q M,W!X.R!T97AT+6%L:6=N.B`M=V5B:VET+6QE9G0[('1E>'0M:6YD96YT.B`P M<'0[("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL M93TS1"=C;VQO3H@)U1I;65S M($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X="UI;F1E;G0Z(#!P M=#L@;6%R9VEN+6QE9G0Z(#,V<'0[(&UA6QE/3-$)V1I2!T:&4@0V]M<&%N>2!W:6QL(&%C:&EE=F4@ M82!P3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X M="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R`G/B8C M,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0@F4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&UA6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^/&9O;G0@ M3H@:6YL:6YE.R!T97AT+61E8V]R871I;VXZ('5N M9&5R;&EN93L@)SY!8W%U:7-I=&EO;B!O9B!,:69E6QE/3-$ M)V-O;&]R.B!R9V(H,"P@,"P@,"D[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)SL@9F]N="US:7IE.B`Q,W!X.R!T97AT+6%L:6=N.B`M=V5B:VET M+6QE9G0[('1E>'0M:6YD96YT.B`P<'0[("<^)B,Q-C`[/"]D:78^#0H\9&EV M(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=C;VQO3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN+6QE9G0Z(#,V<'0[(&UA M6QE/3-$)V1I2!C;&]S960@86X@86-Q=6ES:71I;VX@;V8@,3`P)2!O M9B!T:&4@;W5T&5C=71E M9"!O;B!T:&%T(&1A=&4L(&)Y(&%N9"!B971W965N('1H92!#;VUP86YY(&%N M9"!,:69E2!T:&4@0V]M<&%N>2!F;W(@=&AE(&%C<75I2=S M(&-O;6UO;B!S=&]C:R!P86ED('1O('1H92!H;VQD97)S(&]F(#$P,"4@;V8@ M=&AE(&]U='-T86YD:6YG('-H87)E6QE/3-$)V9O;G0M2!P2!T M:&4@0V]M<&%N>2D@86-Q=6ER960@,3`P)2!O9B!T:&4@;65M8F5R2!,34,L($5L:71E('=A2`Y+"`R,#$Q("AT:&4@)B,X,C(P.T%S2!A('-E8W5R960@<')O;6ES2!N;W1E(&1A=&5D($UA>2`W+"`R,#$Q('1H92`H)B,X,C(P.U=-02!.;W1E M)B,X,C(Q.RD@:6X@=&AE('!R:6YC:7!A;"!A;6]U;G0@;V8@)#8L,#`P+#`P M,"!I2UO M=VYE9"!S=6)S:61I87)Y(&]F('1H92!#;VUP86YY*2XF(S$V,#LF(S$V,#M- M2!I;G1E6QE/3-$)V-O M;&]R.B!R9V(H,"P@,"P@,"D[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)SL@9F]N="US:7IE.B`Q,W!X.R!T97AT+6%L:6=N.B`M=V5B:VET+6QE M9G0[('1E>'0M:6YD96YT.B`P<'0[("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L M:6=N/3-$:G5S=&EF>2!S='EL93TS1"=C;VQO3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN+6QE9G0Z(#,V<'0[(&UA6QE/3-$)V1IF%T:6]N(&]F($Q- M0RP@87,@;V8@1&5C96UB97(@,CDL(#(P,3$L('=I=&@@3$U#(&%S('1H92!A M8W%U:7)E3H@)U1I;65S($YE M=R!2;VUA;B<[(&9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI M="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R`G/B8C,38P.SPO9&EV/@T*/&1I M=B!A;&EG;CTS1&IUF4Z M(#$S<'@[('1E>'0M:6YD96YT.B`S-G!T.R!M87)G:6XM;&5F=#H@,'!T.R!M M87)G:6XM6QE M.B!I=&%L:6,[(&1I6QE/3-$)V1I6QE/3-$)V-O;&]R.B!R9V(H,"P@,"P@ M,"D[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE M.B`Q,W!X.R!T97AT+6%L:6=N.B`M=V5B:VET+6QE9G0[('1E>'0M:6YD96YT M.B`P<'0[("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S M='EL93TS1"=C;VQO3H@)U1I M;65S($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X="UI;F1E;G0Z M(#!P=#L@;6%R9VEN+6QE9G0Z(#,V<'0[(&UA6QE/3-$)V1I2!C;VUP86YY("@F M(S@R,C`[4V%D9&QE=V]R=&@@0V]NF4Z(#$S<'@[('1E>'0M86QI9VXZ("UW M96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@)SXF(S$V,#L\+V1I=CX- M"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V-O;&]R.B!R9V(H,"P@ M,"P@,"D[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US M:7IE.B`Q,W!X.R!T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,S9P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^4'5RF4Z(#$S<'@[('1E>'0M:6YD96YT.B`P<'0[(&UAF4Z(#$S<'@[('1E>'0M86QI9VXZ("UW M96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@)SXF(S$V,#L\+V1I=CX- M"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V-O;&]R.B!R9V(H,"P@ M,"P@,"D[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US M:7IE.B`Q,W!X.R!T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,S9P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[("<^/&9O;G0@'0M9&5C M;W)A=&EO;CH@=6YD97)L:6YE.R`G/D=O:6YG($-O;F-E3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@ M,'!T.R`G/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&IUF4Z(#$S<'@[('1E>'0M:6YD96YT.B`P M<'0[(&UA&5C=71E(&ET2!A M2!S='EL93TS1"=C;VQO M3H@)U1I;65S($YE=R!2;VUA M;B<[(&9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN M+6QE9G0Z(#,V<'0[(&UAF4Z(#$S<'@[('1E>'0M:6YD96YT.B`P<'0[(&UAF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6EN9&5N=#H@ M,'!T.R`G/E-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,\+V9O;G0^ M/"]D:78^#0H\9&EV('-T>6QE/3-$)V-O;&]R.B!R9V(H,"P@,"P@,"D[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,W!X M.R!T97AT+6%L:6=N.B`M=V5B:VET+6QE9G0[('1E>'0M:6YD96YT.B`P<'0[ M("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS M1"=C;VQO3H@)U1I;65S($YE M=R!2;VUA;B<[(&9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@ M;6%R9VEN+6QE9G0Z(#,V<'0[(&UA6QE/3-$)V1I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M#L@ M=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B M86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[(&UA6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1I3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,S9P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[("<^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^5&AE($-O;7!A;GD@=71I;&EZ97,@ M=&AE(&%C8V]U;G1I;F<@9W5I9&%N8V4@9F]R(&9A:7(@=F%L=64@;65A&ET M('!R:6-E+"!R97!R97-E;G1I;F<@=&AE('!R:6-E('1H870@=V]U;&0@8F4@ M6QE/3-$)V9O M;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT M+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L M(#(U-2D[(&UA6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R`G/DQE=F5L(#$F(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!W:61T:#TS1#@Y)3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=VED=&@],T0V)3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=VED=&@],T0V)3X-"CQD:78@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\ M+W1D/@T*/'1D('=I9'1H/3-$.#DE/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C M,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(^#0H\=&0@=VED=&@],T0U)3X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/BT@56YO8G-E2!T;R!D979E;&]P(&ET MF4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F M=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA2!T:&4@0V]M M<&%N>2!B87-E9"!O;B!M87)K970@<')I8V5S(&]T:&5R('1H86X@<75O=&5D M('!R:6-E6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E M8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O;&]R M.B!R9V(H,C4U+"`R-34L(#(U-2D[(&UA3H@:6YL:6YE.R!F M;VYT+7-I>F4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO9&EV/@T* M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M86QI9VXZ("UW M96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&UAF4Z M(#$S<'@[('1E>'0M:6YD96YT.B`P<'0[("<^)B,Q-C`[/"]D:78^/"]D:78^ M#0H\9&EV('-T>6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@ M+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O M;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[(&UA6QE/3-$ M)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3`E(&YO=W)A M<#TS1&YO=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^3W1H97(\+V9O;G0^/"]D:78^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS1&YO M=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I M9'1H/3-$,3`E(&YO=W)A<#TS1&YO=W)A<#X-"CQD:78@86QI9VX],T1C96YT M97(@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0MF4Z M(#$P<'0[("<^3V)S97)V86)L93PO9F]N=#X\+V1I=CX\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)V1IF4Z M(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS1&YO=W)A<#X-"CQD:78@86QI M9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$ M,3`E(&YO=W)A<#TS1&YO=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS1&YO M=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1I MF4Z(#$P<'0[('1E>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE M.R`G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,G!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3`E(&YO=W)A M<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,G!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3`E(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R`G/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA6QE/3-$)V1IF4Z(#$P<'0[("<^0V%S:"!A;F0@8V%S M:"!E<75I=F%L96YT6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@#L@8F]R9&5R+6)O M='1O;2US='EL93H@'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M'0M86QI9VXZ M(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[ M("<^,2PW,S0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`@#L@)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F="!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R`G/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI9VXZ(&QE9G0[ M("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^,2PW,S0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI M9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[("<^+3PO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE.B!S;VQI9#L@=&5X M="UA;&EG;CH@;&5F=#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R`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`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@F4Z M(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1IF4Z(#$P<'0[('1E M>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE.R`G/CQF;VYT('-T>6QE/3-$)V1I M6QE M/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z(#$P<'0[("<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G M/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#DE('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O M='1O;3H@,G!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R`G/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE M/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z(#$P<'0[("<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W!A9&1I;F#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)#PO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)V)O M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M#L@)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)#PO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE M/3-$)V)O6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^ M)#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI M9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[("<^+3PO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F M;VYT/CPO=&0^/"]TF4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X M="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO'0M:6YD96YT.B`P<'0[ M(&)A8VMG2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM M;&5F=#H@,S9P=#L@;6%R9VEN+7)I9VAT.B`P<'0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^5&AE($-O M;7!A;GD@:&%S(&]T:&5R(&9I;F%N8VEA;"!I;G-T6EN9R!V86QU92!O9B!A8V-O=6YT M2!D:60@ M;F]T(&AA=F4@86YY(&]T:&5R(&9I;F%N8VEA;"!I;G-T6QE/3-$)V9O;G0M#L@=&5X="UA;&EG M;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD M+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[(&UA3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO9&EV/@T*/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\T96(S83%C,5]E,#4S7S1A-&)?834R-5\Q,&$R8C-E8S)E93D-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5B,V$Q8S%?93`U,U\T831B7V$U M,C5?,3!A,F(S96,R964Y+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`^)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@ M=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`S-G!T.R`G M/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F M=#H@,'!T.R!M87)G:6XM3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^24Y4 M04Y'24),15,\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^ M#0H\9&EV('-T>6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@ M+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O M;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[(&UA'0M:6YD96YT.B`S-G!T.R!M M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM6QE/3-$)V1I6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL M969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H M,C4U+"`R-34L(#(U-2D[("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$ M:G5S=&EF>2!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M:6YD96YT M.B`P<'0[(&)A8VMG6QE/3-$)V1I7-T96US+"!M86YU86QS+"!C97)T86EN(&YA M;65S(&%N9"!L;V=O(&1E2!I;B!C;VYN96-T:6]N('=I=&@@=&AE(&]P97)A=&EO;B!O9B!M M961I8V%L(&-L:6YI8W,@=&AA="!P6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@ M,'!T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[("<^ M)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=F M;VYT+7-I>F4Z(#$S<'@[('1E>'0M:6YD96YT.B`P<'0[(&)A8VMG6QE/3-$)V1I2!M86YA9V5M96YT+B8C,38P.R8C,38P.TUA;F%G96UE;G0@8V]NF%T:6]N(&5X<&5NF4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E M;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M#L@=&5X="UA M;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O M=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[("<^)B,Q-C`[/"]D:78^ M#0H\9&EV(&ED/3-$4$="4DL@#L@)SXF(S$V M,#L\+V1I=CX\+V1I=CX\+V1I=CX-"CQD:78@86QI9VX],T1C96YT97(@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^1&5C96UB97(@,S$L(#(P,3$\+V9O;G0^/"]D:78^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`@F4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^06-C=6UU;&%T960\+V9O;G0^/"]D:78^/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`@F4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3,E(&YO M=W)A<#TS1&YO=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6EN9SPO9F]N=#X\+V1I=CX\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3,E(&YO=W)A<#TS M1&YO=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R`G/D%M;W5N=#PO9F]N=#X\+V9O;G0^/"]D:78^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`@F4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3,E M(&YO=W)A<#TS1&YO=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R`G/D%M;W)T:7IA=&EO;CPO9F]N=#X\ M+V9O;G0^/"]D:78^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0R('=I9'1H/3-$,3,E(&YO=W)A<#TS1&YO=W)A<#X-"CQD:78@86QI9VX] M,T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R`G/D%M;W5N M=#PO9F]N=#X\+V9O;G0^/"]D:78^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M(&-O;'-P86X],T0R('=I9'1H/3-$,3,E(&YO=W)A<#TS1&YO=W)A<#X-"CQD M:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R`G/D%M;W)T:7IA=&EO;CPO9F]N=#X\+V9O;G0^/"]D:78^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@ MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M('=I9'1H/3-$,3,E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[ M("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE M/3-$)V1IF4Z(#$P<'0[("<^3&EC96YS92!A9W)E96UE;G1S M/"]F;VYT/CPO9&EV/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE.B!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)V)O3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F="!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@-'!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@#L@8F]R9&5R M+6)O='1O;2US='EL93H@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)#PO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS M1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW M:61T:#H@-'!X.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z M(#$P<'0[("<^+3PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!P861D:6YG+6)O='1O;3H@-'!X.R`G/CQF;VYT('-T>6QE/3-$ M)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T('-T M>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE.B!D;W5B;&4[('1E>'0M86QI9VXZ(&QE M9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V)O3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M#L@ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R`G M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M#L@8F]R9&5R+6)O='1O;2US='EL93H@9&]U8FQE M.R!T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R M.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@-'!X.R!B;W)D97(M8F]T M=&]M+7-T>6QE.B!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^+3PO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O M;3H@-'!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[ M("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K M:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO65A6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E M8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O;&]R M.B!R9V(H,C4U+"`R-34L(#(U-2D[("<^)B,Q-C`[/"]D:78^#0H\9&EV('-T M>6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL M969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H M,C4U+"`R-34L(#(U-2D[("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$ M8V5N=&5R('-T>6QE/3-$)V9O;G0M#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^#0H\9&EV(&%L:6=N/3-$8V5N M=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1IF4Z(#$P<'0[('1E>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE.R`G M/CQF;VYT('-T>6QE/3-$)V1I'!E;G-E/"]F M;VYT/CPO9F]N=#X\+V1I=CX\+W1D/CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/@T*/&1I=B!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,'!T.R!M M87)G:6XM6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@.7!T M.R`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`U,U\T831B7V$U M,C5?,3!A,F(S96,R964Y+U=O'0O:'1M;#L@8VAA'0^/'`^)B,Q-C`[/"]P/@T* M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M86QI9VXZ("UW M96)K:70M;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$ M)V1I6QE/3-$)V9O;G0M#L@=&5X="UA M;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O M=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[("<^)B,Q-C`[/"]D:78^ M#0H\9&EV('-T>6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@ M+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O M;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[(&UA6QE/3-$)V1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T96(S M83%C,5]E,#4S7S1A-&)?834R-5\Q,&$R8C-E8S)E93D-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-&5B,V$Q8S%?93`U,U\T831B7V$U,C5?,3!A M,F(S96,R964Y+U=O'0O:'1M;#L@8VAA'0^/'`^)B,Q-C`[ M/"]P/@T*/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M86QI M9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[("<^)B,Q M-C`[/"]D:78^/"]D:78^/"]D:78^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K M:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#$P<'0[("<^4VAOF4Z M(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z M(#!P=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q M-3@S<'@[("<^)B,Q-C`[/"]D:78^/"]D:78^/"]D:78^#0H\9&EV(&%L:6=N M/3-$8V5N=&5R('-T>6QE/3-$)V9O;G0M#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)V1IF4Z M(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3,E(&YO=W)A<#TS1&YO=W)A<#X- M"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0R('=I9'1H/3-$,3,E(&YO=W)A<#TS1&YO=W)A<#X-"CQD:78@86QI9VX] M,T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3,E(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@ M8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D97(M8F]T=&]M+7-T>6QE M.B!S;VQI9#L@)SX-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,3,E(&YO=W)A<#TS1&YO=W)A M<"!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R M+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI M9#L@)SX-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3PO9F]N=#X\+V1I=CX\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^+3PO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$ M)V1IF4Z(#$P<'0[("<^)B,Q-C`[;F]T92!T;R!7;W)L=VED M92!-961A6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M2`R+"`R,#$R("@Q*3PO9F]N=#X\+V1I=CX\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T M>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T M>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[9'5E($IU M;'D@,34L(#(P,3(@*#(I/"]F;VYT/CPO9&EV/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`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`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M2!N;W1E+"!I;G1EF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T M>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@F4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$ M)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z M(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$ M)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z M(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[9'5E($IU;F4@,2P@,C`Q,B`H,RD\+V9O;G0^ M/"]D:78^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1&QE9G0^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^-C`L,#`P/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^+3PO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F M;VYT/CPO=&0^/"]T6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T M>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA6QE/3-$)V1IF4Z(#$P<'0[("<^56YS96-U3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W!A9&1I;F#L@)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E('-T>6QE/3-$)V)O6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)V)O#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T M.R`G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@8F=C;VQO3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^,RPP,#`L,#`P M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1IF4Z(#$P<'0[("<^3&5S6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE.B!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O M;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D97(M M8F]T=&]M+7-T>6QE.B!S;VQI9#L@=&5X="UA;&EG;CH@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^/"]T6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C M,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)V)O#L@8F]R9&5R M+6)O='1O;2US='EL93H@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/BT\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`@#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@-'!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@#L@8F]R9&5R+6)O='1O;2US M='EL93H@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[("<^)#PO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=B;W)D97(M M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@-'!X M.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^ M+3PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P M861D:6YG+6)O='1O;3H@-'!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z(#$S<'@[('1E>'0M M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R M;W5N9"UC;VQO2!3861D;&5W;W)T:"!#;VYS=6QT:6YG+CPO9F]N M=#X\+V1I=CX-"CQD:78@'0M:6YD96YT.B`P<'0[(&)A8VMG M'0M:6YD96YT.B`P<'0[(&)A8VMG2!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,S9P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[("<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^*#(I($]N($IA;G5A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA2P@9G)O;2!T:&4@1&5L M;&EN9V5R($9U;F0L(&$@6QE/3-$ M)V9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N M9"UC;VQO3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^26YT97)E3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\T96(S83%C,5]E,#4S7S1A-&)?834R-5\Q,&$R8C-E8S)E M93D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5B,V$Q8S%?93`U M,U\T831B7V$U,C5?,3!A,F(S96,R964Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'`^ M)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E M>'0M86QI9VXZ("UW96)K:70M;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M:6YD96YT.B`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`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H/3-$,38E(&YO=W)A<#TS M1&YO=W)A<#X-"CQD:78@86QI9VX],T1C96YT97(@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R`G/C(P,3(\+V9O;G0^/"]F;VYT/CPO9&EV/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0MF4Z(#$P M<'0[('1E>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE.R`G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^/"]T3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^+3PO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T M>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z M(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V1I MF4Z(#$P<'0[("<^3W1H97(\+V9O;G0^/"]D:78^/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0@ M#L@)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,34E('-T>6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE.B!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$U)2!S='EL93TS1"=B;W)D97(M8F]T=&]M M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D M97(M8F]T=&]M+7-T>6QE.B!S;VQI9#L@=&5X="UA;&EG;CH@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@8F=C M;VQO6QE M/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M6QE.B!D;W5B;&4[('1E>'0M86QI9VXZ M(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V)O3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M#L@ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R`G M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M#L@8F]R9&5R+6)O='1O;2US='EL93H@9&]U8FQE M.R!T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$U)2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R M.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@-'!X.R!B;W)D97(M8F]T M=&]M+7-T>6QE.B!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^,S4V+#(P,#PO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG M+6)O='1O;3H@-'!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z M(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\T96(S83%C,5]E,#4S7S1A-&)?834R-5\Q,&$R8C-E M8S)E93D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5B,V$Q8S%? M93`U,U\T831B7V$U,C5?,3!A,F(S96,R964Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'`^)B,Q-C`[/"]P M/@T*/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M86QI9VXZ M("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W=I9'1H.B`S-G!T.R`G/C'0M:6YD96YT.B`P<'0[(&)A8VMG2!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,S9P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[("<^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^5&AE($-O;7!A;GD@861O<'1E9"!T M:&4@<')O=FES:6]N&5S(BP@*")! M4T,@-S0P(BDN)B,Q-C`[)B,Q-C`[07,@82!R97-U;'0@;V8@=&AE(&EM<&QE M;65N=&%T:6]N(&]F($%30R`W-#`L('1H92!#;VUP86YY(')E8V]G;FEZ960@ M;F\@861J=7-T;65N="!I;B!T:&4@;F5T(&QI86)I;&ET>2!F;W(@=6YR96-O M9VYI>F5D(&EN8V]M92!T87@@8F5N969I=',N)B,Q-C`[)B,Q-C`[5&AE($-O M;7!A;GD@8F5L:65V97,@=&AE"!R971U2!R M96-O9VYI>F4@82!L:6%B:6QI='D@9F]R('5N8V5R=&%I;B!T87@@<&]S:71I M;VYS+"!T:&4@0V]M<&%N>2!W:6QL('-E<&%R871E;'D@2!L M:6%B:6QI='D@9F]R('5N8V5R=&%I;B!T87@@<&]S:71I;VYS+"!T:&4@0V]M M<&%N>2!W:6QL(&%L6QE/3-$)V9O;G0M M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN M9&5N=#H@,'!T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U M-2D[(&UAF4Z(#$S<'@[('1E>'0M M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA"!P"!B M87-I2=S(&%S2!T;R!R961U8V4@9&5F97)R M960@=&%X(&%SF5D+B8C,38P.R8C,38P.U1H92!#;VUP86YY(&AA2!N;W0@8F4@F4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E M;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#$P<'0[("<^4V5C=&EO;B`S.#(@;V8@=&AE(%4N4RX@ M26YT97)N86P@4F5V96YU92!#;V1E(&EM<&]S97,@86X@86YN=6%L(&QI;6ET M871I;VX@;VX@=&AE(&%V86EL86)I;&ET>2!O9B!.3TP@8V%R2=S(')E=F5R M7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA6QE/3-$)W=I9'1H.B`S-G!T.R`G/@T*/&1I=B!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,'!T.R!M M87)G:6XM3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^4U1/0TM(3TQ$ M15)3)R!%455)5%D\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CPO=&%B;&4^/"]D M:78^#0H\9&EV('-T>6QE/3-$)V9O;G0M#L@=&5X="UA;&EG M;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@,'!T.R!B86-K9W)O=6YD M+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[("<^)B,Q-C`[/"]D:78^#0H\ M9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=F;VYT+7-I>F4Z(#$S<'@[ M('1E>'0M:6YD96YT.B`P<'0[(&)A8VMG6QE/3-$)V1I2`X+"`R,#$R+"!B971W965N M('1H92!#;VUP86YY(&%N9"!3861D;&5W;W)T:"!#;VYS=6QT:6YG+"!T:&4@ M0V]M<&%N>2!A9W)E960@=&\@:7-S=64@,3DL,#`P+#`P,"!S:&%R97,@;V8@ M:71S(&-O;6UO;B!S=&]C:R!T;R!3861D;&5W;W)T:"!#;VYS=6QT:6YG(&EN M(&5X8VAA;F=E(&9O2P@=V5R92!S871I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE M/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[("<^#0H\ M=&%B;&4@:60],T1H86YG:6YG:6YD96YT('=I9'1H/3-$,3`P)2!B;W)D97(] M,T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V9O;G0M3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^.2X\+V9O;G0^/"]D:78^/"]T M9#X-"CQT9#X-"CQD:78@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$ M)V1I'0M:6YD96YT.B`P<'0[(&)A8VMG M6QE/3-$)V9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO3H@:6YL:6YE.R!F M;VYT+7-I>F4Z(#$P<'0[("<^5&AE($-O;7!A;GD@86-C;W5N=',@9F]R('-T M;V-K+6)A6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N M=#H@,'!T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[ M("<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS M1"=F;VYT+7-I>F4Z(#$S<'@[('1E>'0M:6YD96YT.B`P<'0[(&)A8VMG6QE/3-$)V1I2!I2X\+V9O;G0^/"]D:78^#0H\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E M8FMI="UL969T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U M-2D[("<^#0H\=&%B;&4@:60],T1H86YG:6YG:6YD96YT('=I9'1H/3-$,3`P M)2!B;W)D97(],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[("<^,3`N/"]F;VYT M/CPO9&EV/CPO=&0^#0H\=&0^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M'0M:6YD96YT.B`P<'0[(&)A8VMG6QE/3-$)V9O;G0M#L@ M=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO3H@:6YL:6YE.R!F;VYT+7-I M>F4Z(#$P<'0[("<^3VX@1F5B'!E8W1E9"!T97)M(&]F(#4@>65A M6EE;&0@;V8@+3`M)2!A;F0@=F]L871I;&ET>2!O9B`V-"4N)B,Q-C`[ M)B,Q-C`[5&AE(&9A:7(@=F%L=64@;V8@=&AE('=AF4Z(#$S<'@[('1E>'0M86QI9VXZ M("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC M;VQOF4Z(#$S<'@[('1E>'0M:6YD96YT.B`P<'0[ M(&)A8VMG6QE/3-$)V1I2=S(&-O M;6UO;B!S=&]C:R!I65E2XF(S$V,#LF(S$V,#M4:&4@=V%R6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@ M,'!T.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C4U+"`R-34L(#(U-2D[("<^ M)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V9O M;G0M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R('=I9'1H M/3-$,3,E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[("<^+3PO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^,BPT,#`L,#`P/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^,"XR M,#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M6QE/3-$)V1IF4Z(#$P<'0[("<^17AP:7)E9"]#86YC96QL M960\+V9O;G0^/"]D:78^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[("<^+3PO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R`G/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M&5R8VES960\+V9O;G0^/"]D:78^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE M9G0@#L@)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O M6QE/3-$)V1IF4Z(#$P<'0[ M("<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)V)O#L@ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R`G M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M#L@8F]R9&5R+6)O='1O;2US='EL93H@'0M86QI9VXZ(&QE9G0[("<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M#L@8F]R9&5R M+6)O='1O;2US='EL93H@'0M86QI9VXZ(')I9VAT.R`G/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^+3PO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O M='1O;3H@,G!X.R`G/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P M<'0[("<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O6QE M.B!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT('-T>6QE/3-$ M)V1IF4Z(#$P<'0[("<^,BPT,#`L,#`P/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G M/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)V)O#L@8F]R M9&5R+6)O='1O;2US='EL93H@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/C`N,C`\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`@#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@8F=C M;VQO3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M&5R8VES M86)L92`M('!E#L@)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)V)O6QE.B!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R`G/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[("<^,BPT,#`L,#`P/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O#L@)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R`G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^ M/"]T86)L93X\+V1I=CX-"CQP/B8C,38P.SPO<#X-"CQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6QE/3-$ M)W=I9'1H.B`S-G!T.R`G/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM6QE/3-$)V1IF4Z(#$S<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F M=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO2XF(S$V,#LF(S$V,#M4:&4@;W=N97)S:&EP(&]F(%-A M9&1L97=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[("<^)B,Q-C`[/"]D:78^ M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ("UW96)K:70M;&5F M=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M#L@=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN+6QE9G0Z(#,V<'0[ M(&UA6QE/3-$)V1I6QE/3-$)V9O;G0M3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#$P<'0[("<^26X@2F%N=6%R>2`R,#$R+"!,:69E2!,:69EF4Z(#$P<'0[("<^8BD\+V9O;G0^/"]T M9#X-"CQT9"!W:61T:#TS1#@Y)3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE(&5N=&5R960@:6YT;R!V87)I;W5S(&-O;G-U M;'1I;F<@86=R965M96YT3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\T96(S83%C,5]E,#4S7S1A-&)?834R-5\Q,&$R8C-E M8S)E93D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5B,V$Q8S%? M93`U,U\T831B7V$U,C5?,3!A,F(S96,R964Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'`^)B,Q-C`[/"]P/@T*/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$S M<'@[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@=&5X="UI;F1E;G0Z(#!P M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`S-G!T.R`G/@T*/&1I=B!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM M6QE/3-$)V1I'0M86QI9VXZ("UW96)K:70M M;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@8F%C:V=R;W5N9"UC;VQO2XF(S$V M,#LF(S$V,#M4:&4@;F]T92!B96%R3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M'1087)T7S1E8C-A,6,Q7V4P-3-?-&$T8E]A-3(U 17S$P83)B,V5C,F5E.2TM#0H` ` end XML 13 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 31, 2012
Fair Value Measurements [Abstract]  
FAIR VALUE MEASUREMENTS

 

2.
FAIR VALUE MEASUREMENTS
 
The Company utilizes the accounting guidance for fair value measurements and disclosures for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the condensed consolidated financial statements on a recurring basis or on a nonrecurring basis during the reporting period.  The fair value is an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based upon the best use of the asset or liability at the measurement date.  The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability.  The accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.  These tiers are defined as follows:
 
  Level 1  - Observable inputs such as quoted market prices in active markets
     
 
Level 2
- Inputs other than quoted prices in active markets that are either directly or indirectly observable
     
 
Level 3
- Unobservable inputs about which little or no market data exists, therefore requiring an entity to develop its own assumptions
 
As of March 31, 2012, the Company held certain financial assets that are measured at fair value on a recurring basis.  These consisted of cash and cash equivalents, investments in marketable securities and restricted cash.  The fair values of the cash and cash equivalents and restricted cash is determined based on quoted market prices in public markets and is categorized as Level 1.  The investment in marketable securities is determined by the Company based on market prices other than quoted prices in active markets and is categorized as Level 2.  These are also categorized as held-to-maturity securities.  The Company does not have any financial assets measured at fair value on a recurring basis as Level 3 and there were no transfers in or out of Level 1, Level 2 or Level 3 during the three months ended March 31, 2012 and the period October 8, 2010 (Date of Formation) through March 31, 2012.
 
The following table sets forth by level, within the fair value hierarchy, the Company’s financial assets accounted for at fair value on a recurring basis as of March 31, 2012 and December 31, 2011:
 
 
         
Assets at Fair Value Using
 
         
Quoted Prices in
   
Significant
   
Significant
 
         
Active Markets
   
Other
   
Other
 
         
for Identical
   
Observable
   
Unobservable
 
         
Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
March 31, 2012
                       
Cash and cash equivalents
  $ 1,734     $ 1,734     $ -     $ -  
                                 
December 31, 2011
                               
Cash and cash equivalents
  $ 33     $ 33     $ -     $ -  
 
 
The Company has other financial instruments, such as accounts payable and other liabilities which have been excluded from the tables above.  Due to the short-term nature of these instruments, the carrying value of accounts payable and other liabilities approximate their fair values.  The Company did not have any other financial instruments with the scope of the fair value disclosure requirements as of March 31, 2012.
 
Non-financial assets and liabilities, such as goodwill and long-lived assets, are accounted for at fair value on a nonrecurring basis.  These items are tested for impairment on the occurrence of a triggering event or in the case of goodwill, on at least an annual basis.  The Company's annual test on its long-lived assets indicated that the carrying value of its long-lived assets was recoverable and that no impairment existed as of the testing date. 

 

XML 14 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
Mar. 31, 2012
Dec. 31, 2011
CURRENT ASSETS:    
Cash and cash equivalents $ 1,734 $ 33
Loan receivable 32,000 0
Total Current Assets 33,734 33
Intangible assets - net 6,000,000 6,000,000
Other assets 6,000 0
TOTAL ASSETS 6,039,734 6,000,033
CURRENT LIABILITIES:    
Short-term debt 338,000 3,000,000
Accrued expenses 35,500 356,200
Total Current Liabilities 373,500 3,356,200
Commitments and Contingencies      
STOCKHOLDERS' EQUITY:    
Common stock, $.001 par value, 200,000,000 shares authorized; 25,205,101 and 6,195,101 shares issued and 25,204,983 and 6,194,983 shares outstanding at March 31, 2012 and December 31, 2011, respectively 25,205 6,195
Additional paid-in-capital 6,212,672 3,003,342
Deficit (562,406) (356,467)
Less: Cost of common stock in treasury, 118 and 118 shares at March 31, 2012 and December 31, 2011, respectively (9,237) (9,237)
Total Stockholders' Equity 5,666,234 2,643,833
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 6,039,734 $ 6,000,033
XML 15 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
3 Months Ended 18 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Cash flows from operating activities:      
Net loss $ (205,939) $ 0 $ (562,406)
Adjustments to reconcile net loss to net cash used in operating activities:      
Non-cash compensation 63,340 0 63,340
Changes in operating assets and liabilities:      
Increase in other assets (6,000) 0 (6,000)
Decrease in accrued expenses (155,700) 0 200,500
Net Cash Used In Operating Activities (304,299) 0 (304,566)
Cash flows from investing activities:      
Advances on loans (32,000) 0 (32,000)
Net Cash Used In Investing Activities (32,000) 0 (32,000)
Cash flows from financing activities:      
Proceeds from contributions from shareholders   0 3,000,300
Proceeds from related parties 338,000 0 338,000
Repayment of debt 0 0 (3,000,000)
Net Cash Provided by Financing Activities 338,000   338,300
Net increase in cash 1,701 0 1,734
Cash and cash equivalents - Beginning of period 33 0 0
Cash and cash equivalents - End of period 1,734 0 1,734
Supplemental disclosure cash flow information:      
Cash paid for interest 0 0 0
Cash paid for income taxes 0 0 0
Non-cash during the year for:      
Issuance of common stock     5,000
Intangible asset in exchange for short-term debt     6,000,000
Common stock issued in exchange for debt and interest 3,165,000   3,165,000
Statement [Line Items]      
Net assets acquired     0
Common stock issued
     
Statement [Line Items]      
Effect of reverse acquisition     1,195
Paid-in capital in connection with common stock issued
     
Statement [Line Items]      
Effect of reverse acquisition     8,042
Treasury stock acquired
     
Statement [Line Items]      
Effect of reverse acquisition     $ (9,237)
XML 16 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 17 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2012
Description of Business and Summary of Significant Accounting Policies [Abstract]  
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

1.
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
The consolidated balance sheet as of March 31, 2012 and the consolidated statements of operations, stockholders' equity and cash flows for the periods presented have been prepared by Emerging Media Holdings, Inc. and Subsidiaries (the "Company" or "EMH") and are unaudited.  In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in stockholders' equity and cash flows for all periods presented have been made.  The information for the consolidated balance sheet as of December 31, 2011 was derived from audited financial statements of the Company.
 
Organization
 
Emerging Media Holdings, Inc. (the "Company" or "EMH") was incorporated in the State of Nevada.  The Company directs its operations through its subsidiaries.  During 2011, the Company sold its media business in Moldova in exchange for 730,000 of its common shares.  In December 2011, the Company entered into an exchange agreement and purchased LifeStyle Medical Corp. ("LMC").  In connection with the acquisition, the operations of the Company are now the operations of LMC.  LMC operates its business under a License related to patent rights used in connection with the operations of medical clinics that provide medical services related to men's health, with proprietary trade names and logo designs.
 
The Company is considered a development stage enterprise as defined in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 915, "Development Stage Entities" ("ASC 915").  The Company has limited revenue to date, continues to raise capital and there is no assurance that ultimately the Company will achieve a profitable level of operations.
 
Acquisition of Lifestyle Medical Corporation
 
On December 29, 2011, the Company closed an acquisition of 100% of the outstanding shares of Lifestyle Medical Corp., incorporated under the laws of Florida, pursuant to an Exchange Agreement, executed on that date, by and between the Company and Lifestyle Medical Corporation. The consideration paid by the Company for the acquisition of LMC was 5,000,000 shares of the Company's common stock paid to the holders of 100% of the outstanding shares of LMC, valued at $2,500,000, the fair market value at the date of issuance.LMC was incorporated under the laws of the state of Florida on November 14, 2011, and on December 27, 2011 (immediately prior to LMC’s acquisition by the Company) acquired 100% of the membership interests in Elite Professional IP Licensing, LLC, a Delaware limited liability company formed on October 8, 2010 (“Elite”), and 100% of the outstanding shares of Regional Professional Alliance, Inc., a Florida corporation incorporated on October 11, 2010 (“RPA”).  LMC, Elite and RPA are entities under common control and all three entities have the same ownership. At the time of its acquisition by LMC, Elite was the assignee, pursuant to an assignment effective May 9, 2011 (the “Assignment”), from Worldwide Medassets, Ltd. SAL (“WMA”) of WMA’s rights as licensee under an October 5, 2010, License Agreement (the “License” or "License Agreement") with Modular Properties Limited, Inc., as Licensor (“MPL”).  The fee that was payable to WMA in connection with the Assignment of the MPL License was $6,000,000, represented by a secured promissory note dated May 7, 2011 the (“WMA Note”) in the principal amount of $6,000,000 issued by Saddleworth Ventures, LLC, a Florida limited liability company ("Saddleworth Ventures") to WMA.  At that time the ownership of Saddleworth Ventures was identical to the ownership of Elite (now a wholly-owned subsidiary of the Company).  Mr. Christopher Smith, the Company's Chief Executive Officer, had a 25.6% equity interest in Elite at the time of the assignment of the license and the same interest in Saddleworth Ventures.  As of the December 27, 2011 acquisition of Elite by LMC, $3,000,000 of the amount owing under the WMA Note had been paid to WMA.
 
For accounting purposes only, the transactions between LMC with Elite and RPA and the transaction between EMH and LMC were treated as a recapitalization of LMC, as of December 29, 2011, with LMC as the acquirer.  The financial statements prior to December 29, 2011, are those of LMC and reflect the assets and liabilities of LMC at historical carrying amounts.  The financial statements show a retroactive restatement of LMC's historical stockholders' equity to reflect the equivalent number of shares issued to LMC.
 
Acquisition by the Company of the Rights to the License with MPL
 
As of January 5, 2012,  Saddleworth Ventures, with the consent of WMA, assigned the WMA Note to Saddleworth Consulting, LLC, a Florida limited liability company (“Saddleworth Consulting”), and Saddleworth Consulting assumed all obligations under the WMA Note, $3,000,000 of the principal amount of which was outstanding as of the date of the assignment.
 
Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and accrued interest on the WMA Note.  In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA were satisfied by Saddleworth Consulting.  
 
 
Going Concern
 
The consolidated financial statements for the three months ended March 31, 2012 and December 31, 2011 have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.  The Company has a past history of recurring losses from operations and is a development stage company.  The Company will require additional funding to execute its future strategic business plan.  Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue to support its cost structure.  These factors raise substantial doubt about the Company's ability to continue as a going concern.
 
Significant Accounting Policies
 
The Company’s significant accounting policies are summarized in Note 1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.  There were no significant changes to these accounting policies during the three months ended March 31, 2012 and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.
XML 18 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Unaudited) Parenthetical (USD $)
Mar. 31, 2012
Dec. 31, 2011
STOCKHOLDERS' EQUITY:    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 200,000,000 200,000,000
Common stock, shares issued (in shares) 25,205,101 6,195,101
Common stock, shares outstanding (in shares) 25,204,983 6,194,983
Less: Cost of common stock in treasury, shares (in shares) 118 118
XML 19 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2012
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

 

11.
RELATED PARTY TRANSACTIONS
 
During the year ended December 31, 2011, Elite had activities with Saddleworth Ventures, a related party.  The ownership of Saddleworth Ventures is identical to the ownership of Elite.  Saddleworth Ventures assigned the rights to Elite as licensee under the License Agreement with MPL.  In connection with the purchase of the license , $3 million of the $6 million purchase price was paid by the members of Elite on the amount owing under the WMA note.
XML 20 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Mar. 31, 2012
May 11, 2012
Document and Entity Information [Abstract]    
Entity Registrant Name EMERGING MEDIA HOLDINGS INC  
Entity Central Index Key 0001307140  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Document Type 10-Q  
Document Period End Date Mar. 31, 2012  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Common Stock, Shares Outstanding   25,205,101
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
XML 21 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2012
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

 

12. COMMITMENTS AND CONTINGENCIES
 
Consulting Agreements
 
  a)
In January 2012, Lifestyle entered into a consulting agreement with Saddleworth Ventures LLC ("Consultant").  The Consultant will provide services for management consulting, business advisory, shareholder information and public relations.  The term of the agreement is for three years.  Upon execution of the agreement, Lifestyle issued a payment to the Consultant in the amount of $25,000.  Additional cash fees or reimbursement of expenses shall be agreed upon by Lifestyle and the Consultant from time to time during the term of the agreement.
 
  b) During 2012, Lifestyle entered into various consulting agreements with third parties in connection with business advisory services.  For the three months ended March 31, 2012, consulting services amounted to $40,500.

 

XML 22 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
3 Months Ended 18 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS      
Revenues $ 0 $ 0 $ 0
Costs and expenses:      
Selling, general and administrative expenses 160,939 0 397,406
Total costs and expenses 160,939 0 397,406
Loss from operations (160,939) 0 (397,406)
Other income (expense):      
Interest expense (45,000) 0 (165,000)
Loss from operations before provision for income taxes (205,939) 0 (562,406)
Provision for income taxes 0 0 0
Net loss $ (205,939) $ 0 $ (562,406)
Loss per common share (in dollars per share) $ (0.01) $ 0.00  
Weighted average common shares outstanding - basic and diluted (in shares) 17,264,661 5,000,000  
XML 23 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACCRUED EXPENSES
3 Months Ended
Mar. 31, 2012
Accrued Expenses [Abstract]  
ACCRUED EXPENSES

 

6.
ACCRUED EXPENSES
 
 
   
March 31,
   
December 31,
 
   
2012
   
2011
 
Interest
  $ -     $ 120,000  
Acquisition costs
    -       200,000  
Other
    35,500       36,200  
    $ 35,500     $ 356,200  

 

XML 24 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
DEBT
3 Months Ended
Mar. 31, 2012
Debt [Abstract]  
DEBT

 

5.
DEBT
 
Short-term debt as of March 31, 2012 and December 31, 2011 were as follows:
 
 
   
March 31,
   
December 31,
 
   
2012
   
2011
 
Secured promissory
  $ -     $ 3,000,000  
 note to Worlwide Medassets, Ltd. SAL,
               
 interest @ 6% per annum.  The note was
               
 paid in full February 2, 2012 (1)
               
                 
Unsecured promissory note, interest free,
               
 due July 15, 2012 (2)
    200,000       -  
                 
Unsecured promissory note, interest free,
               
 due August 15, 2012 (3)
    75,000       -  
                 
Unsecured promissory note, interest free,
               
 due June 1, 2012 (3)
    60,000       -  
                 
Unsecured promissory note, interest @ 10%
               
 per annum, due July 3, 2012 (4)
    3,000       -  
      338,000       3,000,000  
Less: Current portion
    338,000       3,000,000  
    $ -     $ -  
 
(1) Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and accrued interest on the WMA Note.  In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA, a shareholder of the Company, were satisfied by Saddleworth Consulting.
 
(2) On January 5, 2012, LMC borrowed $200,000 from the Dellinger Fund, a shareholder of the Company.  The note is interest free and has been extended to July 15, 2012.  In the event of default, the Dellinger Fund has the right to request and will be granted the issuance of two million shares of the Company's common stock.
 
(3) On February 3, 2012 and March 1, 2012, LMC borrowed $75,000 and $60,000, respectively, from the Dellinger Fund, a shareholder of the Company.  The unsecured notes are interest free and are due August 15, 2012 and June 1, 2012, respectively.  In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.
 
Interest expense for the three months ended March 31, 2012 and 2011 and the period October 8, 2010 (Date of Formation) through March 31, 2012 amounted to $45,000, $-0- and $165,000, respectively.
XML 25 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2012
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

 

13.
SUBSEQUENT EVENTS
 
 
  a)
In April 2012, Lifestyle borrowed $112,000 from the Dellinger Fund, a shareholder of the Company.  The note bears interest @ 10% per annum and is due July 31, 2012.
  b)
In April 2012, Lifestyle advanced Health Clinics of Florida, LLC an additional $4,500.  The advance is in addition to the previous advance in February 2012.  See Note 4 for further information.

 

XML 26 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2012
Stock-Based Compensation [Abstract]  
STOCK-BASED COMPENSATION

 

9.
STOCK-BASED COMPENSATION
 
The Company accounts for stock-based compensation under ASC 718, "Compensation - Stock Compensation" ("ASC 718").  The compensation cost of the portion of the awards is based on the grant date fair value of these awards as calculated for either recognition or pro forma disclosure under ASC 718.
 
For the three months ended March 31, 2012 and 2011, the Company issued 10,000 and -0- shares and recorded compensation expense of $5,500 and $-0-, respectively.
XML 27 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
INCOME TAXES
3 Months Ended
Mar. 31, 2012
Income Taxes [Abstract]  
INCOME TAXES

 

7. INCOME TAXES
 
The Company adopted the provisions of ASC 740, "Income Taxes", ("ASC 740").  As a result of the implementation of ASC 740, the Company recognized no adjustment in the net liability for unrecognized income tax benefits.  The Company believes there are no potential uncertain tax positions and all tax returns are correct as filed.  Should the Company recognize a liability for uncertain tax positions, the Company will separately recognize the liability for uncertain tax positions on its balance sheet.  Included in any liability for uncertain tax positions, the Company will also setup a liability for interest and penalties.  The Company’s policy is to recognize interest and penalties related to uncertain tax positions as a component of the current provision for income taxes.
 
There is no U.S. tax provision due to losses from U.S. operations during the three months ended March 31, 2012 and 2011.  Deferred income taxes are provided for the temporary differences between the financial reporting and tax basis of the Company's assets and liabilities. The principal item giving rise to deferred taxes is the net operating loss carryforward in the U.S.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  The Company has set up a valuation allowance for losses for certain carryforwards that it believes may not be realized.
 
Section 382 of the U.S. Internal Revenue Code imposes an annual limitation on the availability of NOL carryforwards to offset taxable income when an ownership change occurs.  The Company's reverse capitalization meets the definition of an ownership change and some of the NOL's will be limited.
XML 28 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS' EQUITY
3 Months Ended
Mar. 31, 2012
Stockholders' Equity [Abstract]  
STOCKHOLDERS' EQUITY

 

8.
STOCKHOLDERS' EQUITY
 
Pursuant to a Stock Purchase Agreement, dated as of February 8, 2012, between the Company and Saddleworth Consulting, the Company agreed to issue 19,000,000 shares of its common stock to Saddleworth Consulting in exchange for the satisfaction by Saddleworth Consulting of the outstanding $3,000,000 principal balance and $165,000 of accrued interest on the WMA Note.  In consideration of the stock issuance, such outstanding principal balance and all obligations under the WMA note to WMA, a shareholder of the Company, were satisfied by Saddleworth Consulting.
XML 29 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
WARRANTS
3 Months Ended
Mar. 31, 2012
Warrants [Abstract]  
WARRANTS

 

10.
WARRANTS
 
On February 6, 2012, the Company issued warrants as compensation to a third party to purchase 2,400,000 shares of the Company's common stock for services performed.  The warrants expire February 6, 2017.  The estimated value of the compensatory warrants was determined using the Black Scholes pricing model using the following assumptions:  Expected term of 5 years, a risk free interest rate of 4%, a dividend yield of -0-% and volatility of 64%.  The fair value of the warrant amounted to $57,840 and is included in the Company's consolidated statement of operations for the three months ended March 31, 2012.
 
The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company's common stock issued to non-employees of the Company.  The warrants were granted in lieu of cash compensation for services performed.
 
         
Weighted Average
 
   
Shares
   
Exercise Price
 
Outstanding, January 2012
    -     $ -  
Granted
    2,400,000       0.20  
Expired/Cancelled
    -       -  
Exercised
    -       -  
Outstanding - period ending March 31, 2012
    2,400,000     $ 0.20  
Exercisable - period ending March 31, 2012
    2,400,000     $ 0.20  

 

XML 30 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENT OF EQUITY (Unaudited) (USD $)
Total
Common Stock
Additional Paid In Capital
Retained Earnings (Deficit)
Treasury Stock
Balance at Oct. 08, 2010 $ 0 $ 5,000 $ (5,000) $ 0 $ 0
Balance, (in shares) at Oct. 08, 2010   5,000,000      
Effect of reverse acquisition   1,195 8,042   (9,237)
Contribution of capital from shareholders 3,000,300        
Net loss (562,406)        
Balance at Mar. 31, 2012   25,205 6,212,672   (9,237)
Balance, (in shares) at Mar. 31, 2012 25,204,983 25,205,101      
Balance at Dec. 31, 2010 0 5,000 (5,000) 0 0
Balance, (in shares) at Dec. 31, 2010   5,000,000      
Effect of reverse acquisition 0 1,195 8,042 0 (9,237)
Effect of reverse acquisition (in shares)   1,195,101      
Contribution of capital from shareholders 3,000,300 0 3,000,300 0 0
Net loss (356,467) 0 0 (356,467) 0
Balance at Dec. 31, 2011   6,195 3,003,342 (356,467) (9,237)
Balance, (in shares) at Dec. 31, 2011 6,194,983 6,195,101      
Issuance of common stock for repayment of note payable and accrued interest 3,165,000 19,000 3,146,000 0 0
Issuance of common stock for repayment of note payable and accrued interest (in shares)   19,000,000      
Issuance of common stock for services 5,500 10 5,490 0 0
Issuance of common stock for services (in shares)   10,000      
Issuance of warrants 57,840 0 57,840 0 0
Net loss (205,939)     (205,939)  
Balance at Mar. 31, 2012   $ 25,205 $ 6,212,672 $ (562,406) $ (9,237)
Balance, (in shares) at Mar. 31, 2012 25,204,983 25,205,101      
XML 31 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
LOAN RECEIVABLE
3 Months Ended
Mar. 31, 2012
Loan Receivable [Abstract]  
LOAN RECEIVABLE

 

4.
LOAN RECEIVABLE
 
On February 3, 2012, LMC loaned $32,000 to Health Clinics of Florida, LLC.  The unsecured note is interest free and due May 15, 2012.  In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.  The manager of Health Clinics of Florida, LLC is a shareholder of the Company.

 

XML 32 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 37 82 1 false 4 0 false 3 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://xbrl.emergingmediaholdings.com/20120331/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 001000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://xbrl.emergingmediaholdings.com/20120331/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (Unaudited) false false R3.htm 001010 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Parenthetical Sheet http://xbrl.emergingmediaholdings.com/20120331/role/ConsolidatedBalanceSheetsUnauditedParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) Parenthetical false false R4.htm 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://xbrl.emergingmediaholdings.com/20120331/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) false false R5.htm 003000 - Statement - CONSOLIDATED STATEMENT OF EQUITY (Unaudited) Sheet http://xbrl.emergingmediaholdings.com/20120331/role/ConsolidatedStatementOfEquity CONSOLIDATED STATEMENT OF EQUITY (Unaudited) false false R6.htm 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://xbrl.emergingmediaholdings.com/20120331/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) false false R7.htm 006010 - Disclosure - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://xbrl.emergingmediaholdings.com/20120331/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 006020 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://xbrl.emergingmediaholdings.com/20120331/role/FairValueMeasurements FAIR VALUE MEASUREMENTS false false R9.htm 006030 - Disclosure - INTANGIBLES Sheet http://xbrl.emergingmediaholdings.com/20120331/role/GoodwillAndIntangibles INTANGIBLES false false R10.htm 006035 - Disclosure - LOAN RECEIVABLE Sheet http://xbrl.emergingmediaholdings.com/20120331/role/LoanReceivable LOAN RECEIVABLE false false R11.htm 006040 - Disclosure - DEBT Sheet http://xbrl.emergingmediaholdings.com/20120331/role/ShortTermDebt DEBT false false R12.htm 006050 - Disclosure - ACCRUED EXPENSES Sheet http://xbrl.emergingmediaholdings.com/20120331/role/AccruedExpenses ACCRUED EXPENSES false false R13.htm 006060 - Disclosure - INCOME TAXES Sheet http://xbrl.emergingmediaholdings.com/20120331/role/IncomeTaxes INCOME TAXES false false R14.htm 006065 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://xbrl.emergingmediaholdings.com/20120331/role/StockholdersEquity STOCKHOLDERS' EQUITY false false R15.htm 006066 - Disclosure - STOCK-BASED COMPENSATION Sheet http://xbrl.emergingmediaholdings.com/20120331/role/StockBasedCompensation STOCK-BASED COMPENSATION false false R16.htm 006068 - Disclosure - WARRANTS Sheet http://xbrl.emergingmediaholdings.com/20120331/role/Warrants WARRANTS false false R17.htm 006070 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://xbrl.emergingmediaholdings.com/20120331/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R18.htm 006080 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://xbrl.emergingmediaholdings.com/20120331/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R19.htm 006090 - Disclosure - SUBSEQUENT EVENTS Sheet http://xbrl.emergingmediaholdings.com/20120331/role/SubsequentEvents SUBSEQUENT EVENTS false false All Reports Book All Reports Process Flow-Through: 001000 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Oct. 08, 2010' Process Flow-Through: 001010 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Parenthetical Process Flow-Through: 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' emdh-20120331.xml emdh-20120331.xsd emdh-20120331_cal.xml emdh-20120331_def.xml emdh-20120331_lab.xml emdh-20120331_pre.xml true true ZIP 33 0001214659-12-002341-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-12-002341-xbrl.zip M4$L#!!0````(`$1PL4"'LFO_Z3P``$Q>`P`1`!P`96UD:"TR,#$R,#,S,2YX M;6Q55`D``Q\]M4\?/;5/=7@+``$$)0X```0Y`0``[%WI<^,XKO\^5?,_\'G? MSE$5)SX2Y^A.;Z5SS$M-IY-)TC.[GU*T1-OO_X!E&3KEFS+CNUP M*M5C6Q3P`PB`($A*'__Q.C3(,[-L+LS36G.W42/,U(3.S?YI[=M#_>SA_/JZ M]H]//_[P\7_J=?(;,YE%'::3[IAJ]%H[OWSYLN# M-F!#6N7N]1F M07.+]3);=_;@:M#0=(?I#77'VG/&([8'+9C%MJ-9GZK'9'VTE4R9C_'EOLMYJ'>7=X M+8(;=,;3T<.%%.B@"M1=NI+DE31Y$_;J.U_S^/AX3UZM@<\2\A$_^EYWSWI$ M7CI!W9_6;#X<&2BG_&T@;1I]J!XXAW2N/8^.Y_V:@`CQZA`.IG!F/]WVGK#M M4Z/]!-ADPTE39CK<&?N_37[E.O[>X\PB$A2+"!%HZOSZ]]JG!L21=N.PN=_X MN!>_.6"UE\++YS0"[Q!Z@K_L7><3PJXWVJ#2"7'_2I1RB$KPDZ^#0K4TGT`S MFZ>69ATT4[U:+I[:-YMF+""YY5Q`1//-!9TPH#*]%KN)F7KHEK"%!5_QO$Z>6OC"?X: M1QNARY"W>IH\6MHPZ:OEZ?SA#30S-1X&DX2)6),+.L!X'1EG6>ZSG$.2XT[RO5K\YR.N$.-K>_:^\LM[]A[YE!N M,OV26B;6"[:^1Q^W/?(^6HS:KC7>^MB[B?/-QG+FF_%IN,HO5F'C2RH>)#I3 MY1=;V[4JO]BV'E7YQ59TIU\+4@/I*CISV8L306>J@71KNU8-I-O6HVH@W>3N MC*V`JG%T:7VYINNV<0-08Z\R!S5>*RNX46/\NS:!4,%D2V MK4?5Z+MIW>F:W.O+;P\7L;X;2E'9)_^I`2?0(B`47`H31TJIE!\&U&)V!G%? M-[+)7-0OA&%0R[YCEN038Z/S9["7N"KQYJ_X5`KJ""MN+J4%#RL[G6*(W04S MQ9";^0R+E!'GF"0:7`W)G=2@SOC)I;2[>];GMF.!\7RE0T9\^[C'YRLDCL%? MWES>_W;]]3=R[>H<6WJ[/5W-L[G M&/;]3!)3#N>N9<&U*VYKU/@7H]:EEV#F,ZD'OI1'(B[&%3>8=0X7^L(J$.)A M2`UH3.[92%@.C`($8PLUQV&9(O2FS"Z$YF+,>!R/"J2`D/"'1S!\3Y+25+(K M^,7.)XJ?HT1CMR?IW\F@4TKQX0E!)HDL";Q&)63XHYDF0>CV*8#$?P(MA/-&O;=L%8\@E_E6$32.#1)S3G\)P M39B#>:94H)0HA]BM"9?U?&)BOSA2%FG]7QB_BD@D&$UG-=Z0<>LZ.+#ALY"( MSC0.GF2?UAJU"._$,R8(!CIY*1AX6@>MQD&ST8Q`RF'F`9M,MJ@]P*3@F1HR M'W#.J66-H=F?U'!9.6!2*U-@>@"Z\]:&1^>3L-^=\40SZCBD%EZ&0A4%58:`:N M1:USD6YJ'Z<8YIQ,\M2>M,KGP`KLA9D:M) MGQ5&O&H)3N\.70.?EWG!>ECAFE\Q=7"H_49GBJB8V1+`9:BK#NZ^WSF<'URD M.KB@VQRWVB$D2_XQ%J8.GJUT_EE/NAT.JUP1I,D7@'S#+%; MG?WV43C3*6(>&@P@#E>IAT1F5\2JE407UVQ"V M=FFE)6K`NPV<[<_`=ADXDSI<(DZOB''F.I"N\O\R?2[CFQ1,&HUX&IS#JDI, M29TM!9.LH2VHHTE1J8!+55"R58.I3@5(9BNWY<+9/SYJY\#)K+5%!ANO[4*= MU&P>98QD7HLJN&X"`[=A,-M9-$;M M'T02K!C9!7D6J[DJ?OGJ;79FDC+0^)4EAEZQS86>\+M$F/9GUA,6\]H]TE=F M7[Y"`!(69#?4&E\[;&A_%28"M(2,5P&_^=T",L^(6RP1Y!IIHXS];+<>"L)& MO+:V,G7XM?`)'=^3/L/`W,LKR)7/8/,Y5(NFQ,B[$C2EL]M9X-Q9`GZK:ER< M4IN'RXSFG,6LV,SOF/69VER#I.6"&Z[#]'@-IU76,!,EG'IC-SSUGAO,RF1* M]FI")A!IIJB:*Q*^J.GD+\;[`_C][!GNZ3._(A`O!L2(S!,X)G/OPU9GO].! MGIF?__+Q)_LBP'\0%+L6A5]1N2?T\HLN@F2^`M^H07>^O!-`;"RD/S23BZ=+EA`BM,:;+.($E1WP[W6WO M+VKA=N#YIX$'AT?[T4$GA\M2$*4J=`%8BV]U#(X_SU68?GMO3)4@;;O`1KMC MGO4DM@ALA:3WEX5IW%;(^9BPVWITV7PI4J+SPB#/=#Q"`"F^S+[F#JN==CL< MO]*I5X.@1+UY*=SS9QAS*``Z$==QV`7S_G]MWCH#9DT*=$7;+8LJ.YU89:H, MM^4@+%5M>0-T!9/&92@PN>MQ@8KVP<%A/L(DMV7@FZ=[EXTLOVOQ_="+:0XW M8E-[`(D:'H[3/X^_V;AW?&H-FL.?%^S?=F._=1PJS9;GN3RLQ7W]MBB+5D,: M^P>=SN)@[^A8;IJ]$E8X5X_MUI^[ZV-'5V_EH.DH*^FELS]VSDA[_; MWA=A]O$`TD*=%$*11;LJ!,7]LCP$Q;X3Z9!R0#("TA4WJ:E5,ZK$+:4\RV5` M+;3J=A58\28\P!0]:>P=S8\G]_-OTSJ,5$)G8+E,L"66F-\<:<$FFL3I]?G1 M+GB6O8PJ5W:TWE^!J0A.4`?$TUI5A/XPO44XE=_*-3^GTML?\EA--K94R"U" M8M_ZP)Q-2EVJ/&?GR==AV@)M=:UU&AY59*9T:Z0'DE MUR8K*Z\L`BK5"A=%5F9#9JYJ$L?C%]S]663-A?SDUKCI5IO0-I0,#FT;)F$*Q:OLN$K&3O?>D#-=88W091KO,L>V@NY5S>NIPU, MR^)59'>+9@]%SP3(S2$F$\GCR-;^>1"L()](=9BUS"/2;7GA)**JG>.E_7Q5 M6]E+A\)5`2H]6A0!*BB]R1GE;:^RTE_YHE\ZY^I7'@J*+#,MA%3R=)CT"%C\ MO)JWSZ*SAY1.LK:VJ6EF0;DA^NS`K9"T1)5A*^1\D_,)T_CL5>U-/8C3,.8& MC]VYMA>PK)!X\^NZKGFEO*!T71>4$N_.7,92S2JK9F66&3=O M;$^\WG+E)]CGG@[D0-^,IP>DO(UR]0?K5R[G-BX>)%Y5N/+J>NDG[^0'HP]^:G<8'_&E/_O;C#_A9Y\_$=L8&.ZWU M@%3=YO]E)Z39'KU^($BX3@W>-T](_85UOW.G;K">XU_A)KXD\X0T1O!+EVK? M^Y9P3;VN"4-8)\3J=W]I'1SLD."?7S^0(;7ZW)1$_/O\7RQ\](S_4VV*3EJ^ M?`/C`#>TX1_RK)$7KCN#TQJDC7^OD:ZPP(=D#TBTIS6-H7?4TB3S6!"-&88] MHKAUW.LZ^#ZBNNY_#T&PR+-/U1&C\`4]("_!G)!V)X8^I-NDPLJK`DFA!`$M MG=LC@XY/"#WM;:E7V-%P,J>X!H\MG1P[)$4?L"_]NU'=X;+X+B MZNSZGOQY]N7;);FY/'OX=G]Y<_GU\:$,-.^C-?V(QA!OOPE6G&L'M13_3,@6 MZX^25N499,5F]3A@PMP`Z[;!`(8H9J&&R@Q5^N[7,?9)I"P2`]"%[J0 MRXC_FE%Y%H9`JD6`IV8(_,V6;:EAD)YWI(,:A'KG]+&A$3K(C6)WJ_F/^[W86[E`^4:8#*I%F=FU6 MVJ=OW9G%_#>J4]X@K9_3C5NSY/[QOD\$2)2F4A>_]OQ:X,071V@S<.TLGYXF M))0?34B._O;\2I`VI0^9Z:%-0*P/ZPL]`ANR)-5"/F!33?![8!0^%PA MKVK`@VFSM'4;>4T+&UC2AS$0*2*5$F4!.YA89[)/(XS%!)W!M&G%V8 MF2GVR(4YK389CI$B4-!@EM[WW[L'^;D_A<@$/=5"MA)BN,:1OIW`C.*;(8_( M`][*Z6@T&6K8(GXG6EO=$?4A=5""<4B4PO*%+C`X"H<,*"#$7Q+F.H.53N5H M2REE0"0O^(\YK>](G6")"B(KV(W?8SN!!O!20"14K9)5##($CQS8$%)U`!1U MP8"C7\TBMYHCNM`G1_)R@_QR`6I#AE?"&LI'GOZ*1(7;'\0H%52M-S-RRN'R M#=<"\O*;]Z7=I=7$O?*:=!@_I#FRINT,,(@9Z%,[D%8Y`[_.G%X-#`4[K\^. M6LW##W9*4=RK/&)E&@N>I:)#8N"47GO!-#9$7_5_;?;!QCG;7ZNFJP>ML5CB.&DZ7C@U;Z!+*B2=<, M,\H,@,UUQ0>]#?U@RG?_3&KDT'6F>+'HZ+3F_7]-P4^5&\>;%L<\-UY_48IF MY6\/=F(TS<8$>7L_!CW-A-XZEYI92?[3Y6%(QDT[Q#M9]H MD*<"LPK,FVS?[\%.BK+"-8R_?W@5H+N@`O3.HJZRRK6TR@?`R7M`>^8M1-YD;5+/%.FJ$Q1F:+*1)4+ MJ4Q4V9Y%J:Y.U,YS:4/;X]ONVVQ_!QA'=FD2HI M75]/6C_PFV??[\%.-C#B>MNFWEFL5;:XEK;H'4]6MJAL4=FBRD&5#VVP#TDT M.M.$)4\=GA#7Q*=926+E6,I6C\))*Y45>"39(I=4IKVEIOV+?P;XUYG-6UGW MV^-3UEW*NEO*NI5U;ZUUM]^U=2\X67B7AA-]#L!2K,?G[Q_1KGLM3D@+SXYO M=KC91-'F<>L-E6\#>T<9GC(\97C*\)3A*<-;%_E2TNKI4]#_IFF,]7JU,HK` M1#OUX1W90F_<0S_.LYZ]6%4V/9O^UMHI?$S>6WM\\,$CI+H&U;Y_(-%K_OMU MI'C1*Y+4"9&OZ8@^B&OY$]/_G5<'QZO2@33^Y2JAN7/8WG^O$5+YK?);Y;?* M;]=<%.6WV^.W=>6SRF>5SRJ?W02?S:T@>.]1*UL_6'>'77=\Z[IV.T,<6+'7 MJC,QRL*5A2L+7Q]\FZI:9>'K(LJZX]M4U2H+?_OYQ*PKDM-V[VSK7^)]/TEU M1[Z\F]U_9>+0!LJ3'YPV4*!-+XLH]]DD>93[;*!\RGW611[E/ALHGW*?=9%' MN<^:R9<[!YUM34OMB5UPCJG6^]5Z_QJN][?;[S4X*J=53JN<5CGM.HNBG'9[ MG/;=[JQ3/JM\5OGL9OELJ'+@?93/EH_-@*>3?!]>F%L;A0C+6G]AW>_IW?VD='.R0X)]?9RD4)-`E6:8I(TNVF>[>1"WYAOQO MUW9X;URV5M/N+%ZL2=CGXX"1V&^G?RZ<*%1D*VM0?",%F M49#85J.6-08_QYCARH8E(=/1R!*O?$@=AH0XJ(+"/Y*,G8HPK$"=ZQ"*'$]D M_"%'FQ"^G($GF"9&@3`A=D#-U@QAHZ065LDLYMV(O=0CT2;7SMZ%?U10 MRYPI?+\[!2\E`'T59GWJ(%0^[5\Z9\@MIY&G+X3^P@W#:R%@)#?X,T04[[X= M0L%9?%?'.",L0IVP3PF34'!1TV*::UD8(;K4YIF>C;'%84-;TG68'1#EX._< M0G=$BNBW0D."S-2\:$,.%)QG=`1'2UX'O[ER>-$KQP9%W^>.>:]?[E(Y.K@#!GRC"[0CW MOSV"$7\VA/;]TX\_$/(Q:/6;K^TS4[\V'6KV.M3XGCF/[[[?J_@^J5%*35-&]@3PZW;.SM32A>S*;UX;T MS,ZG*6&+H#O&]EAVTNQ??\^1_`2;0$)`!E7-@X`M'TF_\[3..0X6\+%@3'DC M_AT;W?AWX?U88M"'7KY4)UCZ\?"QIZ+$SKR&YINKA*-G=&W1:ZE^0_<*$BZN M[]O77R\^7W9[\]"R]1Y&^3PKE.#4O.>;2X&@@J9\`105#%4;M.L`TES>Y;S[O10TOYFS5KHS M#;6)L<<5%LR#IZ'G..-WWI,+REE$?<%M3H-Q@W3!N&(-PH6\P5%C,N)'@8@H MT!;[7:`C8=VDBI=^VV]7[08!+^F1V^`PH364NQU5_XBAJ>$0[),'WX)5!OZ- M`AM^.Q9H435@;=!L@0\6"T(*MI%+,:2B#+L'C\#H\%R1<]0X*!_'85:(Y@Y0 M`*.&8[2J0%F[\#4\(/.JTF?F2;)@=;DEE/D2SR&E$XP<1UE('MS@*CB=M9H? M?A1DR*@#`^/HL14'>C#@H1>,$VL'+0;8.[`M'/+-Y3A0+X3Q!-G'GY/A6H<_ MQMMGDSO$A4A_:?YX4&GN36UY<0LH&3"Y^*=[TK0,/"&--L;]4-IC\?VPWXD# M_%=$`YB$,ZY\IO2UX]E-/Y_'F_\$?XS)?NOP@(P9#43FW;/!`'<%?&&T`!O@ MLH[)1Y5;\)[D_6;`/FPT+#L8C$`;%T,969O<-9RG)1UA96RB;1G_UD"S\XFA M8R`'2O86-D5$CKPRW6:YO<61HQ`\C?_B5;FY)OM3K>^-J'LS49?9Z+'S!?N2 M^BEA+`=CH5,*X/9(Q7NH%%^*JX%YT1-*1@;`P,@V0YQSO*0_1JE$'R3`2T>] M2G^6T`*(!>CR$#>2J3-`VX!:(!7P,>G(":ZH`ZZ%E$F`5^YB,"QQO]2W4M;A M=OA,[HD,1U$N0$Q6,BF?6*@^PS'IR`M"6%,0G>"V`,BSTIM8";!3LD`P;HG^? M03\)M&"\!`4Y0/-)?*K?-J$/>_OU\]V_2E_ZK,]-0;J^W-^5?/OU$K\O?0T; M.[S-D[.C[+W4LQ[-3/S.\-@7<&ZF0@=QG.#L<&])P8!YWO0='^J?JJPG?6E5 MY=.4UM;9)O1+D<,^U[1BH[N<&$QJBLJG'^T,>ST508T M.O$;JRWC)8-)+3'9MJQH%,F0H0&D`>3Z`6F$I,&D;IC<7B%I+&##2,M9F"45 M^%)O1*:7=7M8TD![UAT`+:VYJJ<_MDUZX( M9=4^.TE]+F8MRZ)=4]FO2?$*%Z9%!EBH0%4PX*+>2;&:D;.25-362E-1/]2Q M4:@<]G=`..FZ]I).B+=TC;+7?J-FGXN86>5KXY'\!BUOIY?8<,;&;GQ7F04+ M[_G2WB5]R)P[N6KE6Z%^TG,GY+#+RK>O`:^4.2EY/VL-I2E?L1"[9?5^LD_- MDXK0S((L,7_CN\UAB)*&0=O&$(6-^>C/QR(?M=C`V7PQ^]-154#3*)(Y^.;8 M\$T-%$XMUDU"=*-C( M'GZZ]*A[AW69'Y&"=?>;>&'(W32.>,DKJN/U-XZXO&E?D[MNIWOQ:_OS97?) MG*/AJZ*<"9^I7=6A#=.-2[ZP?A#18$R.5"'-!KF\ZA`'!!:SR>Y1"V4M M5M'^6=7"[R15V0?D"ZP*MRG<<-FI+%0=N0*;+C'9(HT158F;!=BU:!`PU5;( MCIBL$M\\2=J:E0QVH2I.QVV5!L1F`QHY82,;+^G)%(4"9+.MVCPY%`M6BR'% M(O&6%<"C:$@H";#7&Y:N9B[Q68"2BNPW#_<.\"_97&F4E;2WDXOQLWINY815 M*7%9%'SVDLGWS4A9P(:>8ZM;T::GTPQU2K7^<1H=56J_]@"C.8BBFSJM4O(TI5HSQ<`TN0W+W">L&/V%;-5=FR#7(;V M>])K7RXK+F`$Q1N1OCZ)L9QUKXG(,!`W$-]PB!NM*)HT4JO2O-K3G'0C/G29BN[TU79I#<2-AEQG#!.+ M#OP2.5G5`;+?6E;I!OQHOMDMK(%YS#9E, MI;J[4NWT9[:<:?7I!DDSU8^2X.?QFP0_GU]/K?DAIFGYKH!NQ;`O;M[H=H MO/.JY;QD0GPBG2@(@"CB>T'(/==XXL:.WPH[?I4V0$V!;WC8\+#>/+Q2TT9# MZ"_1)Z]B\./USW)9LJHF4WDI=QY71G^N[)];_DX?OU)RG0R%]P,5# MX$6NG4`E>.COMTZPY%/\GX-R^J?(B??D_R(1\L%X9S9Y+R"B$+4Y.GU]V&9J MA_:;!^0V"D1$X=;0(Y3T0L_Z$[^SAE0PTGX(&!L!X0UBTY#9A`KB#;+&I6?J M7$6#]%GXQ)A+PB$C'6_D4W=,J&N3'H#.84]>$`[A>U=$3@@8;!2OPX?8^'PN M1,1(\V-B:Q,QI`&3C^2A()8W&GDNS!%IA,O+!X!!>[46A"(%\_&HWM?R)'W#7XCYU8`,=ZEI,3I%:5A`Q.SNF MZ:EE^.VJ3:Z]D)4V0;]P83:NX""#J*0I?K*:&ZX#CM\@(K*&!7(J:'`3,'VY]5I@\$\M]&ZG0.B`W+OF%NI+'3Q(>O[SJH-H,O"=`QF[R1PP\`Q$V&U"`<*.$9/D(_%HN)`X?L+\B)`*?_\2!Q_J,/`0@+/'I M0Y;RJ9S=DT=`03K(S)G8RLWYAZ(`6X"#ID'P&OVT%D@=24BE>B,YCX<+>T5! MV23IR9,H4W7UY'6[*A^U`;LB?`:2_)$Y(+&6B[\H/8:/2!0$!BC!(GY;5B\2 M?\LG6Q=I70R?D^HDKP02T0\3!%`J!40HX)2`-E%H!$;Q66#AJ/O-P[T#DAZ+ MS%;,3B[&S^JY;X7*3;6@+I)=8M]]!MA)#8YPB&`!;@^'@BAYI8!^U,R!!3XT MY0>\!7:(>S:YL4*O#YNE;*M#LG\>;],7+QA)_7Z`HWO1PW!JR!&L2*A$X^[Q MB6*7W7>'[Q0#-4]/ICEHUH[__6^1>/=`J?^I-P0#X)X%HW/6A_]_#S\[(,/^ M\;__0\C?DVO:EH6/%[=TC'9\V[7;RC2ZY+3/'1YR)LZYL!Q/`(>E@Z`AA!M\ MQP8_[9S_<73U!\[EC\.C/XZ:._]`@OP27/FO5>X+6!:Q&X:3(MS^:0=-2X[_ M("`S9^P00YO*K_QIYS`-."`/LJ`4W`I'Q`+))7QJP9CR1OP[]M;P[T+(-?$$ M0\\OQEOCX6,?5X%]9T[&7?;[X>E2`M4H*W%WJU]QOX*$=J=S]ZU[3KK_N>U> M][J]>0BJMW^J&3G/LX.D[H5\&3/A:>[UPNLX;9[XR^FQ_@<,]:0/MA;V`;YH M9;2>3D>SYD&0AL==4K6\B-3;@#-1!HY:PO&<66R$)N7V(;+DK;41[(:37K`P MDAJ;69X*V'Y2,58UV'R/E%>A;S.]J-O#D`;8FPOLYC8#^Q6:IO[52Y(PV++V MW.2)O-W1B1-39$^CDTC:$VO0/2?-S=86ISYMCZIK6W]%7'!Y:,/R1"B,SM,' MF1J+!Z/\#,RW`.8MDP"\:`+PE%[*9M,W^RK[1LZIUJ9[(&-RAK\#4"2KNLP34: M&34!O.%=P[NZ\N[ZS`L-$)\S+]3'ZG/5,\[^9]D)+\P\**8O7+B6-V+W]+L^ M.0JO.H^=/CB'J)JF,'QX7\(<^/GBNG-SU27W[?_$!_I?Y+"1. M+%7&,MLKB,M

62?.9P],IE[&C"97`B/]KT0'LNI M`P^P6!!2)`"&]3WU\E&DB=_X;<#"*'!5OJ+E!4!1B+GZ`^XPNY2`WM"+'+M\ MZK!VDU,LI:"XZ@@/B`XC?VK2:0(FKK//7.J@&GEN-]679ZWFAQ\%/-GAUACSF64R<;(> MY2/#!0Z-D_I2HD7 M"J[%-206#8(Q3.*)!G:B>7!!RY;C5^I$2J>!,O">J)PBK@9(&+![.`A1FSP- M8;XN@Y\$KH841W9DL0))R MWUQ.(LZ#[P>(7&`)Y3`I.2-Y",;VGEP6B"'W25QDR+-``S]K&?R`&OX1[@2% M37T@"["K2!LQR76J"@-W>6*@ECT+I8Y`:N+E`/IAX*0XB9SO+(;(>\VS'-ZB M:RRK0JE"&J+[5P1+AX6-]/&332[_"G/YSUZ?RY](I-=(AON;SK]^OKD\[][U M?B#=?W^[N/]]'KI>%AI85<=&ZN ML*9-^_[BYMKH0/UU8"'X';^ZDJI#BN!W?10M,LJ72)]8J,J`=1.4X$Y>-)%W ML1K-?[F3A,B;9Q4AT*YI;TLBR8<2TD"/6HXLM+?P381#8DXA/ZND!FG;E01=E_,"]+RE?]TJU MKFP$-K*'GWZC`:+>J/QM4OG-0RUT_F_MN[OV]?T6E*ZKO]C,5[L]3=S6$KGX M%,L3J2;S`E#ZQ^&0!S;Q:1#*F+V?.,JMQO&4RUI=:EC9%BQXY/AJP&7DP1CKX$\S89B!;1K",-HE$\GKH M,Y[D(CT+O#W@!H!$\95`]8\X<&[\'%;0GE=&C!\HC#22? M'N]5KLN4=92L0K%BZ\F'QMFQ4G2R!';VBGMR;UUY*%ZN-+CGH8R9X-"Y]VUS M%Z*MH56U;'$P?6AN-4Y`AF&EG0''\!2X4KT-4$$E1$+&-?F`3%(X.#DX@*R2 M(FPNP1`+(0"?Z[GOV,AWO#&;NNMY02%C-TEE="#7X2S"02PJAD6Q5B6*:H?! MY\VC)90S/5MI.=,Z]$O7D[ZRXF!'Y<7!]".^?JG7VX"3>A614_X)PP>!!F@_ M@AGRP!;QF38`E3F7RTA=PTWK+\DH(UHE]8FVAR4-M#<4VMWO++#P5.4M^CS; M#/%7:)WZ%V.[R;SA1MJPK+S$LBG*IBWIK7+:35$V4Y1-&Y@OI56Q0;>^5=@V M0R%^53%8H_[T0:C&`B)]C;@%@L+`71/2UP?WP_>M;4#Z3)4X?_&NS5"(77F$ MP?Y;!P^L.XY1C3HA56-9L0VVLX&Y)J0;F-?314RFLD&%NI/`^IOHR>?72U\> M-95^RP56[2O]KD8$UA3RAGL-]QKNU9%[W\K+K^+RX_K:-+FWQ.0='CKFGHU' MX?'OXEGX51H]&M1AW:;*PVN6F]J5(%YM[+^FX#=\K!T?+^5%?/W9=V7O,C2$ M^^H#.C4V?N*`CLPJ,L;/E@I-8_P8X\?PP]ITIC%.#PCCG61\`K,(2ER0Y9Q8;]5F0."/PWZ[#0T:&U"8H=1YED7W@ MTG!8J`OZ*\P0Y)`JYI+4P4!Y55FT(BNI[0U*AY+%5W#EN$6=I!A^X2Y)6GE; ME;+QJ!"P:W&'&[F.LLJXFB`5Q.$6UCICN=JIE^JKK"*NFOG5[>6,FJYN7"U= M7BK+^"7U@N)Z'O(/L'A'03$ZNQM_N:?I->ILJ*(*%>GS*94E6O'(D=TJD M"Y&65E?]`E1!D^DRL/-5:EM`Y11U5<<;C;ALU2/:KMV!QP`9S+7*6W^9AEYK MU69)U:%IA=&YN;JZN+_J7M_W2/L::YM>WU]=RZT:O&E1Z^(,A=M#EWP M]E(^5^0Z%6$EF>BOJ.PTE[JU5F=.3_%5DIN([UC?AJ`(3Q4\_V2N;\83/ MD_1=5M?2@QG7G'W=LC^3@Q/<'UF5,?-+E+]->+N0EGY*JQE!,&X4:I]S5U:Z50UQL`D8N-'<4@8,:KM*FI(2=E+?IM/E2;DW+/4F M:]N5#O#-EX55F145BOMF1?>S18X+@U%0_+(6:F(&Y=:$%[7^@.RV9&'Z\H9\ M@'-\*!A4LB;80%89PQK`?-2/`I%6L(OKO@I<+M73)*[7'_FJE'Y&8U+^+$>3 M[#R%OK:D%_^?;SM5MG9S>325RF8Q6V`)W+2YL>\S4Z(]TH![D2B5:R(Q[9.JH%Q5!YRT_:>D3RJS2IES[A+/C3Q5 MJ1@LU+`\/L1BS255F5YU__T-W"C2_;5;]YK1JVJCM[#CL+A.KJWFK8\S ML;!:!F>C[0?S\M/_!,KV\)R&[&$X2JI!8X?57R)G/$?9YG*.G@<.2S%R%GAC6T18 M?PL1!@8:)B;;Y&=&'6QS!4_AENIZ!I*`V[0A759L:9FY4+O'RLBJ@%4\J"HB MGMZ7N'!^P!ZEA9E>EBM5KY!5%M@&RQ`[:)%CZ6H.HD#V<,DYLJ_SI)9L\U7: M;;E6'N=,6`&7A>-O!I]CDQDLQ)ZLPCV^&?0`5'S`+?`LVZI-#W#\+?;T!M/Q M32S!G`X\;!#\YV`2**JC$O/O63/O(V*^0#'X M,]1!G96S%B?45_V,OCFW(V<4KMPF7)C$\VZO_X?>_BZ_7%EXM.&VS+=J=S\TT&Z,GMS>5%&J-_$T/SK9GCA:9B MQ2O9)5*[^E[OQ1832;M',60LC'MREO1^"B?O2UM3B&)OB@81N>Z,/Q`F^S/* M,51PT/&>L@86ZL@J-@)A@LDXPY`^HMG$7/S.IX'J%MD=,5R&!W+%;$[)SS`Z M_`4/NW"M]ZH[*"@%#K\%&#;9Q[%W8@MM!V.1.]VKGW<.5%-+V7J,1K;JIES^ MQE6^%O9!7ZM8:A8);LBFF-1&2*CI[\N.FT+%33R'.;)EB(NJ$QO/6U$@`T.Y M6PZ*W=KCR$DLB]YR=^>;:V]Q[7(@KR8`!`__`DL]. M_:1Z50DUL::Y&<,\C'4&/\EGT:D?_>[-:UW? MV:U"37>Y]XDBPSN[(_#=I4Y?UGW('DB.^4E(.7TBY13W`T.@IK#&L!$O[F;3 M'G=I3_R1B$&^:-G$XM*LK\^N2>(69R*4'F8;Q8=3(B['18E9(^I[G< MT(D"6+)4?CW8ZHJB_))T087N%)OZ;#",M2T@[RH2JIK[0<)_<.8^3YX^`+,+ M/C.5"9DGB'"IWB\\>3.^'D4O/CJ#>:+!?(*WT5^H*P/#CDH`L1"P4J M**M[HS`+$:\RZ`EC#TJYR-A.D>-\?%A[,L?CVR$\[XS\#=O(-T5X$RM<2$P8 MFZHKMM3;9P1XU&SUWD4P-Z,`BD$O/7+9PL44N.UHJ=18PJV-:,L?A@GC5IO46?V\$Z1 M["?9RTC;85#",(]WH[!U0UJ_;JT+HB-$R!22-;Q2+/6@'`7*2C!PE6?3$93Z9X@ M/?L#6TQU,K6ZH/8;M_"+?&9B'/^HB1'W2[ID^DX9*2ZR-6%[$F8@['$[)"X' MG^+W5^-WMY6W._X&_L"_E50CW:ZR"K+'A`/M&B2M@2/N'T`R`M)E;]!O#PKI M4N3AW=T4O9$?`8)N$51KZ9UG8L[%:F-+.6LFV?NXECBI]S2GU]&%'OO5ZUOJ MT'P>W_[`:W&8(A[3)8_/&^PDAX'`/K-VAR/5ZQY;VO?WS1G@>!P8X>/#Q!U? MG[*@,TIP]/`*:1RI`D6*-M110%Q32@8Q:`?CN"CS+!G!B'0`MMO$D,MHPB1- M<8=*>VOMNS,,)$\ZMYP?303N^A&4QZ^[JS#Q+S@;Q>9 MSK[*,D^VJ*T`KX&FTQH4[+LZN8R>)G?>(D^H?VLY.)%J`'8+UZS<$APS4O,X;J#$K.(I1_.S(HNT)(@HBU( ML'SW"A](K`UGUQ*!82J8E9?1=`6Z6RTWZ.A^@JFO1BW1.05-!?KDB&HXG?<+ M4,?27;[[2-W01X&"8N?'9AF8%+1#IE2SM8B.>X;846*KS>1N1U MA5@+//#X-+]Z^<80C!YF?Z87Q0C@]-D_H^`$T<`9=A\9[,:X7V$-"R!_-A)# M[V61[YC4:R<#S\!8`E?(]EKR5%&H\XYYY=/L5T:\^"I:!>HR)<8&!QKS-I79 M0-GK#9YL.8:L:D#=8V-:B#*$*OL9>LAC9-!:H`=$!_5*G/[TC.,QJ1=RL3`&4"(8!>/C5 M[ZI'-#+:#H->/C32.!/`;P&*8Q-%0[.'EA1\LW7AR?IZ/KE#3^[)6%1:6J9B M_(\F>=E-4M:IR6P8`.JWN6J5T#,UB'UFHBT8)Q7E`L(_\_'8#`H!( MW':F3G;<<%SIX-QP8UW--/P<6:!1W46%3LYA;Y5SIPM?0H@G!*2WJRQ>$29U M%6!A8)8V;?C`[LQ-C^Y@/+B*=_1$AK`'?0>"8^5+-&1!:Y&.F'VO4Z/ZK'Q] MA\![CG,$];Q*;/F4&?50@.S7=^K`9N..R81\SZR7J1@A]HO;XC!WKIC'(X=RT/7`$BAN<,GZX+Q9'P M;P*@O!I95_NU2Q$<]8#3>\3G8UC6RYGO_)\CGWZ1>$B`C..T/#N^CEOR=$)M M@PK@8FA^+C'";AQE(%X6[QV(ED0I,5,*,-,JJQ2HH92&]2:GV!JZM2CUM'-' M^266G=9U;K115QVFR%*;?ZOMDBKR-9:8^H_OZ-B=00$)>"M!I15LTDUL"&TN M*S1AD,W;">%1652A*(WX0)*6%YQ0IF1H<)-Q%@V+)9`NR@U(DGK1(&R&/M") MLT0\#T$3.-DV%W M'>Y&7VQ3?F\N\Z27YSM)5FZ4DTZS.LNL8Y19ZIQZ3L'*V4C7JJPVDAA21:EU MT"*%P9&98-QRQWAM3HJB`3;QF!+3`1;V&00'#.;5[T8H[KM$L(\GP4A("2BD M-VJ=)L'F+72Z!*;A7B@S2!Z[>EXB,5U4UG3-3:P=8)2R*3=:N$K*K`21EK96 MLI0%_!V;JT!`'I%H%Q'&TF&:791!/S&M%,F@`)KH9YGJ3MA_*2WR9TS'_',. MR/0G_!<^_@502P,$%`````@`1'"Q0$D2%+=]"P``*I(``!4`'`!E;61H+3(P M,3(P,S,Q7V-A;"YX;6Q55`D``Q\]M4\?/;5/=7@+``$$)0X```0Y`0``W5U; M<^.V%7[O3/^#HCS+LM9MFMU9-R/?MIYQ5A[+V^8M`Y-'$A**4`'0EOKK"U"D M))(``8J4">Z++^2YGX_``0B`GW]9+X/>*U"&27C9'YV=]WL0>L3'X?RR_VTZ M&$^O[^_[O_SSKW_Y_,-@T/L"(5#$P>^];'IWT1^8LZAW'W(A@*,Y]'[[#PK] MWM7YZ*?SWF`@N0(<_OE)_GA!#'I"6\@^K1F^["\X7WT:#M_>WL[>+LX(G0\_ MG)^/AK_]^C#U%K!$`QP*F:$'_9Z@_\3BBP_$0SPV]8!]_4*#5,#%<*=+2R'_ M&Z1D`WEI,/HPN!B=K9G?3TR4MRV4I.3K`GWBT^CCQX_#^.Z.5`C"):)W;HOH M]7K;^%$2P!/,>O+WMZ?['7?,"4N@$J[IUS\7$+()[/;_T:8;^K:7A3X/O:SR>P:L<5=0-YJQU\M]-W\F*QD MDR`>RD8=.9#Z?ADARQ6%!80,O\*]:`:7T&AN%.(/??-0X$5![/2#^#^C&=8< M0A_\5+?TH^EF(#8E-28@7L:`0+:\A&9]/]0_0^PE;L4B-I@CM))J1T,(.$NO MR"B-!N>CI*G],;G\^YBQ@U8H0"\07/:S%SGFTM_DXK`M2Q\I$;#DFT<1-CX. M?=EDK&1VOP+/V6]#FGA52IKU]0`B8YIU&U$OE2O^S."CV,DD%$,6+9>QM`$6 M,$WY9Y0L"QD@E7PZ,/13;RNIQTFO7`*A/M#+_@=9A;P!GB_XMB1I+=]W.!1Q M>1"/JR^*'!3.\4L`6V^*&;V!\'=G@##V/!()PY_``^&$:$)$XW$= M42J\R952 M.DMLUJ0ORZ%.US\:2%=Q2".O_'XK!C]D`[!'#Q,EW(0O@"884E;R5=F2&%BS MN933(WW5Y-M>FAH+/SOSZ&[MG,QN,%L1AH(OE$0K,00.(CE,%5<]$G(<1N#O MQOV:=KVVH,Q0\BA!+@&NL7CH>HP:\M6@_.@,*+\2'C]0#P2%-C6%-7T24C.] M2TBJZIT&,!9B$B",SIU!0MRD)L-1$GK*[)?2)#%1T[B491LO-)G5L*;9=&?6 MY@&C%QQ@CF,@3CGQ_I3SH4!9]IU!DEA;\B0Z1G(7_%8W8'J"HF_M-U'6>2$6 MGF4P;9(LT:Z2F$+=&:1/%X3R9Z#+*T(I>9,S_KF4EU`DD5%1.)'T?"*)C3>Z M/"?"9&:50M2UBCMS8.G(_1%M9'=:/NFA)LI-=^2(7$VYE4\66=?)Z<"<%Q75 MM;%M-]+MTZ^A@-B'(:Y!@4&JG3:6T/E*@+L MO++(OU;0Z>;2&LH^62XQC]<1B(KE.AYSSR'TA'MY!)@I4Q244#J!!&/59^]K MY?*O5+0:+>X,@(Q#'N,@QSBL<1421L\J(T$ET;G7U1*N)(Q-5;X4U=P^:`DR MM]O+M?F!+_$CDUO]<^H9IJ9O3';=3LG-,+USBAQ4IJ<1B'_9E5/D;Y755"TA[3W MP!2Q"4L&T*G[[J[+&N<'2%`7`GN`5P@BF0%^Q!XJ5^@:J=`Y$0]4>\,H0 M06S=RH!&(3&>\]!)9/;C97EZUB2,&#S(IS4M)\WG([=RS.86X%]GN&0^$ M]6-_B4/,N$3G*R2^Y-OF2DQI4VW'Y"8*CO+8B`Y;J<[->*5%AQH>FKN[D4WV M[G=?(Y:'XSWKPX(E%N.2ECN7[=W=3W"!037^1`3FG"#6Q_Y]%\!.O!EDEKUO:6 M]@.7%@I\OF(!@ZO--R9W'N\JX[$G.L'XO6\N,M49T\7^]HPMEB''Y)W4B$JV M3*F@/=Y*4$&K<\7O#:PH>#AV7?P=0)Q@488M">7X?_'U'/:JL"3QM6)I#V]' MX(8<%8<,SNRU2I39:7.N3/Z"<"@[WDFXW9H5O]Z>S)0[,*UHTZ,,2FF[!J4J MGM?`D$&-M'L=.MZ ML>*RHM4BZI"V^U#2>]XHAC)JG%OI7K37>,1`%18ME)PZ6J`I1%4[>J`NL%3: MG%M+7S3["1BGV!,C?.F]$5MJUE7'(W=6K6OF-O9>5IB&TC"53T3E MF;H/,XM8-#\95="70LV=ES$:/^4D+3MFK4()8_E:!17C=[-6P1R54ZQ54&IU M[EWR(]K$JYJ>R=@3SE*('QWMMQKR([OCN-/A7T5NY]K!,F"1NM&Q:1`5!L0# MR:J*5:/-=E=H"F,]`#]>L"JWI$QFXHH?23=!V0';,^PG'TP,G0-F?2IUG:U"S6-GW83K)(VN11+)K+=L6H:LJ[AQM+?&FC1:W#O1()# M9,L]M!2_1/'R--6AC';$BB9'0=PUV%3RO:&F1J7'Z<[K">*#!1\1Y1M#MZ4C M5:"G0-IE[!C\;@@Y12W.[=FYG&(UBKG*]O2SG>7=^,3Y8K"@L(&7Y-#K!H;UM^T1;1+DUFSVB= MG]PS4^X/Z-92MGGFN,ZH,=_VPW(*XYE8'7_9D#1SP*RDM7E2D!D4I.EPY4X3 MTHI.3E"OI[D#IXYI/=Q]^?)1;@X7<&@4Z'6DFX%_E/0N/P@-A+.A!^,X2US_ M,L%VMU_1ZSM"A7G)=V"]S3-%(4->[INH[^*6ZQ^JZ.C&GQ-"WFYWT`E`J=A"I)G^ MT@[KDAORQXN`G[CR?U!+`P04````"`!$<+%`A)0TI#8'``!!6```%0`<`&5M M9&@M,C`Q,C`S,S%?9&5F+GAM;%54"0`#'SVU3Q\]M4]U>`L``00E#@``!#D! M``#M7%MSVC@4?M^9_0]>^NP8DFV[R33;H:3I,).63)/N]JTC;`%J;"-A'G\[EDRP=^>35ZV7@6]\A98C@R][@I-^S(':)A_#\ MLO?ISA[>C<;CWNN_?__MU1^V;;V#&%+`H6=-'ZWKZ"OB+++&F`L`#N;0^OPO MP)[UIC]XT;=L6[;R$?YV(3^F@$%+](;9Q9*AR]Z"\_#"<1X>'DX>SDX(G3NG M_?[`^?S^YLY=P`#8"`M,[,*>)>0O6'SQAKB`QZIFFB^GU$\!SIQU7UH)^#DR7S>HF*\G:-3E+QL+\6S@H^CW]Y/!5;;L$FI@_.S\^=^.Y: M5#1$)1JLO2.<;%DK-U/BPX]P9LF_GSZ.\RK!`-*Y"&L`/006Q) MX+1_=C9P9#MG1#`C/O)DE.^X^`P@YI/9V_\BQ!^%=G%/_#&$ESV&@M"'Z;4% MA;/+'@R\A9TB2H\^*P=TGD1_-IF-`%M<^^2!M69##C1K!Z!N:DKR=$ MN>.AP$ED'.#[U;II")$R3=+Y>:RR1&M!*?$=8CD[V!Z<@J:PVU!T870B;K1%-IK-[2HK@H]J[0@",)(3OTW MXF>N7[CD$'O02WN6VAYBZHNU2?7QB9M3PI8-#-0R848,<<#-5)*"\&*SB)?T.PJ]X1-(EXJ MDSA"+7/(".N6!87PE@:1U#-.&645L`RZ!O"G#O:74Y/"G5^VMA'O+?O:B'A( M$:'BA@CZ.ORG789?:DCA0KKQ.QQCL5R"[W.KU(0"E7*)D_1R!R6":GV](D'Y M6";U+QL!8)*@#5A#CK MDA`?(1>Z0^\MH%CNB95,*!=*'*01,C7VM6RJ%70=DCK:?W8Z_%TW"B)?9CM-%?7`UF9YW2:9["@&+Z*-^B5`BD;A))6$J M%:JMJ15T)8PZO"^Z#.\'@F7:2;A-0,_C$S[(N#+.=403%Y6*FAKY!O;5HD`Y MGIH++[OD0LQ5F3:'E*VL$K.3'\DL^BVA<8@XIV@:<9G)NB=J`[?R@FV"KA.( MK8!VQ,2J)/,!'%8G.=U.MYH][E^&;'+O%D#H.8FX/%67QNGWNUK1[:WOMJB1 MU&I@7#5ARL$T-#CO?'X;,Q9![RJBDMB0(N+]`_P(#EW!>18;O'VRT:Q9=HZJ MT\Q(JNQH=,UYIA:P)K'2-Y!"JP'0G$/Z=N4D4K3[F5A4:?;.-%(A:WC4:=KU M"C'Y]$18Z#\)Y:MV0KMWPLDWA+$)%K=#PH`_F2D%/T`^F=V#98%D[8(FH6@) MU$AZ'L1AU=QMJUL-L7=,/6^_#">OK&:\*_1=+.Z@=RV<>@7=]>LSF>/S[$17 M0SP[OY6)&\F;AD;6G,U*`36Q[C2KG,MQ;![@%'HC(C>Z?$&\`CV:-%$ECW1- MC*3)#L964Z4>J(8NG::E`W!.LUKEX^4M?*-DE&*9K4FL4PS(^FTH]'[3E=98`V%.LV) MJX]QQ/93KBUA]7Y_Y_:E)\5E[8UDU[YNJ*;9#CUH7D3K-(%^2\D,<9GH*A!I M^T;BFLP-(T.O5;PZIMFFFF!UFJ76O:YT32A$Z$;.6X.Z\):KV&TV[]F%&Q.&EXY!?\+?;X94<*=^T<-G1?- M;M'E6,;]2Y=Q'ZNXCU7B[J&UL550)``,?/;5/'SVU3W5X"P`!!"4.```$.0$``.U]6W/<.)+N M^XDX_P'KW8CICK!\:>]L;/?9X499*KLK1E9I5.6>Z9C8F*"*D,1IBJ@F6;*U MO_X`(%F\X9(@P(ML/\RT3&8F4,PO$PD@D?BO__Y\'Z$'G*0AB?_T[/6+5\\0 MCG'?X99ND! MK>*,"LC\6XS^]E<_#M#;5Z__XQ4Z.6%<41C_]A/[OVL_Q8BV%J<_?4[#/SV[ MR[+]3R]??OKTZ<6G-R](O7K_\VX?SS>X.W_LG84QEQCO\#%'ZGU+^ M\)SL_(QWM<;^^3J)2@%O7A[;DE*P?YV49"?LTO'[Q.0V>%5UDKP&- ME.2?._3%;WK]XX\_ON1OCZ144*@0??S9].LAE'^_A$3X"M\@]M^/5RLI]X\O M&<7+&-\R'9W[USBBS7(1V>,>_^E9&M[O(UP^NTOPC5A6E"0-4>PK_O7A?:_]?B\3\V&?UY]SC. MUC?OPIBJ(_2C2Y*&#'N+ZS1+_%U6MLM_\I^>F;!D8<8^`(CE9?,;L,8:7R'! M*3DD.]SJ#O^/T>\`*:4!J?Q7&+5T']$.,M^"XY./FV*?KB\WZ?'6V MV"[/T-O%^>+B=(DV/R^7V\U_O:Q^?_>;+9(F>/QD5_X.^J?FMQ<4+W>$&N8^ M.VE\AIN$W!NJG_313_US_X0@G"@CR*"=EU-9VR)-<99*[$K\LO@8K9=6MB)N MR,XJ.C+E^&^1>HO-9G)02[X]47^R)E";-!4DU:H;&WRGAR2AYJ'$H(2F`<4V MC0-$2IIU`Z<>KJ^7%%N5P_6D.>)7IB8"^JPB]+=(VB#5*'P_+ MIWYZM_S]$#[X$>U/NLA._21YI+'\+WYT:&,,1EQ\#@VQ%_"@BG]BB';HA"0K(X3J[.43(+WDHR;^=O#KAMO=O M?WS^ZM6KB>-D"!2(BN6_0CQQ)"O\[$3UO9IHK%-4Z%-I#((V?!_<,0S]\.I- M@2#VY!_+^WU$'C&N0)TNXF"=W>&DG";R.6-+]Z9LQ2\$LUE!TK1S$+@&9'=@ M"Y)\.T<(6X-6Y9`&"_'*`1WY]\PK(9^[;4J(KOV(^_;T#E,`!7Z&V1M<2*X- M""EW\(0)1[O"V_E<_(MI+<@87:2OZIN6!^6NK')>@#:;/BS^R4V>#6#IX3H-@]!G`1Y* M233Q?-\!X(@[W8MV`?K(:V\5N+"#B?;&5'MBJKTPAWM@`^Q]P?>\GGE;DOD1 M*C6[F,'@*5:">*,+L,$EV=ARJ$&SB"IC'UR^6-I3D2Q`>MJJE$4T?90YGC>Y M3`CU;-GC)5521N,FMIZZ9W/`[DH+A+3XZ4I2*^!".F'GB30MR/&L9/3*M\_1 MGKWG@3\N*9ZS11?&88;/PP<\)"3Z%4=0"9?MQ\:./CZVPWA9NA^J:-#E^CT1>^=>TT.Q\7R+[ M.$VXE6\K8,E4,O8<1SBY$(E5!;?JL+:=CSK M0A$#3$<`^N`3D">B$?540Z>3\;?Z`EG_YN-K^.JUA&&.#]%5&N%2\$N42+J]XA?#G/8[3J?./],HCX`_= M@;N8O(%X&")&/&5R2#-RCY,SO&='""60UU"5YTHD5'99V^JF+4^22(4K4K,E M/%[Y`@7%FXESKC4Z(\`OW,JQ%A/7DJMA()AD,B$&M];`77OPH5RWH<\6.>OF M5EJ-8C;1NQ3&4#^M.&H%Z)08 M?/U6]"IGJ$6P<+",6<2HO0YX3#>\)`DO_9)E27A]R-A:RI9TX_-^W* M+:_JA5/98#*,\&-A)*?"+4LH#?%#;8LM.>Z3JBR3TZ:\?&%_XC%T(/"283'3 M+@#ELHUZJ:@A;6]*[P?V9&"O-)2'&=I;]+3\RHI%FW6SLVD3^S2U-8C=3&\# M+"PA,>^9L`*0Y'4M`FZ\M@Y[18W9Q[HMJ>H`MT'LY4]0RAX]1__VXM6KUVCO M)^B!O7Z.:`_887WV/Y3>^0D[1'?([D@2_B\._A_ZC^>O?_SC\]>4AT7$?VR3 MAFG*-C'8.T;Y[\]__,\W8DIRR%C1SX`?/\W0&=[A^VNO61]>Y_+I'Z^> M(TJ^Q[LL?,#1X_1AMQ`]1*?R;H!=IVI&U<,!T'!9C9HUEB^K6>&0E_XQ1Z(8 M25\#D*0E@Z:"DE$AH`><7)/AP/3&UJW]\,?G/[RJ_%KEY;I^C9-6CJURY((9R@^#8#!RA;@ M';(S"U`[<@L!L'O%']-:AH&"B;D.FO:BYZM,9WH<`>-DU=T#HP**1=-?,*1D ML>^PH!HUI;+L2UY8A=SO$WR'XY0&A*MX1^[Q.4G9L;/US=;_W(Y.^G%7Z9=& MW+9)F7VZ:IVJ:=BH,H'32)978R@+$=594,AYT'<1Y?I^\IS/7C@BEMKMY(>: M"&EDC=H`>3QKWR;83P_)HW2-4DY0?"H!@959RANTLSRA7+EQ"14WSZ=)5%C(\;!S' M3=;X87&1*8+8?RL$/;7EFWY8D@58=FB:ATO<$YU,:FX89FFVN!2O9Z^+'=EY;H5?6F)T;$TB50[9#[%W, MT3])U4)TW[*)TC95A5&=9I]:GJ5VD+81ZC2O<@[YE$,%$#W[,G3^9#DHU4*3 MIQ*76,'6<48E="3L(]MU!N4V_SBC6]&!8'(-Z,"?K%_-SD_OV;21D!Y"F:U'PJ[K5L&$H. MK+`W;&4]-]-+0"O]*^F5)23;=?2>0N6\KND:HJ,P21T7O$+>L'`:JH*'>U15 MI4F??GU&57E':7O2')6W%#:O8%34KZN#V^94V7$:Y=1U:>; MEOE4ADTJLJF,)(GNHWVNNX=VXI2J7B`B5LIMI5.9B*@E4]D@>)+#GI=^LDXV M&4LHX,2V4)S(G:\=M#0IMP&A MRF7XSXD5V!=#8Z+L]KQ++?@I*$3Y[06%NTSE9I,.,]R/@H$IR@4].$.Y0/YL M(*]2I#C96*CM`NH"0DFRL1@1XT$\/TS"([)[>>E1#57QXV545G#7-&T'>;EP M.>QE/-[I^F*S/E^=+;9+MMQ&__-A>;'=H/4[M+Y<7BVV*THP+B3`K]Y$ MNX2X0CP0&".F_/D1IG/_!QP?\`8G#^$."ZYGU%"527D2*KN]4G73EFES4N&* M+4P)CU<\FWAQ2JZ?,-TV/58$*B/K+=7%9T331*-?@ MB*$$YOD<[W&,$S^BYK$([L,X9*;!SE`6QM*.+(R8RD`#QF07=QAUS#(,@;:E MB$I@(KR"[CFZS2FY0_<;M#.YK,H0&:2?XEIA#HBW%O7T`N)T09`F^-$$/6Z# MG6&"'*/@ILR.WW5"F^E'"Z%>I!$-+)*11S!N5>LT2\A*P]4)B*>O8WFMT+Y: M'L\1K?>8N426[5F6;&DA24%1_%P1A15L%4W:.26Q8#EJ1?0>^W_$L()(_IK$ M$T-6I2("^*A-V`H(*^2.H6NG7LJ!RGE9DR]&Z3)O9:OV\7S6!8E)LS^%'Y4L M)8'IBP^BI[="/+@[=KX.THS<#/3<'B_[=:RH5@S>WT^\]@37-3'61]->M&R5 M]1@#:CQ;.@O3/4G]Z'U"#OL+DM%_[_C=4@<3%U?7L>!I(9!*'0X!,:=`X4 M;`X<9/8++LLU(2(,+6<:61I$E(:1)"""'`@=3J?@CD%2+1U^J3"13=%=`F7L M_#T6O+RC7RB_N?9`NW>,;=*W^(8D1='HK?\9I\O/=%I$DB",_>1QE>'[%%31 M;(26&GF$P[3D(!=QT$_@(I]QJ`[JX.HBNN3RT3\A#F++)%#LQ63BK MC,F?.I@;WEC(B+`4)7P.TF`[:?3K\@).(X,OT!G(-@N^N8-QW($L=OK2',*( MN2KYL?-CGXN`\BV.\4WG%C,8<9G'HB:V2WT`=<0RQT77AB(?0LWJ7<[430#U M2\S4T,J;4/+4LB@F@X_CBS<&PQ$;C+X.)$ES<`;!TIPFS[U*NIG.FVT:`4^9 M>S4R<)QL\\.'GBCW[)M-6-RK2:^\!+"X=RT/C7='\;-)J1G8#@S"7P?V!HY[ M^[1E$O)^*68]\LSWB5@W"S&^V?<8]MU_9OL4+'S4E*=N?D7S1PI)S@X)^XEW M?HK7A^R2EVTNK[>49!Z.T525/#5<4[895H-_!.LTK"%[J,S5&JYAK\Y:7XG\ M[H)D&+W^SZES-4>Q#C(F##N988.UV$@?&\WPG[:3'L$YC^"4Y^>,Y^N$1W>^ MDEBXYGS)#=J<(G8P-0U3Q*.AF+]BEP&]6+SX\ESR.*YX/!<\K.N=RU*CL..= MR^2%"X@P5N&RH(;5X:H`K),NE_"T+4*G[AI!17)<((G^<--!S6E&#@2.9)YM M!#OAW%DM038CG@MF!UR?&@FZ56;G-_!*5#LU?,<;CBX3*^'&$#XMP`5?FL@_4A.:U?L*>.X5Y-3G&>N)^:NG MI"F9&QE)5T9W3=)Y48I=ZNI-I2N>"9'=8?1(QQ.$XX`.,F=XA^^O<8+>O'Z. MF$MZ$@J5W,UHIM`1#TWAK!I\>B0J].8O#UD9\]L=K^G;7&@LM@M2\4WLQE>F&D0$E,VD>!XPU%Y;;- M97';UUL_#7>+.#@+HT.&`TE^AR%7\4&@7%9H-NR:W9`';TP.?:B,S@[;GD[: M=L4M+HQQXJP&4TR0GAIK6A>0N;*[GB"<4^8[[7JKUZ(K**WE@//797(&SF75 M='_H+'1Y\S:IJ#*I^=G*MLG/\KI+>^`9))3","S<-C`09Y(4"K2&>>YO]W$M M5A)[[(:/X&ZL?M)X>^?V+JB??&THHINU">=J#0G%U>YY&I%L5_0$7;/N<4E! MWL$GX!'M[*77/JJ%E^PEN-^>Z^P\Y_%:M/7-J9_>O8O()]FU31#2\K(0%:G= M%2&`3MAY)TT+BNM`5(RJ^_E.%YN?T;OS]5\GOI\/I&!BHHG631\*CMK]'@;8 MF<1.^,V9A?->_GX(LT>]P>AYNI:CX'%E0OIN.;,E95,@HU)(D%@7,Z[E7SZN MMK_.QK``0!!9&!@_75.3LPIM#HZZ"8QORX(MF94U7K;-*7_IQFX:#3DRD%(F MP!)R4N_X;_1W_N1_9H+QIAJZ8!:IJ8W:;1E4"WFGQV%N&*?D?D]B^L]T\3EL M;W*":-LH%=*Z`:VJ&XXP+&D"`&DA9X7PYR@G0!4%^CNCF0OFE3KNF@``$FV+ M$+$(#`0"H!%W7IJ].2/W?ABW]UE4-.6NBI#&;@]%U:SECHE$M&)_1,CAM4&/ M_IZ_F1CU:HT1T!=N[7"(2&O[&1#U3S`*G(I;"GB#^>B]ONZJ?KJV4Z;#OH(YW`*TO5/.:ME/?[!-_A.`T? MBAJ%'WA2;`M06KKC/94R.LM;#37-6U;U4XA777`HX_(:KXIEQ:GO.-0ID(`_ M=OO.0PEY_?)#("I&!?X]B?FL5@9X\?L*Z*WWM@`7-V<-[(Y8):!;U%[^"/%G MDP-8HA"B_8@=P#;)&D`=5*N&Z8;J'#-+Y;*TPT*]*7N*PC0]X.#I:5E^&6M_ M/8_GB!9!$.;%`"[],%C%I_X^S/Q(Z)1`M,5'4--:P1K4#3O'I6M"CG,UIU>] M1NP]'9M103$M\&&J)48J:)J#DJ4RC:EPX]0U#@0?7ER7/CZAT]!=_@*Q/TD< MXQWC0I_"[.ZXFS\;K^H27#)O.P2\QO/"5SCSZ6PL*-,[A.Y7351\#@F1E>&H M&[;SM%+9J]\.(<%"Y5R".!S-B$N(*S`/(:6G<;G#I3-*P>5ZLY#;7_W^R%,I@ZV M^^I=%EC;:G[4"W(%A\V%G@M"6EV3*R>UO0M5VPG+@^'J%I17H9;M)I' M*06(2HG)M^]WN071)72U< M2SL!L8P]+W2YR?PD`ZUCBQH#+6EW&;VW/F7;X>?\7`0_"S%U@`Q2K6B=6P>$ M[H)WAT.X]CTB:LS"AQPWRUAU@]80J&%!Q9>,&\!6R?R08U2703X6#P.8-\U- MM.<%8A"I?<`O$4B2D@_N@31F`A?MSXHOUQ?EFKD7^L6/#GC!IA8I7[GNIG69 ML1V3O8!LEBE@9IVS30P#MZ9*%P,*\98W-WB7L?KJ"7Y@$\Y\!IB_GSJ7S!`4 MI*_&VGEG,.YZ-EH_'$YNE[GG,#=,.9_:,@5\0YBFO'N#V*:P.6/C%$A16^=\ MQD1SE.A,50LPM:UVV;7&JH?F1*O6E1=)<'!*V$0\NR.!:AE;PR):UY:QN%L" MU73*X+KY]-S2<4@^A=;%9*D(ALJR\],[5N")(G-7 M>SG+B1($1*#%#1`0`W_-PQV9@^1`)D.61$XX=T><`E$G?F MKY2GLO_YC-0VJ((MGSCP!BI!P"65N?F#1?#/0YJQL\/IEDA2Z?/091^%[;I3 M_9B/QXF,F"W/B?3IJ.V!(\,V54=(C$1YKW_Z(WI'DD]^$J"4/4+^4<+4YT9Z M(8;8*;)]KL1$1OV@B0U@YS+$'SMHM+DA8`,-YC6V`4?P;N>&'+8;K?4=JVM" ME.;Z5$9H`3Z`P[(46:"QN.*&#L!R2(YGHK(#`A0%.+R-3P])@N/=XS;Q:8#` MSP$NXH#_*^+Q0N6*:O5>Z4^D4MAR`S[#^7];MC1VLX4B1VO6RL6,_7'L7-2( MO96[N-$ZX96B4%9Q3^L.1[H<"/ MS&9R].6[%-FNY-?C5"8MQ-:^2+YP8`!*>3$VV27O9MX3T`7G!=EJ#1B59#OR MM8JR37_%'D21JJ)L$JT71JI@4!9F&QPAAO="WG M#"_C=`4T1=*_4ZA-LI[.#@[ZZ1VOQ[DE5YA]SS#"C@G81A M&O=J+3!334JY*"ZO;&&,;< MW0X9I%7A!LHHWF,\KW^&Z4BT"_G,@/X=X6+"L+@G21;^KRB-PH2E4!B(QM^Q]]_GHS<%22OU M]R;\3`=QG]-.:U(P51,CE32-2,E268\1CD:]O;:Q.%4;38O\!Z1V5@=-6M)P#CXUL4>A?A]$<(N<>:"']%=FY M!>4N`[M3*/$#7)R88803CXQ&6%`8HQ9!4C/LS29,[*K.6381K+AKL, M!VQY56N28G*I.;;('9NBN#.NS;#3BHD)MIB]LYK-)<=W?/=C;E8E4;7"HI3@ MD%I3DTME26HTS6'V=>D_,M?)5D9WN^2`@_-J&@Z>CT&$:&=H2B$#S=D@'1]J M%J=IN\^\3BG2*_G0=^4XRB-4OV!&^YS[.7O"F.LK,GQD+;(^,O\S/E+/S0<8 M01(P432`MG;JJ)(%F4R:6,B4ON7TD&84*,D9YDO'>C\B8Y#ZC`Z#8_\@ZY!K M7R!HQ\3N.^PR&]\5A#2"SBGG9K92!"A,5(,:J3FV^52FIP/:B%<)X`R83M#" MN#EC>06#2GN)"`K@8C](B'BLR&G;#XI$*56037U9@#A/2 M7X.MBPS`_+5K#6:'3L.3+>HTWM%!RDZ7?(-I1Y53`G6.@XMD@[V_`./!QLV& M>_\.CS7X@#;@>XCSN(7?1.13BIA-S3%WU0)./:Q=O2-O+J>/[4^_0R_I*]N< M26U\`$"`V@>H!`SA`P`='L0'J-LU]@$J<1T?$);$L_5)9W2;_%'5L9(C=H7Y`]1WM&R!=W<4DZK=7WQ1"QU&S3 MW@V%5,8^9Q`[KHL^(9K97/4;GC5*G@>B1QR[$K+#.$C?T>^^\2.\OJ%/@@,; M7;$P?0?.4(Y0>@8[>P9WR'(<@K2C,%8]NU?2Y-%E2JGF==+"0/?$7#TMT]/R MU:S-&&)3&MC/.`JVY(.?'9(P>]S@'?MO=P?"G%%J<%)&QX:GZZ!K`U2T9V*( M4C$2@[SWD]]P7K9"A2MVMLWRIQ MG5V$FY)X]KL($#CIK!T.2;7-*^1H;=\`U=-,%%D9<]I#&A:?D_AVBY/[,WS= MV3@`,P@FAA(&9Q-"=8?<302E[<`F@!+VUL0O(GX\HPF>1MG"B1T(((()G9A/ M/)VH\B[K"^V(95FE'.K+BXTC)K&Q&U[B=I2BDR^U#RN0=W[!5D(`^FM8F MM(HCT*_AC';-N+V)^@)ME.3SX$1L43TF]AQ):[X^-;BK)R`JQ]C-W`YZ(7<4U@+]W()+';$A0Q$WV&T*TK?D7@& M=1.]1,6M1 M<5^&B2`>5]2K%TWO!GKA@]@HKG5%AH&$VIT9LX2FT[AW$H26L6\8?YT8E86Z MXZ-TQ'N6#_M]A-D2CQ^QKKZ+R*=5?$.2^_R&,/'^K"%7>OJD'N\9<66V!7M+<1+WE855T;H5*(YE-V*M;4B1KE:51:'1.:&6:U`(6X[+XZ@K+VRA*1W49L MX=B0J,)BC;`#Q/S=U"`4:("H/ET;?A5%'7MRY8T['V:.NKQ^Z9CY%@>"E<2S MXT`IB657@8XS&V:_M$V9?KH'\N8_J;'*WP;,H<29Q?^?=LP5"3E3KN(Q&[W M7-&HY8ZX6+)BEUO$X.5/4?48L><3;U2K-$4@G[:UH2R@K&T2`Y0^+&Q/J1M+ M_&@5!_CSG_&C$+<2F@9PVS0.D"MIU@5TNZ)UV&USE.`MGB/^`M$W<4;E+]"[!T%0(#8VXG7*G0Z)-`/WEI;D%#7U@R`L!C63[\+ M(YR&K_-T\`"U37@?2:BVW0-TB[L):@X9Q@)W;EA[:`CHA MN.MT#N$M:-XEP)OBH1"O`\B_[:%-.&[XB.F/)=FRN\)PE+ M_]ID?M:9C$)(FU&2F-1%?*3LA)/(2-:"-B82,QZCH6+/\/@>Y01SP+Q&M>WX M!P*$9N0CY.C$/"#40.P!WP=W#/,_O'I3()X].4Z'V9THO$7]B4H3EM:2C)+% MR>H,I%-N%FHT+>G7;)0"JN4;=CE082\U0O3WDO1_YK&8`T)#9UW'`$.M)1X5 M9W>UQP1X-M:$TUT2[IGT]TN9^:QN<6ZFE33J2:F>V;G^:I64[ZXS"^!VUX=4$ MH?4-*D4A*@L5PMCSFCA4R4.E0/1W)A)QF5,[$L:POR"P- MZXS02!^??PG6R:J3G"TWIU>KR^UJ?8'6[]#;CYO5Q7*S08N+,[3Y^.'#XNI7 M]GRS>G^Q>K+T=/WQ8KNZ>(\NU^>KT]5R\\TD8?CZ9I3PC_;&Q"B# M(H#B$=.3M\LWS[SM'4;T]X0)KAE(U,>P(>4<)^$\2[<^U%Q MC1D51Q]$AZ`\O\F,-QNB>T`YG=[2_ M),:MKM9^H1^EA)(']!LQ1O8VP9'/+NI#X3V;7O*S,K1EUE=2E:6C36!_=W>4 MS'\/8[_VTS`]?KD`4_]]'\;Y[.0[]AA_]N_W$7Y>W*#XG#;X@.,#IG^QMWX2 MTU^>?O\";>^H()R?<\X[FN`]M07ZS_3XL[L*\Z,(I;7XQJ_BFWT9WY";XJ>6 M*PSY%WSQS;'"?,33=*R33>%D2R9.A3J9P#E:=G'ZPZ:&AIHG_133-%D8;V62_8`V MJ',#R,^AV0S5]H).L4\(NE+08]L$$_MU,S+VZN8(U@L:.\TD>17-?`;0 M?C`QLV+U$&LDPM"&IQ^$SW@I2S]ZGY##/EV5.^"LB_E=9CBHKC+3#\NNQ)6; M:K;B[+;3'/T8RXTT^UXHMM!LA7MGJ\WE.E\$YQE4']]N5F>KQ=7TZ5*NH$A< MXZ&U]64IM;;IY=A:1O5"@BY2U]G\2;+]_'[39!1E\`$4NU=AR!B9"&W=L@>,0ZZ3Q_SJ>!T`;O#@F_FT$6 M28!HBP^HIK6K@0[IAF7=5?/JXNV4[-M#;8"RC$ M1H--"S614!FL#49G8+^2T!5,K[-4-^$IN#L#V20H!-5S>R4)M;[(+T_MEF2S M"3OARM=;GSJTU+(![&P&X6/KPA#]F&C`48:2``ZGE^H,-O#!&H)?I",-&Y#*+DI& M+AAQ\:DTQ%8&!>N(G2UIVY";D8;5:[X_WI\ZFT$*J&=BIHZF":EY*NLQ@]$$ MEVWK1R0(:=:ZAMOY&`3IA)W!:%H`W-8MR2XX77]8HNWB;U,O9(#TV+VY&SRJ MJ#@$=WK/:AP1]$HRB``HY<;@9O@`=,&Y*8`&#A6?E[]$_#;WV0P5$&VJ3$(] M2"@8E`8Q_?#`BZ3>D2C`2G?_YY?7ZVO-K\@2_>;7^=UL#,`4%Z*ZMI?&#VRA1[HW!JPY2,53!B MI0FZ&;%@'1G"V$#CEH;5J[__`\HI9C.$`96L,2OU0*;FT1G0$'7RA/O'BA0O M"+4RN\)=@A:D*T-D3X#3JY2\7IT`511S*@0'5+-)6G%L2>!)M>5OP8$U)O<4Q75GMB5 M]WY4U.4*RNI4\2TKH,5FI4S9O#K4T;-5!:RF+O7D&H&RTDP#(=#Y*&^64FF4 M03EDPN08^9$6Z9#U[$?Q^#Z3>!>H9UVB8Y^\1F@:X_3+-_CVOE[U';!P`^+>^^L!CG(DGD`:J)SV4 MTYI*ZAEK\TESC%D,-V4IBJ)5_44&<(96:1T%@Y.2*?H.N2FSHVQ'7S=%P>X= M2]H51+.\N\```)U2*F#0%(:CY^L658'C;+RQB=W"%F:\YL$B#D[Y\'F+8U;$ M3C],]6,N/J0ALY4E]NNHG54:MRFW4$-1WNGZPX?5EI=TX7G#^43^_?)B^AKD M/2%#[#39M%TS&94=VR%V9C8M&41[\9I8M)NAM5Z$SU%A?7H;9O0GWKI^&.G\2+ M#I2X90Q6,HJOUT^&E?5:==O.BOLV+;?F?A*]D@WY.1_:Y7<)I_DEPJ1V<>X) MK\V_X\8?Y/SHN[`D_7Y:N[>#('$"B:8?Z"6J\@=/Q1[,-I/TR_\SL0RV]\0N M]2C-(C[<7^.$;QD4EI&@0\PNM0C9=;A!OH-0OV;ZSL\0I42'E+ZE9K+SH]TA MRC<8NH94WEN!]K05W@0*#DEYAP=]&))@XCV'*4U,MD,V!R.;]MRY)(!6D78^ MIE*N\V/G_K]1;O4<5P6PB7:"&E6?0==5Z53SJ,^C3+RF) M#UF>%5+Q#W!\"-#=(4X4J9LU/62D MDN8M@G\>4CYO8H",FZ>0PO(4$KO8J=SKWYRB]SC&[)HIWD)>7]J/T.;%XL7Q MYJE'.B(C'`=TN'C]P\LWKQGP7AUOJ2IE+:+?_)02?L!!Z%,O4=S8M7EQ]>*\ MDI6&GQ$=6+*[M)#XX\LWKSB2YW@F"@)QS3$IN)44CL98C.XPU7SLS&FVU<3F MQD9%F,%)+*MK@U^?!<@&VREM8,0LA#N29%N7L\]-=\:WG03]B4[>&^ME#5@;XFK7<\ZXWS)U.?WA.K M@F@^8/N47H.H?C)O.%T"0X4?\?-D`";I^^&";J MFC?A,1;$]GD@D^(9YO;VAZXZ!]C6)`HOXT:V)J?X25K:\(>/YFAP;#S=?#,U M5]!YBL8V8N*5G]Z=A0\TEL&!?IT;2%TF5VFH[=*I8%VQ3*#2-J)(F=+P>HP` MW5**&!WVM>%U%HM=4$T30WVT\I_43+6,IPFAY'BF-2"FV,CQ5:%*YN6'PM68 M2Y]^@M_Z*0Y.R3V;9(K&!71UM=&(0BPR`OE53O@4024O%Y79C#G#^V,@]HR?;V^ MECFO+X-*$L1H4(MH!C5FC#R_(4A*4]!PM2K-3(8JUYF0@^*+A157.#CL^!=D MZ8E%WB]''4MS\(,@+":F>S\L4ACW84;_'1QPOO>+(A+?XH053,CO:.+I#NQ< M&?Q#BG!>'XD*81155UCJ(YU!917-Q%-@]ZB6!31/!M=&!3XT*S;# M@OH-<)5E/GGK`\!-4LIC.+B-6>B.>@SF-=85,?E3F?I_@.QH"T1X73V65 M[WIQ'T,6,VY+F^S55=N`QK11E:F:R?).UQ>;]?GJ;+%=GJ'-EOXG/SBZ?H=. MUQ\NKY8_+R\VJU^6**^=/+75]D,2L=1OVZ*-A-0-W`K*X]G[F@8+B:!G;"'V M+:9Q!BN1>\D/1]`7/-FI3'J2^`"'$@MEN)!HY2L<_B0[_^&F(W*?XD*^QX7P MQ8.CE++>UW<1%?0].D$QSE@(D?F??YK6S[A$*QD`+TU_Y$!PY:,&,*M1C[ZW M^UUN"QVOL[UDU6M(O,BR)+P^\.,36R).Y&SOV`PCO3H^[U2Z[0'[(7ZJ]1%\ MQYU2'M)WVI9W*O=\DY_<'P359&`L=4[_NVRD41_@BS5+PYP0DOF18B_NZ5HG MW^O[9I^N0?5E6.@LHA=(Q^4E?5Q*U4R\:0GHS7#U2?LPY[YK$)_ES%>Y+4;/*N3-P:\MFG_YMVT M/D=CU*0R>]]`DE>2(TZ/*$,CN;RJ?(_X^1G&-'G"?@\,$2O==I+OX2(:.?:S M!+#KXRE3X)@M(_"O37$:<$:>R,.+EY4Y.2'^BI"K.#@R.G8GJ+1PAJ\SZ14/ M2J)VO84FD9N2"\*&'55=:,L&%%YHLGCLGS.ZQ4RCKFX!!I5:RS0"(:V@#,/@ MVG?J?)V!@%]#MGR[?TQOJZO:] MA'K5*^2S=\S@\>?='7V(\S+V>S+0D"[Y:"2#J`I364(K02/ M_=>GAL2G_+6")U.?)C)(P4U#[RFL<@*.,#Z>@[C"$:N^QB+K MQVWBQZG/2\')1DXH>?%9M>16M@WMC)T1`UJ16ZN6V2LH$"=!=9K9#*Y@I1-3 MS32M3\=5F9DIKJ:W)_T@VX-38V7.!],>71S&]DP'31,YWM7RG%,OL`1&N1X*'10(#>3F/R8HN6O[#2E?-"O.K(`%#1 M$LR+C@U`(3&;33Z^EKF^L=KA4\N`;>])9`RYMZ?N]J`;>]*F>^_J223RG%B^ MEY7`0YS5T#_:'L` M^N@?2UYC_O)P'86[=Q'Q.\GELO=E5GGGO5TZN:PYRSQR@5A%`GF'VLL?H?P9 MX@\G3A27ZH5HOV4K-;Q-5LL)UREWS%$JXQL)YX3.F:[P#HJ_30Y+0 MH;0S(@'ICZ./CMYRI`%VQW94T3>C&D%TW!Y[A9+CJZE'"JB.B;$>VB.`AJWN M[0V!-'+1\'R<:8%4\*9>Q+MX8U^,N]F$'=:;`C7%L0NZHLAU'N_,H()UZY,3 MQ<<25)3."5J5H<6ZFN;43IE5LK[YJY\D?MS!'8Q8<&I'0.SLG(6\(^Y.[0C; M@!VP$+`VTG<^%4_G%6Y[1#0 MC9H=QZYZ2=^1I.XA6H%;>\0R8JIRYB!,MNES!AVSSJ2#M:5,JH.(\!;!`W/7 MO&17Q%Y.GE5GHG[23SN=7#L`;R/M;B9H:OBK@24^IC@*]:28G M]9UX5O=&,361D0HF)AU29],262?<34H$+<"F)!W&UGGOI,CHVE."R>LK@A0K MG)=H8""8E;0YQ',2'6;&+!4>/^`D#4F\ON%G&Q;W+'DS/^'0WO2#$1\+?2N) M+>MX0SIB6Z9;TX:J"K>2U3NM7S`<\J>=FR!KU-E]<2N;@YO-W`BK5@-LA-FN$CCX(=:K!W9]4*XJV(CFN_&LO#XW M>G8A>$8AB1'U#]E=BG`<4-_P@1KH'7KS^CEB9= MP;1-A2L4%/@!$[O;=,WDA&S<1G MBV^SPC`!V1V8B/Q6^EDAO;C*CY=>Y/C.`[7C@->`>GWB^)@#_VL'O+3NS"20 M'VT4XS4I.WMA%B)ZC6B%B!'MOMGI,4>W8\NN++\0Z'*D0]_1B3(O'3CU):!6 M4.SI"H2`[N4.0T#+KIREO`FH2X"8@DM7]("_*Y6+L):@1F;@ZZCGT#1(@,NP=D M)Z\6E3L:PW)1$B9UO:@VTQ`%HR0=&Z1B5+*VFZ6<4U&E?YQ=UF'113E4YI[([+YT(JVZ7MQ%F>UNW M@Q]BYZVM^Z"\R-M&M,>GSB=OV4M4YY]-\.((B,0M'CKW?EO(;%P$[M!.9NAY MWM;[+8O9'$DS]3T2:>,X'_5/&UE?'*&K.S M1H%4N7EUB+WC,>VYC,]2E1#==VR"N4U5H5.G50=PDPU%TO/LD'7!-I1&7<_]+77;G>^7=3#*(S7TRV1W M85+.^_V4;5H>1XB))_]]("&;\/<`1?W'G]._Z,/R$?T_%J33)_\?4$L#!!0` M```(`$1PL4`WI`M7SR```,`3`@`5`!P`96UD:"TR,#$R,#,S,5]P&UL M550)``,?/;5/'SVU3W5X"P`!!"4.```$.0$``.U=67/<.))^WXC]#UK/LRRK M/7VXH[T3I:M',;*ED-3CV:<.BH62.,TBJDF6+,VO7X!7\4`""1!5`&6]^"@F M$GE\B1N)7_[VM(SW'DF:133Y^.;P[;LW>R0)Z3Q*[C^^^>UF?W9S?'[^YF__ M^]__]_=/>^=K?\=Y=EZ[SS)&8,\N"=[__H2)/.]HW>' M/[S;V]_GI>(H^>-G_L==D)$]5EN2_?R411_?/.3YZN>#@Z]?O[[]^OXM3>\/ MOGOW[O#@7Y\N;L('L@SVHX3Q3$+R9H_1_YP5/U[0,,@+45O%G^[2N&;P_J"I M"Z3@_]NOR?;Y3_N'W^V_/WS[E,W?5"+RSXA*:G+^-9+0MW0IZ0?\*QL_?^_>$!+W=P3).,QM&QD3=DN!OYL\O%<9`]G,7TZ^C60\QT9WI$O$_LUXWA=3 M*I+E)O("G*Q+?)52UF+FSU=Q4`8T&X&L>&28"`TSLR[W34[#/_AW-FDU'X8) MN&QUS-*99/V6!.MYQ'Z]"E)FHP>2L[X7,672F,=U.>]N6$F7JY0\D"2+'DG9 M/%@=8`K8VP]EDE_0++LB*9]IT.3F@=G2*)*%C.P'Q`--\UN2+D_(G5'P=AEL M85H=IFQ\=OJT8GXS:\/[+*S+>$WBH(S'_/DV#9(L"(T'I2`O^YYG@T?RYYK% MQNFCZ=AHP,.ZE!;LFVI6+.:,?<7XEZP'SI\R5-.DCF9UYRY"%N8D!3BU`+%-.S($/.E M8YJJE..__"ZK97:7Y2F+R)I1S-<2/[[1*<(^<_U110[TE6K;-2/AVWOZ>#`G M$;?D(?\'5_AP_]UAM>3]%_;3[Z4`U^0^XO4F^>=@T_%6&LI(*HV$)%T-VCB9 MI5UM@C2L&;)_=D`R7%*O*`Y6Q4!E/WR(X@9?BY0N-5U"40JVI?]Y#U/!7D[W MQ(QIRL:.Y9[+3IU\S"1.@_B33/\BST,L`3"]#29G[!!1<_9*K+*&"#99%R.5-3,ZS#SRO'O=QWB M9U',Y@Q,A'N:B@-<2-$)[R[%9#RM5F],:/?X5O[]Z^[\6XM[R]@"(Y#VI]Y( MH_@T&5=*%#+S89=AY;SO=^\\-J&/Z%S<)$MI>N[LTDS.KS(5QSFXQ[GR]`^[ M]_2F3SACOV2`KP&JGK?[5)/SMUS-<1X?\*Y\_J,KGY<05'M=0"?T>YMNHIZ' M5;7A^P[WROL_[<[[,R;)O)`F#NY['A=^JU3O?IN,9V4JF7FSQ['RX(>=SX[+ ME7:^#%7ZYR?W>,+4N*I,J)`=]XL*S`9`&@K/VI&+:VF7DAYMVNL?"%Q M_(^$?DUN2)#1A,S/LVQ-4B%,%+0=A$"T$P,'3N4QN`!KJ"&Q\\6U?])XS91) MRYEBO^N7TG0@T*>9F.OE*HYQ^8!S[>H=KJY5C5*Y['--5C3EY]WX/O-@L(`:B@1L/.E]RNUG=Q%)[%-.CO#('?.WYO?Y^8LV'5QGBX MPW73Q7]?[SH>#(QSP7YPL",Y[G"LO3W+47)`NYI6F=836SM,#<)[*Z:[95@Z M8M7]8=5V`ZY6C+?AZJZ-L0LINBU#]]HN*U(7JQ:VI&WM'^\Q81>$]8CES2:) M?PKG\.MZI','RI?&5'S0>EP_O@BRN\(`ZVS_/@A696=.XCRK?^GWZM7/OS?2 M\&L",>4"00TEAK0"EI1TY)C%@JZ7!32A1DU%UM>Q3^:LV4$YB*(5[+8.,N8\ MYF&F@T,@WH0B<(7`%3Z%XLRRC.39QNA`@7.C,Q*UZ-X MS=+.VI6N/.=)&*^YA\7RJUL:6^PV9AS'SMTLR!`^U+H->_,?QM MM81W_US%HD@8H'7"D%;^EY(Z:W=$4D&-"HI6HJT'S0'*7U1/U6Y@RVK@4:S@ MO,X81UK,7OA%0W\C%KY(Z@K*H$1`[*+I*S^KZ9U%,2B:>J1@4E1E$*]&`'@W MTU'6Z#8#REIY6Z!7F[]M`7`3WE4TB,4!6@$<<>5C!;&[7CQ*:%IL])42J<-> MHT3=HR-*.`MRI!>IB>+=P);75/3PF!K\#>9VKA!7>&YD4"XY(B@K-\HHG06N M0"@H8C&DL*H>Q"C&551+SVYD2OCSL)3S]3<>!0E07*%U*,IGFD.1B2.N/*D@ M=A:?8KG4P:I=3FH'K\(8Z5=J;H1N6,OKXY&M48^_80YDR+-W]D:\X*BUZ*ZU MQKZ%XT/"BB1+X!AJJ1(>A!O2%5178=1R='?U6U99 M&FI7.)?(I)SR&I6M,XQHE776#*#$A%H$L\(Z!O*@G3`#`1UIG6[KH25#DHSAE MNN[M\MHX MCA`'2;!FZ_R!IM%_-@M'0]!`E$.P#"BG`Q*%DH;@&'(5@\)"XB&+H"@R8"D! MT:6"P%!130T(0N5&@:#F*`:`A5Q#%@$`YRO42-;G9XY"0SQ@XO$L M\3-^KB!\&J0)%[2>ZP#AJ2*KDQ="9,Y"M"\1%*5*.D!##V)5Z1N*5Z\;L!#G M(BTCS-'?`Q']AQ^=W80-GODB%E]?+40*8FCG'T%9WW.54+K;+*UVW2KA:ME8 M([Y99%:?E1K)I=Y`->3B[DXPPO?4EG5Z%X/AJHL-5M,J_6T:P&=6784.)!#0 M4&#)*WS MRIX@T.ZC@JR>64)D[F;-/8G`B;.*#M#0@U!5^H;BU>LM5P&%- MV,W"/]=1>:;&702MVUZA6"]?>J0T6Y MDAHJ+[[")*J*ARZV"G^[SPL:))NSE?9N&G;Y0N<>I43U*4L!!!YH1*I6HQL#MVM=[M*_W:%_D M/5JW]RY?[]&^J'NTQT'VP`__O]0E)_0:"A(?8ZM)2C#_<6SA.^84'3 M9R98S^&B3TT"V=8G?QTJT0#IP"Z'2U@(5 MTO6/S6D6JT_188OYZU5#S9$>QW.OT/!7]T.SRT7G[1_YTS]`ZSZ:46>09\3( M7\A9LPZVWQA1GP\W8#J*R68*LAF"]WBPX.*^UWXP.&]/\R!NG[=W\J)&7C23 M?.L(,Y9$TS?O:JCH_<6*KJY(_"#8-A.,[SU\>6@XWL20JEX6\F`\*L*`AFJJ M=04Y*Q^F%&=1$N7D(GHD@[=2AT['$=>O67@KNGXWM^?U M_L^])XQ]]"0@LLIGFV+^3!>$`S+A2,Q'1Z`G=\/15F=P/,%A5C$+K0*>)J%P M:"6EJ:PEIO'0UQAE5*X'>#2MXX_?C[[A^IJFT/EFSLM*4^AT_/::IM`UF%_3 M%*K2%#K-*_V:IO`U3>%.@-9*=23(&FZV:X[V M'DEZ1YV/]V;S>51.[*^"B$W_CX-5E`?]>;6"JI[;`52>XP.GG`Y,0(X^#,.N M21Y$"9G7Z3YF8;A>KHL3RR=D$871\!XZMD!S]UI9P'-(:*NL@PX,\]8:VXB# MM6X._M3*E'O;=,GD?R!)%CV2\BEK55,GY93)=U`H5=(!A8C9M,\0?(H2FA:3NG*BU@,$]+FRW>"S1V"P-6]6 MF&#;L^5A]1[FX;:C]E86+;>R6/D2<;X5<^]^+'BE8)2 M_>3JM);H\2J;K[=+Z_#A:&A+&?F-,C7A<'/2F[ME)O!`*VR.#ED5/BQX-]FH MCVB:TJ]\U:7?%<,4_83>+0H?<"`Y(JI6"G2YX&2HD)L/H=_+72J_9B8F$B>4 M=7X(&.=FE&HZGH88JIY)<./[7I9:T/URN@T"`#K_08!24!,'$$\Q%)P^@WF\ MSG*Z).D)6?&S,@`0%%3UV!"@\AP$..5T(`!R%`/@)[^&@,JAGW+(Y[O'K<8[ M/M`_3',:J1K3:IYJU#S-Z`663*8-&.6M3!Z`BEJ]RUC0>9EKJ#GOF5TNFHN7 M[I(.E3M^C5#`/%I!U=SH%U.YFPH&,+&H<"-P\_MIS;^NC,I4I_484B74]"[&I7MMGX$+$WI-BV^)4DK!>, M^2LT\V641%SH/'HDE1K]QEJK4-UVXPIY#00CQ?$`P;+W)?+;>BB:>$73[K?; M%):S&SGS;LSZSUL.!A**^PRB@\+F#5VN$[MN%K*:-B,\TH5VM M*JP#0T$T?9-`1$7O,W9TM44C"<'8AR.D]>D(\;`"^-I,;+M?G?D9[T2JTJGK M7R7C,I%=CV'+KY,\0=I)C?69YL*D6+\&4<*;Q\ND)N]A9R27S0L`1ERF@44[ M-C+`K''%XK5PIWO?/)%D5IS+*=4%3AJJR%KY-X5DTT`44DNC9@[B[.&>.*@1 M=K"#'>1,!!98/0UP(6$-[Y!/"J+HZX.>,B)?89PEIZXO-N5R8=3G,C5F"*)_9`02"QAEZDL,/29.GVG<^OX MAN)HK/&[$;--5<"P,U#!A]S)V[#5#GJG'?1*WV@HVG6,!X$Y6B'QVIWCO4JE M3E!6)9.BPHF6HNB+CYX1AMQM5.@)"F]K37`.=I72190+COX,/VP>_:@_^#P; M`>5'SQW:'*9]CX=A=P-Q@T4JX_+UCIAV>9^1-=8:^&-!^A75AY+?.=U0;M,LSQ( M^'+E49!%X2R9GT3Q.M]<]*J\/8I'94\S'CZCQX95T"@SK*Q&HT>#>-&R.1O3 M]40O5-/>9%'P0>^C0'Q\AJ,MZUC<#0$K%(^]#QV_W8R?/9C@=11'@XGI]#%L MPV*&:#:L&L#U9N'3^XO8Q\,DR,YN9+<>!"HE*7*P#>0#GPLQ*MWDD]0K[?85 M,X%D',GE\:$2L!&=LP\\^3$Y(>7?@.$L&-"0LB6LA5/Q(B"11`H]W/)9?6E.] MP^877/-\]^+35EXNJDR='JR/:CRBK%%FN!:*?EK9A1EN><,&Z=OYV%>L_.A# M*X!]_$RB%1CNJC?0NCQ]Z`<:F4IQ>3M$$[Y1,7N*!F]98&C[CA?2NL=!UZU4 M3SG`_P7/CJ/%O'SP>T^R$[H,HJ3G;RE-90HQC7O_2KU(<;H!;A:QYEX'6/K@ M[>/-^^*?R/*.I,,QGOC[\&GVZKLS#\L=1]6Z=+TJ9-=[DKUFXT,^2N`)<*%7 M4;3R-]:]][:.CDC/*UCZ<-6J\\2NT/<2"M$KQ=[[6:T/TKM"1CYD5Q),`:&V M6DX'S\:]]S)6-WP;#K'SH5>^)CD3E,Q/@S3ATV*AN^5$E3T`(G\=C=(*Z66( MEX>7[69AN%ZN8[[(`>TQBWMRW7*;5\>0Y?R%BJGNV-X>S]Z'O(SB-64A:#"D MFTQ\,*F_T-#0$(D&.4/''%0)XR9BQ$-BV_P3,E9;2<)JZS<[86 ML@>W6>%M`)!TN",P)/44JQKJ8?`G9V=^E-N?9M82=`;1_=+`8]1\R8V+:91T MWD+QK%$"QMZE(?1G07`Y^31(4,Y3^)DJ/F(B).+MPR+J:R)//R"Y@_2;8KS: MJMA>?C(/+E]U]C4W:QA,!?X:XR>2/]!^TAF=(J)-8ZB(IW@U4!>#1AQ;X`RO M3IXTKW+^=[1N]13I(+41@E($KA[E%#`E54X;2GUNP%51IPG,9$NHA?Q'04:* ML^\DR0K5-5:UY0P0Z]L``T^A--H48]>\H4H`X#D^MBP9LHY!'H8#9D[Q(K"G M88S1\PQ-]#D^A%G?[\]N*7!WRSU68-P,CI:HEXUZ/.0%)D8B-A<_EN MV$\:EY<>+9*5]Q1A8PV!@9I!'0#F#%8Q8K2]X>-\C(/<6?IIKH<8*4I<%#GQZM,$MR%+RF M]_(#U=LU(G)7>Q=)NM[O//G_M_R*C!QTR`=DQ'AI%P9<;7"$QO%0EBD5$C)O MLK87,"?S:N%AZ'D$\08-,F)_$8)7$8D:*4,?+FJT9>2K!T$2DLO%ER!E(\7! MJ@V.6``"`?$$0*!441<$(H9>//&SR3]K88QDA]G@I8.7-`*R:B(,"L=6V'[- MR-ZD;Q,/K6.&;`)[35;!85]A-,8$*-AH5M`D MI_W>&4K*!>]16.FR,$),Q>)%X$9H#OOHJ:MI,/2C$8@L=8B-Z(70LV1>]]A, M_AN2/D8AR2[3XSB(!E=;CSF+Z-7.??]1NXLW7_)); MC\'7_)*O^25?\TN^YI/YJKYDV/9A5(_=X+2#I\YF5( MZB[&2,ZEN4KI8S0G\Z/GWS+"!I?5A?GD?A;FT2/S&($L8,Z@CBY]!NY#2^9N M:L$HX",S@VJ+6#.HSH=D'JV;6E4+430?M_2:'YX-HY@?']SLL=_2<5#=577# MZWK;J;2%%3]%M&D[":#F$;9;P*.8\SIH+'4 MD[9UHF:"B[;]'&S%-+^>X?>B`D5;N4U.^TV@7L=Y0CK)`\8N#^9W;N.V M=*RVU8`II'[!S8%[;,%O`M+&]OG5$!<#N="`\E'\6AG3-3,:,1*)'T24` MC2(@P`5%G$';`&Y"D"K-T(4GOEHQT$35^3"W&DIZGCPRM6D:#2\)8&A!$+5I M)X\>6'&[L.G4X\-2DD"A(L]&D4TC%PX1=8K`?>RPR.1!I#2#72R)JO/A2:2A MI->$Z1&%Q57@[$$))S$Y"*4>^>1A)%7?+H3Z5?FP]03WM=6]*;ZF&88IFZE? M1,%=%!?#0O0P"<-$.7"2,ID\``U,M9W!E5P`'][]',I^S&8];$Z3GI!BPJT& M)E0`!.&@P.0!IS"!77`-*_/AF7&@>]],@#5&8D`A^5BL7VCRH$*88@OCL4&% M%;C>F=T0WV*7:M"!&G27+[%SW'%7.*A.O)3UCM\?G^#N!/[5=0Y0G:\$9F/.\2(8R-L[ M&8.IGN/%&\7*.5YI=3[,3Z_*O#/\N87R)'\Q2&5JL,#+GZ_B(,G9[)K?8%MQ MNGZ[95:Z;MPT2_O6`F*P1,<:"=5,2B0IFDE="0QN-'OURAFW$3YU-I*ZOO.N MH)XH2O6,8`.5RAK'O_/H%2C;>2]O@IA<+M@O\S6W#1&NWN`+"!*,`@4FBDYM M4UAI-A&5BC'J=*5P*/;?23R_I9^"?,W?HKXA(?][.%_6+PCB#BSX8O"'-,UV M<`A7+L:CTX3*>*6-YS7&\YFIXM'8-#;PJ%.Y&(\_373]IAI'G]&T'9,7-$C@ M`WEZA7I3(T6AB:+7R"0V)T*JB@W6DKP::@+6.8N2(`E'+"DA&,B;8!F#J2XI MX8UB94E)6IUOX\]-8MH+FMS?DI3-\NX&JTCH`M*'%#H%?&L9,2`!'UN0F`+5 M*DHJAQ]DZ%;JP]'E)DMV)H63BJRR'$@V4>@@U;8!&+@J^"[\"^]'C?M/XWYS MJC@U-HT-Y.I4/OF]YF_L+2M[/:_F6U?C>UW)6UB'^OO9/AS::6MW36+>EO-L M8L^*X1]$*H#>@/0%`$^AOFW8#:MK0.?RJ9'3Q8*$;%9T^A0^!,D]N69"7B9< MUUE2W$/@.Y6/0:YE@^G->L=7[L.: MMUA>U,/F)D5;6]/HHM[#<(0A]""G5]&TE[![2LY8%Y*FSRR"BJR>`BBJB5O@ MDQ!/`FYH9?4!)F-MGCUF5;[9D[,>_.4`Z_?OOBEH#=2U"ZX50PC?)6:CNFX* M%R.HG2:NUV1NUJM57!@DB&N#G"<+FBY+EP/9?O5*U>GCD*6\1Z"9^GI`1-?A M2VH5NB2WP1/)^*,QW'L-\_IMMCZD6B@?*U7 MZ.#AI\:[K4_3_1QX&O7Z,'KKO(ZV>>:5L>R\[%NQ4KT/]LO!P"@7[`?V MK?K"_[AC\S3VR_\#4$L#!!0````(`$1PL4`JY8]O"PD``%!'```1`!P`96UD M:"TR,#$R,#,S,2YXH?.; MQL1NJG9/UQM_?/SG/S[\TFPJMYCB"''L*=.5,HC_2SB+%9UR&("C.58>[A'U ME&Z[<]E6FDW!]IY%_A@,`M3AXI8C@CCUESCM"RB3C?G3%FK;2O!7T1F<8+Y:8E8T MMNP0'%?-=J>YT8"&E,9!\?@>CUJ"KP5$3:#"$7'7%@8B;T^+5*;WK:0S(_4P MR4D$;07"//M'C/DP!&MN3T^.$!,*2Y&ZVY:/0K_8-+*C4)I]=--UU+FZNFK) MW@8L;D41RQM1&G+$P8%D4]JX7!(Z"],6:!,\U]FJL/!,D:-<"R/?-!@)EKZ0 M6+8M).QB<3:S5??W,L)G(%M&(@0_8@/1W0(6!NXB)1MN)LZ&0)&;&R6G)0P2 M+G'$"9AIO:1;KZ:5B_Q3M0(6-_;?LE(>GIVJ%+`02MZP3CZ:GJH3L&#_NZHC MAG%``47\F%CZJ:$\D;,74A;ZQ!.[6A?Y(G38"XPY!&'BW30.=Z^ER>39H/@1 MMIMV&[9`Q0;_D[L6_.Z9AFT.];[J:'VEJPY5HZ]_+4^Z4Y!CGGB=59]Q=K<5\:6L&T8]%;FW+,8K`-@O, M"2A;@N"J^Q,4T/]`JC75F?FS%R*=!3$*_#6`W3'D3TO<5O;@3\C MS0!4S8%BCC5+=70@J!WXM5`U9]K7F/#5$4#7),>QO*B*I8!2^VNB.Y]K&%_1 M.7N(+09^^%3BFQNRXW"^.\DU>ZI]IPR&YGWMFB_!M(^9&Y&E$,2<=6-&*&9, MI9X=!P&*5N;,)G,*!V\74:ZZ;AA3#B.-`5^7X!3P;QSC^&JX3+;@/F&N'[(X MPN(?S>Y9^E@$9+$$NA-;-S3;5E0#5L=D-%*MSZ+=UF\-?:#W5/!\M=HU47".J"U&8D:WM=Z?E.'Z_O6OG\%-[$(1M76ZH-0H541@@ M$GU"?HQ'&`D[RJB:P%'<5>97YSE1`T@U'-6[U[K".8-5W.<*681*O8#>*IXP` M?;39P`YVE\2V=CZV]75[;":Q3>Y!DZZM]W75JC>B9(TUQU(;^/B.V8O3_OS&%?L^Q_I76H M&IGJ&9P(4X3&,/5>,?A`7PE"G7QJ#;F;"&&Z,='Z6S7?&J2*(&6U'QO/Q7ZO MTUD8!5*?!*@C_65@OT=(R@+@;_G,(,M::0[2>U6I'*)M]UJ1EV/.R46AFXL$!&Y->#!5SE' M.TIQ'+9V6F]-1]C^*3[Y2H93ML:K8?O6ZY,P`*LL,&7D$2=)7\E%2@'#<5#? MGW:E8H[&EG:G&;;^2J MRN=>S(592'YDKFA.>EQ#0\/J":;>QS%'>%]PQ]2R1QFL/8PAD=791/6C%4X:_QJ"] M]KBY8LJUEB%RE4-$E,+AU"M2=>U3?:]T`B06]E'RE1M?.1&B#+E;Q]^#O640 M_9:#R-*&,A\8JY;S67$LU;#57GT&/@6K88BHA5U,'L4M18+07EOIG5^N=#0T M50/`Z6GZ)W%I48-1$8Q[%(%#9#%L_5]I[>[W?0#N50NHY.D8?=IBGB80H(EG#04 MFGN&-4-L*K_"SYXC`7"=[%E,\H1K&+IRL%WH"QE;V.?KETW-S5!GS\Q+/^0_ M*HT8PCW[==P]$3:@&63:G/!8Z'4;A?$R(R5`TE`H\7TQ^$V#PPFI MH21]T^2%PTW#PU/"L]8EJ!QZCIPN@8,?U/A8R5`%B2+(*K>TK4:^K2FTB0OF MJGJB=)!,SV*]MS7TXN3FY["*W_2=JH.?>=>'G6O;"J\U8F*HY*7F-<_:OW%1 M_$#C%*V05QKPC:VAPKO&PK511OD&,"\4L0C+$L*WA='A:\8"U:H0ORWU[C&9 M+R#-4!\!B#G>JE\R,^8BRHND'/)KXH*[]8D?RTQFK?$+^7>,(*E_Y%*59X8^ M$5D-]@91&/2QN[X>69\LI'[EI#]7E>1K4^3+T8V0%SK7+2)4%*AWG?`4ON^9 M9;@1'/\*TXQ2[77&8C&(O,82"T^@-0@C"R_1*GGT!;KA,5IMZB=2_5,9OX/^ MWU'1Q/]>K&[&_G-7]FZ=JR#8'B)X6P%V5\JBO?T@Q<_?T[,B5X'U\UUOR^Z9 M?$46+^C[L;:6=9;DU`G__0]02P$"'@,4````"`!$<+%`A[)K_^D\``!,7@,` M$0`8```````!````I($`````96UD:"TR,#$R,#,S,2YX;6Q55`4``Q\]M4]U M>`L``00E#@``!#D!``!02P$"'@,4````"`!$<+%`21(4MWT+```JD@``%0`8 M```````!````I($T/0``96UD:"TR,#$R,#,S,5]C86PN>&UL550%``,?/;5/ M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`1'"Q0(24-*0V!P``05@``!4` M&````````0```*2!`$D``&5M9&@M,C`Q,C`S,S%?9&5F+GAM;%54!0`#'SVU M3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$1PL4`E.$6"=S\``*=4`P`5 M`!@```````$```"D@850``!E;61H+3(P,3(P,S,Q7VQA8BYX;6Q55`4``Q\] MM4]U>`L``00E#@``!#D!``!02P$"'@,4````"`!$<+%`-Z0+5\\@``#`$P(` M%0`8```````!````I(%+D```96UD:"TR,#$R,#,S,5]P&UL550%``,? M/;5/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`1'"Q0"KECV\+"0``4$<` M`!$`&````````0```*2!:;$``&5M9&@M,C`Q,C`S,S$N>'-D550%``,?/;5/ E=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``+^Z```````` ` end